id	sid	tid	token	lemma	pos
chd-221	1	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	VERB
chd-221	1	2	e1	e1	NOUN
chd-221	1	3	cancer	cancer	NOUN
chd-221	1	4	health	health	NOUN
chd-221	1	5	disparities	disparity	NOUN
chd-221	1	6	the	the	DET
chd-221	1	7	capci	capci	PROPN
chd-221	1	8	network	network	NOUN
chd-221	1	9	:	:	PUNCT
chd-221	1	10	a	a	DET
chd-221	1	11	cancer	cancer	NOUN
chd-221	1	12	prostate	prostate	NOUN
chd-221	1	13	consortium	consortium	NOUN
chd-221	1	14	of	of	ADP
chd-221	1	15	india	india	PROPN
chd-221	1	16	for	for	ADP
chd-221	1	17	conducting	conduct	VERB
chd-221	1	18	nextgeneration	nextgeneration	NOUN
chd-221	1	19	genomic	genomic	NOUN
chd-221	1	20	sequencing	sequence	VERB
chd-221	1	21	studies	study	NOUN
chd-221	1	22	devendra	devendra	PROPN
chd-221	1	23	sharma1	sharma1	PROPN
chd-221	1	24	+	+	PROPN
chd-221	1	25	,	,	PUNCT
chd-221	1	26	saloni	saloni	PROPN
chd-221	1	27	someshwar2	someshwar2	PROPN
chd-221	1	28	+	+	PROPN
chd-221	1	29	,	,	PUNCT
chd-221	1	30	bhumandeep	bhumandeep	NOUN
chd-221	1	31	kour3	kour3	PROPN
chd-221	2	1	+	+	PROPN
chd-221	2	2	,	,	PUNCT
chd-221	2	3	nidhi	nidhi	PROPN
chd-221	2	4	shukla2	shukla2	PROPN
chd-221	3	1	+	+	PROPN
chd-221	3	2	,	,	PUNCT
chd-221	3	3	barkha	barkha	ADJ
chd-221	3	4	khilwani4	khilwani4	PROPN
chd-221	3	5	+	+	PROPN
chd-221	3	6	,	,	PUNCT
chd-221	3	7	maneesh	maneesh	PROPN
chd-221	3	8	vijay5	vijay5	PROPN
chd-221	3	9	,	,	PUNCT
chd-221	3	10	ayam	ayam	NOUN
chd-221	3	11	gupta2	gupta2	PROPN
chd-221	3	12	,	,	PUNCT
chd-221	3	13	as	as	ADP
chd-221	3	14	ansari4	ansari4	NOUN
chd-221	3	15	,	,	PUNCT
chd-221	3	16	sugunakar	sugunakar	NOUN
chd-221	3	17	vuree3,20	vuree3,20	PROPN
chd-221	3	18	,	,	PUNCT
chd-221	3	19	ashok	ashok	PROPN
chd-221	3	20	kumar6	kumar6	PROPN
chd-221	3	21	,	,	PUNCT
chd-221	3	22	saurabh	saurabh	PROPN
chd-221	3	23	singh7	singh7	PROPN
chd-221	3	24	,	,	PUNCT
chd-221	3	25	amrit	amrit	PROPN
chd-221	3	26	ravi7	ravi7	PROPN
chd-221	3	27	,	,	PUNCT
chd-221	3	28	praveen	praveen	PROPN
chd-221	3	29	mathur8	mathur8	PROPN
chd-221	3	30	,	,	PUNCT
chd-221	3	31	ashwani	ashwani	PROPN
chd-221	3	32	kumar	kumar	PROPN
chd-221	3	33	mishra9	mishra9	PROPN
chd-221	3	34	,	,	PUNCT
chd-221	3	35	gopalakrishna	gopalakrishna	NOUN
chd-221	3	36	ramaswamy10	ramaswamy10	NOUN
chd-221	3	37	,	,	PUNCT
chd-221	3	38	renuka	renuka	PROPN
chd-221	3	39	suravajhala13	suravajhala13	PROPN
chd-221	3	40	,	,	PUNCT
chd-221	3	41	nripesh	nripesh	PROPN
chd-221	3	42	sadasukhi5	sadasukhi5	PROPN
chd-221	3	43	,	,	PUNCT
chd-221	3	44	jayaraman	jayaraman	NOUN
chd-221	3	45	valadi12,20	valadi12,20	NOUN
chd-221	3	46	,	,	PUNCT
chd-221	3	47	krishna	krishna	PROPN
chd-221	3	48	mohan	mohan	PROPN
chd-221	3	49	medicherla2	medicherla2	PROPN
chd-221	3	50	,	,	PUNCT
chd-221	3	51	geetha	geetha	PROPN
chd-221	3	52	kumar13	kumar13	PROPN
chd-221	3	53	,	,	PUNCT
chd-221	3	54	bipin	bipin	PROPN
chd-221	3	55	nair13	nair13	PROPN
chd-221	3	56	,	,	PUNCT
chd-221	3	57	rupert	rupert	NOUN
chd-221	3	58	ecker14	ecker14	NOUN
chd-221	3	59	,	,	PUNCT
chd-221	3	60	17	17	NUM
chd-221	3	61	,	,	PUNCT
chd-221	3	62	bhawana	bhawana	PROPN
chd-221	3	63	bissa11	bissa11	PROPN
chd-221	3	64	,	,	PUNCT
chd-221	3	65	tc	tc	ADV
chd-221	4	1	sadasukhi5	sadasukhi5	NOUN
chd-221	4	2	*	*	PROPN
chd-221	4	3	,	,	PUNCT
chd-221	4	4	nandita	nandita	PROPN
chd-221	4	5	mishra13	mishra13	PROPN
chd-221	4	6	,	,	PUNCT
chd-221	4	7	rune	rune	NOUN
chd-221	4	8	mathiesen15	mathiesen15	NOUN
chd-221	4	9	,	,	PUNCT
chd-221	4	10	keshav	keshav	PROPN
chd-221	4	11	k	k	PROPN
chd-221	4	12	singh16	singh16	PROPN
chd-221	4	13	,	,	PUNCT
chd-221	4	14	nirmal	nirmal	PROPN
chd-221	4	15	kumar	kumar	PROPN
chd-221	4	16	lohiya4	lohiya4	PROPN
chd-221	4	17	,	,	PUNCT
chd-221	4	18	jyotsna	jyotsna	PROPN
chd-221	4	19	batra17	batra17	PROPN
chd-221	4	20	,	,	PUNCT
chd-221	4	21	obul	obul	PROPN
chd-221	4	22	reddy	reddy	PROPN
chd-221	4	23	bandapalli18,19	bandapalli18,19	PROPN
chd-221	4	24	*	*	PROPN
chd-221	4	25	and	and	CCONJ
chd-221	4	26	prashanth	prashanth	ADJ
chd-221	4	27	suravajhala13,20	suravajhala13,20	PROPN
chd-221	4	28	*	*	X
chd-221	4	29	+	+	ADJ
chd-221	4	30	equal	equal	ADJ
chd-221	4	31	contributing	contribute	VERB
chd-221	4	32	authors	author	NOUN
chd-221	4	33	1	1	NUM
chd-221	4	34	urology	urology	NOUN
chd-221	4	35	and	and	CCONJ
chd-221	4	36	renal	renal	ADJ
chd-221	4	37	transplant	transplant	PROPN
chd-221	4	38	department	department	PROPN
chd-221	4	39	of	of	ADP
chd-221	4	40	renal	renal	PROPN
chd-221	4	41	sciences	sciences	PROPN
chd-221	4	42	,	,	PUNCT
chd-221	4	43	rukmani	rukmani	PROPN
chd-221	4	44	birla	birla	PROPN
chd-221	4	45	hospital	hospital	PROPN
chd-221	4	46	,	,	PUNCT
chd-221	4	47	jaipur	jaipur	PROPN
chd-221	4	48	,	,	PUNCT
chd-221	4	49	rajasthan	rajasthan	PROPN
chd-221	4	50	2	2	NUM
chd-221	4	51	department	department	NOUN
chd-221	4	52	of	of	ADP
chd-221	4	53	biotechnology	biotechnology	NOUN
chd-221	4	54	and	and	CCONJ
chd-221	4	55	bioinformatics	bioinformatics	NOUN
chd-221	4	56	,	,	PUNCT
chd-221	4	57	birla	birla	PROPN
chd-221	4	58	institute	institute	PROPN
chd-221	4	59	of	of	ADP
chd-221	4	60	scientific	scientific	ADJ
chd-221	4	61	research	research	NOUN
chd-221	4	62	,	,	PUNCT
chd-221	4	63	jaipur	jaipur	PROPN
chd-221	4	64	,	,	PUNCT
chd-221	4	65	rajasthan	rajasthan	PROPN
chd-221	4	66	3	3	NUM
chd-221	4	67	department	department	NOUN
chd-221	4	68	of	of	ADP
chd-221	4	69	biotechnology	biotechnology	NOUN
chd-221	4	70	,	,	PUNCT
chd-221	4	71	lovely	lovely	ADJ
chd-221	4	72	professional	professional	ADJ
chd-221	4	73	university	university	NOUN
chd-221	4	74	,	,	PUNCT
chd-221	4	75	jalandhar	jalandhar	PROPN
chd-221	4	76	,	,	PUNCT
chd-221	4	77	punjab	punjab	ADJ
chd-221	4	78	4	4	NUM
chd-221	4	79	department	department	NOUN
chd-221	4	80	of	of	ADP
chd-221	4	81	zoology	zoology	NOUN
chd-221	4	82	,	,	PUNCT
chd-221	4	83	university	university	NOUN
chd-221	4	84	of	of	ADP
chd-221	4	85	rajasthan	rajasthan	PROPN
chd-221	4	86	,	,	PUNCT
chd-221	4	87	jaipur	jaipur	PROPN
chd-221	4	88	,	,	PUNCT
chd-221	4	89	rajasthan	rajasthan	PROPN
chd-221	4	90	5	5	NUM
chd-221	4	91	mahatma	mahatma	PROPN
chd-221	4	92	gandhi	gandhi	PROPN
chd-221	4	93	university	university	PROPN
chd-221	4	94	of	of	ADP
chd-221	4	95	medical	medical	ADJ
chd-221	4	96	sciences	sciences	PROPN
chd-221	4	97	and	and	CCONJ
chd-221	4	98	technology	technology	NOUN
chd-221	4	99	,	,	PUNCT
chd-221	4	100	jaipur	jaipur	PROPN
chd-221	4	101	,	,	PUNCT
chd-221	4	102	rajasthan	rajasthan	PROPN
chd-221	4	103	6center	6center	NUM
chd-221	4	104	for	for	ADP
chd-221	4	105	systems	system	NOUN
chd-221	4	106	biology	biology	NOUN
chd-221	4	107	and	and	CCONJ
chd-221	4	108	bioinformatics	bioinformatics	NOUN
chd-221	4	109	,	,	PUNCT
chd-221	4	110	panjab	panjab	PROPN
chd-221	4	111	university	university	PROPN
chd-221	4	112	,	,	PUNCT
chd-221	4	113	chandigarh	chandigarh	VERB
chd-221	4	114	7	7	NUM
chd-221	4	115	brainpan.co	brainpan.co	NUM
chd-221	4	116	,	,	PUNCT
chd-221	4	117	gurugram	gurugram	PROPN
chd-221	4	118	,	,	PUNCT
chd-221	4	119	haryana	haryana	PROPN
chd-221	4	120	8	8	NUM
chd-221	4	121	department	department	NOUN
chd-221	4	122	of	of	ADP
chd-221	4	123	pediatrics	pediatric	NOUN
chd-221	4	124	,	,	PUNCT
chd-221	4	125	sms	sms	NOUN
chd-221	4	126	hospital	hospital	NOUN
chd-221	4	127	jaipur	jaipur	PROPN
chd-221	4	128	,	,	PUNCT
chd-221	4	129	rajasthan	rajasthan	PROPN
chd-221	4	130	9	9	NUM
chd-221	4	131	dna	dna	PROPN
chd-221	4	132	xperts	xperts	PROPN
chd-221	4	133	private	private	PROPN
chd-221	4	134	limited	limit	VERB
chd-221	4	135	,	,	PUNCT
chd-221	4	136	noida	noida	PROPN
chd-221	4	137	,	,	PUNCT
chd-221	4	138	up	up	ADV
chd-221	4	139	10theracues	10theracues	NUM
chd-221	4	140	innovations	innovation	NOUN
chd-221	4	141	private	private	ADJ
chd-221	4	142	limited	limited	ADJ
chd-221	4	143	,	,	PUNCT
chd-221	4	144	bangalore	bangalore	NOUN
chd-221	4	145	,	,	PUNCT
chd-221	4	146	karnataka	karnataka	PROPN
chd-221	4	147	11	11	NUM
chd-221	4	148	department	department	NOUN
chd-221	4	149	of	of	ADP
chd-221	4	150	biochemistry	biochemistry	NOUN
chd-221	4	151	,	,	PUNCT
chd-221	4	152	central	central	ADJ
chd-221	4	153	university	university	NOUN
chd-221	4	154	of	of	ADP
chd-221	4	155	rajasthan	rajasthan	PROPN
chd-221	4	156	,	,	PUNCT
chd-221	4	157	bandar	bandar	PROPN
chd-221	4	158	sindri	sindri	PROPN
chd-221	4	159	,	,	PUNCT
chd-221	4	160	ajmer	ajmer	PROPN
chd-221	4	161	,	,	PUNCT
chd-221	4	162	rajasthan	rajasthan	PROPN
chd-221	4	163	12school	12school	NUM
chd-221	4	164	of	of	ADP
chd-221	4	165	computing	computing	NOUN
chd-221	4	166	and	and	CCONJ
chd-221	4	167	data	datum	NOUN
chd-221	4	168	sciences	science	NOUN
chd-221	4	169	,	,	PUNCT
chd-221	4	170	,	,	PUNCT
chd-221	4	171	flame	flame	PROPN
chd-221	4	172	university	university	NOUN
chd-221	4	173	,	,	PUNCT
chd-221	4	174	pune	pune	PROPN
chd-221	4	175	,	,	PUNCT
chd-221	4	176	maharashtra	maharashtra	PROPN
chd-221	4	177	13	13	NUM
chd-221	4	178	amrita	amrita	PROPN
chd-221	4	179	school	school	NOUN
chd-221	4	180	of	of	ADP
chd-221	4	181	biotechnology	biotechnology	NOUN
chd-221	4	182	,	,	PUNCT
chd-221	4	183	amrita	amrita	PROPN
chd-221	4	184	vishwa	vishwa	PROPN
chd-221	4	185	vidyapeetham	vidyapeetham	PROPN
chd-221	4	186	,	,	PUNCT
chd-221	4	187	kollam	kollam	PROPN
chd-221	4	188	,	,	PUNCT
chd-221	4	189	kerala	kerala	PROPN
chd-221	4	190	14tissuegnostics	14tissuegnostics	NUM
chd-221	4	191	,	,	PUNCT
chd-221	4	192	vienna	vienna	PROPN
chd-221	4	193	,	,	PUNCT
chd-221	4	194	austria	austria	PROPN
chd-221	4	195	15	15	NUM
chd-221	4	196	inova4health	inova4health	PROPN
chd-221	4	197	,	,	PUNCT
chd-221	4	198	nova	nova	PROPN
chd-221	4	199	medical	medical	PROPN
chd-221	4	200	school	school	PROPN
chd-221	4	201	(	(	PUNCT
chd-221	4	202	nms	nms	PROPN
chd-221	4	203	)	)	PUNCT
chd-221	4	204	,	,	PUNCT
chd-221	4	205	faculdade	faculdade	PROPN
chd-221	4	206	de	de	PROPN
chd-221	4	207	ciências	ciências	PROPN
chd-221	4	208	médicas	médicas	PROPN
chd-221	4	209	(	(	PUNCT
chd-221	4	210	fcm	fcm	PROPN
chd-221	4	211	)	)	PUNCT
chd-221	4	212	,	,	PUNCT
chd-221	4	213	universidade	universidade	PROPN
chd-221	4	214	nova	nova	PROPN
chd-221	4	215	de	de	PROPN
chd-221	4	216	lisboa	lisboa	PROPN
chd-221	4	217	,	,	PUNCT
chd-221	4	218	1150	1150	NUM
chd-221	4	219	-	-	SYM
chd-221	4	220	082	082	NUM
chd-221	4	221	lisbon	lisbon	PROPN
chd-221	4	222	,	,	PUNCT
chd-221	4	223	portugal	portugal	PROPN
chd-221	4	224	16	16	NUM
chd-221	4	225	department	department	NOUN
chd-221	4	226	of	of	ADP
chd-221	4	227	genetics	genetics	PROPN
chd-221	4	228	,	,	PUNCT
chd-221	4	229	heersink	heersink	NOUN
chd-221	4	230	uab	uab	PROPN
chd-221	4	231	school	school	NOUN
chd-221	4	232	of	of	ADP
chd-221	4	233	medicine	medicine	NOUN
chd-221	4	234	,	,	PUNCT
chd-221	4	235	birmingham	birmingham	PROPN
chd-221	4	236	,	,	PUNCT
chd-221	4	237	usa	usa	PROPN
chd-221	4	238	17translational	17translational	PROPN
chd-221	4	239	research	research	PROPN
chd-221	4	240	institute	institute	PROPN
chd-221	4	241	,	,	PUNCT
chd-221	4	242	queensland	queensland	PROPN
chd-221	4	243	university	university	PROPN
chd-221	4	244	of	of	ADP
chd-221	4	245	technology	technology	PROPN
chd-221	4	246	,	,	PUNCT
chd-221	4	247	woolloongabba	woolloongabba	PROPN
chd-221	4	248	qld	qld	PROPN
chd-221	4	249	,	,	PUNCT
chd-221	4	250	australia	australia	PROPN
chd-221	4	251	translational	translational	PROPN
chd-221	4	252	research	research	PROPN
chd-221	4	253	institute	institute	PROPN
chd-221	4	254	,	,	PUNCT
chd-221	4	255	37	37	NUM
chd-221	4	256	kent	kent	PROPN
chd-221	4	257	street	street	PROPN
chd-221	4	258	,	,	PUNCT
chd-221	4	259	woolloongabba	woolloongabba	NOUN
chd-221	4	260	,	,	PUNCT
chd-221	4	261	qld	qld	PROPN
chd-221	4	262	4102	4102	NUM
chd-221	4	263	,	,	PUNCT
chd-221	4	264	australia	australia	PROPN
chd-221	4	265	18	18	NUM
chd-221	4	266	division	division	NOUN
chd-221	4	267	of	of	ADP
chd-221	4	268	molecular	molecular	ADJ
chd-221	4	269	genetic	genetic	ADJ
chd-221	4	270	epidemiology	epidemiology	NOUN
chd-221	4	271	,	,	PUNCT
chd-221	4	272	german	german	ADJ
chd-221	4	273	cancer	cancer	NOUN
chd-221	4	274	research	research	NOUN
chd-221	4	275	center	center	NOUN
chd-221	4	276	(	(	PUNCT
chd-221	4	277	dkfz	dkfz	PROPN
chd-221	4	278	)	)	PUNCT
chd-221	4	279	,	,	PUNCT
chd-221	4	280	heidelberg	heidelberg	PROPN
chd-221	4	281	,	,	PUNCT
chd-221	4	282	germany	germany	PROPN
chd-221	4	283	19	19	NUM
chd-221	4	284	division	division	NOUN
chd-221	4	285	of	of	ADP
chd-221	4	286	applied	apply	VERB
chd-221	4	287	biology	biology	NOUN
chd-221	4	288	,	,	PUNCT
chd-221	4	289	csir	csir	NOUN
chd-221	4	290	-	-	PUNCT
chd-221	4	291	iict	iict	PROPN
chd-221	4	292	,	,	PUNCT
chd-221	4	293	hyderabad	hyderabad	PROPN
chd-221	4	294	,	,	PUNCT
chd-221	4	295	india	india	PROPN
chd-221	4	296	20	20	NUM
chd-221	4	297	bioclues.org	bioclues.org	NUM
chd-221	4	298	,	,	PUNCT
chd-221	4	299	india	india	PROPN
chd-221	4	300	*	*	PUNCT
chd-221	4	301	corresponding	correspond	VERB
chd-221	4	302	authors:prash@bioclues.org	authors:prash@bioclues.org	PROPN
chd-221	4	303	,	,	PUNCT
chd-221	4	304	drsadasukhi@rediffmail.com	drsadasukhi@rediffmail.com	PROPN
chd-221	4	305	and	and	CCONJ
chd-221	4	306	bandapalli@gmail.com	bandapalli@gmail.com	PROPN
chd-221	4	307	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-221	4	308	e2	e2	PROPN
chd-221	4	309	cancer	cancer	NOUN
chd-221	4	310	health	health	NOUN
chd-221	4	311	disparities	disparity	NOUN
chd-221	4	312	abstract	abstract	VERB
chd-221	4	313	the	the	DET
chd-221	4	314	cancer	cancer	NOUN
chd-221	4	315	prostate	prostate	NOUN
chd-221	4	316	consortium	consortium	NOUN
chd-221	4	317	of	of	ADP
chd-221	4	318	india	india	PROPN
chd-221	4	319	(	(	PUNCT
chd-221	4	320	capci	capci	PROPN
chd-221	4	321	)	)	PUNCT
chd-221	4	322	was	be	AUX
chd-221	4	323	established	establish	VERB
chd-221	4	324	in	in	ADP
chd-221	4	325	september	september	PROPN
chd-221	4	326	2020	2020	NUM
chd-221	4	327	by	by	ADP
chd-221	4	328	a	a	DET
chd-221	4	329	group	group	NOUN
chd-221	4	330	of	of	ADP
chd-221	4	331	researchers	researcher	NOUN
chd-221	4	332	and	and	CCONJ
chd-221	4	333	clinicians	clinician	NOUN
chd-221	4	334	interested	interested	ADJ
chd-221	4	335	in	in	ADP
chd-221	4	336	identifying	identify	VERB
chd-221	4	337	inherited	inherit	VERB
chd-221	4	338	and	and	CCONJ
chd-221	4	339	somatic	somatic	ADJ
chd-221	4	340	risk	risk	NOUN
chd-221	4	341	factors	factor	NOUN
chd-221	4	342	that	that	PRON
chd-221	4	343	are	be	AUX
chd-221	4	344	related	relate	VERB
chd-221	4	345	to	to	ADP
chd-221	4	346	the	the	DET
chd-221	4	347	onset	onset	NOUN
chd-221	4	348	of	of	ADP
chd-221	4	349	prostate	prostate	NOUN
chd-221	4	350	cancer	cancer	NOUN
chd-221	4	351	(	(	PUNCT
chd-221	4	352	pca	pca	PROPN
chd-221	4	353	)	)	PUNCT
chd-221	4	354	.	.	PUNCT
chd-221	5	1	the	the	DET
chd-221	5	2	consortium	consortium	NOUN
chd-221	5	3	aims	aim	VERB
chd-221	5	4	to	to	PART
chd-221	5	5	improve	improve	VERB
chd-221	5	6	the	the	DET
chd-221	5	7	patient	patient	NOUN
chd-221	5	8	care	care	NOUN
chd-221	5	9	and	and	CCONJ
chd-221	5	10	treatment	treatment	NOUN
chd-221	5	11	in	in	ADP
chd-221	5	12	india	india	PROPN
chd-221	5	13	by	by	ADP
chd-221	5	14	exploring	explore	VERB
chd-221	5	15	and	and	CCONJ
chd-221	5	16	expanding	expand	VERB
chd-221	5	17	the	the	DET
chd-221	5	18	utility	utility	NOUN
chd-221	5	19	of	of	ADP
chd-221	5	20	genomic	genomic	ADJ
chd-221	5	21	repositories	repository	NOUN
chd-221	5	22	associated	associate	VERB
chd-221	5	23	with	with	ADP
chd-221	5	24	pca	pca	PROPN
chd-221	5	25	.	.	PUNCT
chd-221	6	1	these	these	DET
chd-221	6	2	aims	aim	NOUN
chd-221	6	3	are	be	AUX
chd-221	6	4	achieved	achieve	VERB
chd-221	6	5	by	by	ADP
chd-221	6	6	advancing	advance	VERB
chd-221	6	7	discovery	discovery	NOUN
chd-221	6	8	in	in	ADP
chd-221	6	9	genome	genome	NOUN
chd-221	6	10	science	science	NOUN
chd-221	6	11	particular	particular	ADJ
chd-221	6	12	to	to	ADP
chd-221	6	13	indian	indian	ADJ
chd-221	6	14	phenotypes	phenotype	NOUN
chd-221	6	15	,	,	PUNCT
chd-221	6	16	translating	translate	VERB
chd-221	6	17	scientific	scientific	ADJ
chd-221	6	18	discoveries	discovery	NOUN
chd-221	6	19	into	into	ADP
chd-221	6	20	improved	improved	ADJ
chd-221	6	21	standards	standard	NOUN
chd-221	6	22	of	of	ADP
chd-221	6	23	care	care	NOUN
chd-221	6	24	.	.	PUNCT
chd-221	7	1	one	one	NUM
chd-221	7	2	of	of	ADP
chd-221	7	3	the	the	DET
chd-221	7	4	vital	vital	ADJ
chd-221	7	5	goals	goal	NOUN
chd-221	7	6	of	of	ADP
chd-221	7	7	the	the	DET
chd-221	7	8	consortium	consortium	NOUN
chd-221	7	9	is	be	AUX
chd-221	7	10	to	to	PART
chd-221	7	11	combine	combine	VERB
chd-221	7	12	the	the	DET
chd-221	7	13	data	datum	NOUN
chd-221	7	14	from	from	ADP
chd-221	7	15	the	the	DET
chd-221	7	16	western	western	ADJ
chd-221	7	17	,	,	PUNCT
chd-221	7	18	european	european	ADJ
chd-221	7	19	and	and	CCONJ
chd-221	7	20	other	other	ADJ
chd-221	7	21	ancestries	ancestry	NOUN
chd-221	7	22	,	,	PUNCT
chd-221	7	23	and	and	CCONJ
chd-221	7	24	identify	identify	VERB
chd-221	7	25	common	common	ADJ
chd-221	7	26	and	and	CCONJ
chd-221	7	27	exclusive	exclusive	ADJ
chd-221	7	28	risk	risk	NOUN
chd-221	7	29	profiles	profile	NOUN
chd-221	7	30	associated	associate	VERB
chd-221	7	31	with	with	ADP
chd-221	7	32	pca	pca	PROPN
chd-221	7	33	in	in	ADP
chd-221	7	34	indian	indian	ADJ
chd-221	7	35	scenarios	scenario	NOUN
chd-221	7	36	.	.	PUNCT
chd-221	8	1	these	these	DET
chd-221	8	2	findings	finding	NOUN
chd-221	8	3	would	would	AUX
chd-221	8	4	additionally	additionally	ADV
chd-221	8	5	allow	allow	VERB
chd-221	8	6	us	we	PRON
chd-221	8	7	to	to	PART
chd-221	8	8	validate	validate	VERB
chd-221	8	9	them	they	PRON
chd-221	8	10	in	in	ADP
chd-221	8	11	experimental	experimental	ADJ
chd-221	8	12	settings	setting	NOUN
chd-221	8	13	to	to	PART
chd-221	8	14	explore	explore	VERB
chd-221	8	15	the	the	DET
chd-221	8	16	molecular	molecular	ADJ
chd-221	8	17	mechanisms	mechanism	NOUN
chd-221	8	18	underlying	underlie	VERB
chd-221	8	19	pathogenesis	pathogenesis	NOUN
chd-221	8	20	of	of	ADP
chd-221	8	21	pca	pca	PROPN
chd-221	8	22	besides	besides	SCONJ
chd-221	8	23	understanding	understand	VERB
chd-221	8	24	new	new	ADJ
chd-221	8	25	personalized	personalized	ADJ
chd-221	8	26	therapeutic	therapeutic	ADJ
chd-221	8	27	regimens	regimen	NOUN
chd-221	8	28	.	.	PUNCT
chd-221	9	1	keywords	keyword	NOUN
chd-221	9	2	:	:	PUNCT
chd-221	9	3	genomics	genomic	NOUN
chd-221	9	4	,	,	PUNCT
chd-221	9	5	consortium	consortium	NOUN
chd-221	9	6	,	,	PUNCT
chd-221	9	7	prostate	prostate	NOUN
chd-221	9	8	cancer	cancer	NOUN
chd-221	9	9	,	,	PUNCT
chd-221	9	10	genetic	genetic	ADJ
chd-221	9	11	variants	variant	NOUN
chd-221	9	12	,	,	PUNCT
chd-221	9	13	collaborative	collaborative	ADJ
chd-221	9	14	convergence	convergence	NOUN
chd-221	9	15	.	.	PUNCT
chd-221	10	1	citation	citation	NOUN
chd-221	10	2	:	:	PUNCT
chd-221	11	1	sharma	sharma	PROPN
chd-221	11	2	d	d	X
chd-221	11	3	et	et	PROPN
chd-221	11	4	al	al	PROPN
chd-221	11	5	(	(	PUNCT
chd-221	11	6	2023	2023	NUM
chd-221	11	7	)	)	PUNCT
chd-221	11	8	the	the	DET
chd-221	11	9	capci	capci	PROPN
chd-221	11	10	network	network	NOUN
chd-221	11	11	:	:	PUNCT
chd-221	11	12	a	a	DET
chd-221	11	13	cancer	cancer	NOUN
chd-221	11	14	prostate	prostate	NOUN
chd-221	11	15	consortium	consortium	NOUN
chd-221	11	16	of	of	ADP
chd-221	11	17	india	india	PROPN
chd-221	11	18	for	for	ADP
chd-221	11	19	conducting	conduct	VERB
chd-221	11	20	next	next	ADJ
chd-221	11	21	-	-	PUNCT
chd-221	11	22	generation	generation	NOUN
chd-221	11	23	genomic	genomic	ADJ
chd-221	11	24	sequencing	sequence	VERB
chd-221	11	25	studies	study	NOUN
chd-221	11	26	.	.	PUNCT
chd-221	12	1	cancer	cancer	NOUN
chd-221	12	2	health	health	NOUN
chd-221	12	3	disparities	disparity	NOUN
chd-221	12	4	7	7	NUM
chd-221	12	5	:	:	PUNCT
chd-221	12	6	e1	e1	NOUN
chd-221	12	7	-	-	PUNCT
chd-221	12	8	13	13	NUM
chd-221	12	9	.	.	PUNCT
chd-221	13	1	doi:10.9777	doi:10.9777	PROPN
chd-221	13	2	/	/	SYM
chd-221	13	3	chd.2023.1001	chd.2023.1001	PROPN
chd-221	13	4	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-221	13	5	e3	e3	NOUN
chd-221	13	6	cancer	cancer	NOUN
chd-221	13	7	health	health	NOUN
chd-221	13	8	disparities	disparity	NOUN
chd-221	13	9	introduction	introduction	VERB
chd-221	13	10	the	the	DET
chd-221	13	11	cancer	cancer	NOUN
chd-221	13	12	prostate	prostate	NOUN
chd-221	13	13	consortium	consortium	NOUN
chd-221	13	14	of	of	ADP
chd-221	13	15	india	india	PROPN
chd-221	13	16	(	(	PUNCT
chd-221	13	17	capci	capci	PROPN
chd-221	13	18	)	)	PUNCT
chd-221	13	19	network	network	NOUN
chd-221	13	20	is	be	AUX
chd-221	13	21	a	a	DET
chd-221	13	22	bioclues.org	bioclues.org	X
chd-221	13	23	and	and	CCONJ
chd-221	14	1	brainpan.co	brainpan.co	NUM
chd-221	14	2	supported	support	VERB
chd-221	14	3	consortium	consortium	NOUN
chd-221	14	4	of	of	ADP
chd-221	14	5	six	six	NUM
chd-221	14	6	institutions	institution	NOUN
chd-221	14	7	.	.	PUNCT
chd-221	15	1	the	the	DET
chd-221	15	2	network	network	NOUN
chd-221	15	3	was	be	AUX
chd-221	15	4	formed	form	VERB
chd-221	15	5	to	to	PART
chd-221	15	6	explore	explore	VERB
chd-221	15	7	the	the	DET
chd-221	15	8	utility	utility	NOUN
chd-221	15	9	of	of	ADP
chd-221	15	10	genomic	genomic	ADJ
chd-221	15	11	repositories	repository	NOUN
chd-221	15	12	associated	associate	VERB
chd-221	15	13	with	with	ADP
chd-221	15	14	prostate	prostate	NOUN
chd-221	15	15	cancer	cancer	NOUN
chd-221	15	16	(	(	PUNCT
chd-221	15	17	pca	pca	PROPN
chd-221	15	18	)	)	PUNCT
chd-221	15	19	for	for	ADP
chd-221	15	20	advancing	advance	VERB
chd-221	15	21	discovery	discovery	NOUN
chd-221	15	22	in	in	ADP
chd-221	15	23	genome	genome	NOUN
chd-221	15	24	science	science	NOUN
chd-221	15	25	particular	particular	ADJ
chd-221	15	26	to	to	ADP
chd-221	15	27	indian	indian	ADJ
chd-221	15	28	phenotypes	phenotype	NOUN
chd-221	15	29	,	,	PUNCT
chd-221	15	30	further	far	ADV
chd-221	15	31	translating	translate	VERB
chd-221	15	32	scientific	scientific	ADJ
chd-221	15	33	discoveries	discovery	NOUN
chd-221	15	34	to	to	PART
chd-221	15	35	improved	improve	VERB
chd-221	15	36	standards	standard	NOUN
chd-221	15	37	of	of	ADP
chd-221	15	38	care	care	NOUN
chd-221	15	39	.	.	PUNCT
chd-221	16	1	we	we	PRON
chd-221	16	2	strive	strive	VERB
chd-221	16	3	to	to	PART
chd-221	16	4	carry	carry	VERB
chd-221	16	5	out	out	ADP
chd-221	16	6	this	this	DET
chd-221	16	7	mission	mission	NOUN
chd-221	16	8	by	by	ADP
chd-221	16	9	ensuring	ensure	VERB
chd-221	16	10	efficient	efficient	ADJ
chd-221	16	11	sample	sample	NOUN
chd-221	16	12	collection	collection	NOUN
chd-221	16	13	,	,	PUNCT
chd-221	16	14	research	research	NOUN
chd-221	16	15	and	and	CCONJ
chd-221	16	16	development	development	NOUN
chd-221	16	17	besides	besides	SCONJ
chd-221	16	18	educating	educate	VERB
chd-221	16	19	the	the	DET
chd-221	16	20	stakeholders	stakeholder	NOUN
chd-221	16	21	to	to	PART
chd-221	16	22	address	address	VERB
chd-221	16	23	the	the	DET
chd-221	16	24	issues	issue	NOUN
chd-221	16	25	related	relate	VERB
chd-221	16	26	to	to	ADP
chd-221	16	27	social	social	ADJ
chd-221	16	28	stigma	stigma	NOUN
chd-221	16	29	associated	associate	VERB
chd-221	16	30	with	with	ADP
chd-221	16	31	pca	pca	PROPN
chd-221	16	32	.	.	PUNCT
chd-221	17	1	organization	organization	NOUN
chd-221	17	2	the	the	DET
chd-221	17	3	institutional	institutional	ADJ
chd-221	17	4	sites	site	NOUN
chd-221	17	5	,	,	PUNCT
chd-221	17	6	viz	viz	PROPN
chd-221	18	1	.	.	PUNCT
chd-221	18	2	amrita	amrita	PROPN
chd-221	18	3	school	school	PROPN
chd-221	18	4	of	of	ADP
chd-221	18	5	biotechnology	biotechnology	NOUN
chd-221	18	6	,	,	PUNCT
chd-221	18	7	amrita	amrita	PROPN
chd-221	18	8	university	university	PROPN
chd-221	18	9	,	,	PUNCT
chd-221	18	10	kollam	kollam	PROPN
chd-221	18	11	,	,	PUNCT
chd-221	18	12	birla	birla	PROPN
chd-221	18	13	institute	institute	PROPN
chd-221	18	14	of	of	ADP
chd-221	18	15	scientific	scientific	ADJ
chd-221	18	16	research	research	NOUN
chd-221	18	17	(	(	PUNCT
chd-221	18	18	bisr	bisr	NOUN
chd-221	18	19	)	)	PUNCT
chd-221	18	20	,	,	PUNCT
chd-221	18	21	jaipur	jaipur	PROPN
chd-221	18	22	,	,	PUNCT
chd-221	18	23	rukmani	rukmani	PROPN
chd-221	18	24	birla	birla	PROPN
chd-221	18	25	hospitals	hospital	NOUN
chd-221	18	26	(	(	PUNCT
chd-221	18	27	rbh	rbh	PROPN
chd-221	18	28	)	)	PUNCT
chd-221	18	29	,	,	PUNCT
chd-221	18	30	jaipur	jaipur	PROPN
chd-221	18	31	,	,	PUNCT
chd-221	18	32	mahatma	mahatma	PROPN
chd-221	18	33	gandhi	gandhi	PROPN
chd-221	18	34	university	university	PROPN
chd-221	18	35	of	of	ADP
chd-221	18	36	medical	medical	ADJ
chd-221	18	37	sciences	science	NOUN
chd-221	18	38	and	and	CCONJ
chd-221	18	39	technology	technology	NOUN
chd-221	18	40	(	(	PUNCT
chd-221	18	41	mgumst	mgumst	ADJ
chd-221	18	42	)	)	PUNCT
chd-221	18	43	,	,	PUNCT
chd-221	18	44	jaipur	jaipur	PROPN
chd-221	18	45	,	,	PUNCT
chd-221	18	46	university	university	NOUN
chd-221	18	47	of	of	ADP
chd-221	18	48	rajasthan	rajasthan	PROPN
chd-221	18	49	(	(	PUNCT
chd-221	18	50	uor	uor	NOUN
chd-221	18	51	)	)	PUNCT
chd-221	18	52	,	,	PUNCT
chd-221	18	53	jaipur	jaipur	PROPN
chd-221	18	54	,	,	PUNCT
chd-221	18	55	indian	indian	PROPN
chd-221	18	56	institute	institute	PROPN
chd-221	18	57	of	of	ADP
chd-221	18	58	chemical	chemical	PROPN
chd-221	18	59	technology	technology	NOUN
chd-221	18	60	(	(	PUNCT
chd-221	18	61	iict	iict	PROPN
chd-221	18	62	)	)	PUNCT
chd-221	18	63	,	,	PUNCT
chd-221	18	64	hyderabad	hyderabad	PROPN
chd-221	18	65	,	,	PUNCT
chd-221	18	66	sawai	sawai	PROPN
chd-221	18	67	man	man	PROPN
chd-221	18	68	singh	singh	PROPN
chd-221	18	69	(	(	PUNCT
chd-221	18	70	sms	sms	PROPN
chd-221	18	71	)	)	PUNCT
chd-221	18	72	hospital	hospital	NOUN
chd-221	18	73	,	,	PUNCT
chd-221	18	74	jaipur	jaipur	PROPN
chd-221	18	75	and	and	CCONJ
chd-221	18	76	queensland	queensland	PROPN
chd-221	18	77	university	university	PROPN
chd-221	18	78	of	of	ADP
chd-221	18	79	technology	technology	NOUN
chd-221	18	80	(	(	PUNCT
chd-221	18	81	qut	qut	PROPN
chd-221	18	82	)	)	PUNCT
chd-221	18	83	,	,	PUNCT
chd-221	18	84	brisbane	brisbane	NOUN
chd-221	18	85	,	,	PUNCT
chd-221	18	86	australia	australia	PROPN
chd-221	18	87	form	form	VERB
chd-221	18	88	academic	academic	ADJ
chd-221	18	89	partners	partner	NOUN
chd-221	18	90	while	while	SCONJ
chd-221	18	91	dna	dna	PROPN
chd-221	18	92	xperts	xperts	PROPN
chd-221	18	93	,	,	PUNCT
chd-221	18	94	noida	noida	PROPN
chd-221	18	95	.	.	PROPN
chd-221	18	96	,	,	PUNCT
chd-221	18	97	theracues	theracue	NOUN
chd-221	18	98	,	,	PUNCT
chd-221	18	99	bengaluru	bengaluru	PROPN
chd-221	18	100	and	and	CCONJ
chd-221	18	101	tissuegnostics	tissuegnostic	NOUN
chd-221	18	102	,	,	PUNCT
chd-221	18	103	austria	austria	PROPN
chd-221	18	104	form	form	VERB
chd-221	18	105	industrial	industrial	ADJ
chd-221	18	106	partners	partner	NOUN
chd-221	18	107	,	,	PUNCT
chd-221	18	108	supported	support	VERB
chd-221	18	109	by	by	ADP
chd-221	18	110	the	the	DET
chd-221	18	111	scientists	scientist	NOUN
chd-221	18	112	of	of	ADP
chd-221	18	113	these	these	DET
chd-221	18	114	network	network	NOUN
chd-221	18	115	groups	group	NOUN
chd-221	18	116	in	in	ADP
chd-221	18	117	the	the	DET
chd-221	18	118	areas	area	NOUN
chd-221	18	119	of	of	ADP
chd-221	18	120	genomics	genomic	NOUN
chd-221	18	121	,	,	PUNCT
chd-221	18	122	next	next	ADJ
chd-221	18	123	generation	generation	NOUN
chd-221	18	124	sequencing	sequence	VERB
chd-221	18	125	,	,	PUNCT
chd-221	18	126	clinical	clinical	ADJ
chd-221	18	127	research	research	NOUN
chd-221	18	128	,	,	PUNCT
chd-221	18	129	big	big	ADJ
chd-221	18	130	data	datum	NOUN
chd-221	18	131	and	and	CCONJ
chd-221	18	132	machine	machine	NOUN
chd-221	18	133	learning	learning	NOUN
chd-221	18	134	.	.	PUNCT
chd-221	19	1	bioclues.org	bioclues.org	X
chd-221	19	2	serves	serve	VERB
chd-221	19	3	as	as	ADP
chd-221	19	4	a	a	DET
chd-221	19	5	hub	hub	NOUN
chd-221	19	6	for	for	ADP
chd-221	19	7	bringing	bring	VERB
chd-221	19	8	together	together	ADV
chd-221	19	9	the	the	DET
chd-221	19	10	steering	steering	NOUN
chd-221	19	11	committee	committee	NOUN
chd-221	19	12	composed	compose	VERB
chd-221	19	13	of	of	ADP
chd-221	19	14	principal	principal	ADJ
chd-221	19	15	investigators	investigator	NOUN
chd-221	19	16	responsible	responsible	ADJ
chd-221	19	17	for	for	ADP
chd-221	19	18	accomplishing	accomplish	VERB
chd-221	19	19	goals	goal	NOUN
chd-221	19	20	for	for	ADP
chd-221	19	21	the	the	DET
chd-221	19	22	development	development	NOUN
chd-221	19	23	of	of	ADP
chd-221	19	24	these	these	DET
chd-221	19	25	scientific	scientific	ADJ
chd-221	19	26	panels	panel	NOUN
chd-221	19	27	.	.	PUNCT
chd-221	20	1	the	the	DET
chd-221	20	2	consortium	consortium	NOUN
chd-221	20	3	page	page	NOUN
chd-221	20	4	can	can	AUX
chd-221	20	5	be	be	AUX
chd-221	20	6	found	find	VERB
chd-221	20	7	at	at	ADP
chd-221	20	8	www.bioclues.org/capci	www.bioclues.org/capci	PROPN
chd-221	20	9	.	.	PUNCT
chd-221	21	1	current	current	ADJ
chd-221	21	2	progress	progress	NOUN
chd-221	21	3	and	and	CCONJ
chd-221	21	4	future	future	ADJ
chd-221	21	5	activities	activity	NOUN
chd-221	21	6	the	the	DET
chd-221	21	7	consortium	consortium	NOUN
chd-221	21	8	efforts	effort	NOUN
chd-221	21	9	began	begin	VERB
chd-221	21	10	in	in	ADP
chd-221	21	11	early	early	ADJ
chd-221	21	12	2020	2020	NUM
chd-221	21	13	with	with	ADP
chd-221	21	14	seed	seed	NOUN
chd-221	21	15	funding	funding	NOUN
chd-221	21	16	obtained	obtain	VERB
chd-221	21	17	from	from	ADP
chd-221	21	18	brainpan.co	brainpan.co	NUM
chd-221	21	19	in	in	ADP
chd-221	21	20	2018	2018	NUM
chd-221	21	21	.	.	PUNCT
chd-221	22	1	as	as	SCONJ
chd-221	22	2	the	the	DET
chd-221	22	3	collaborators	collaborator	NOUN
chd-221	22	4	converged	converge	VERB
chd-221	22	5	,	,	PUNCT
chd-221	22	6	there	there	PRON
chd-221	22	7	was	be	VERB
chd-221	22	8	a	a	DET
chd-221	22	9	need	need	NOUN
chd-221	22	10	to	to	PART
chd-221	22	11	bring	bring	VERB
chd-221	22	12	equivocal	equivocal	ADJ
chd-221	22	13	thoughts	thought	NOUN
chd-221	22	14	,	,	PUNCT
chd-221	22	15	action	action	NOUN
chd-221	22	16	and	and	CCONJ
chd-221	22	17	debate	debate	NOUN
chd-221	22	18	on	on	ADP
chd-221	22	19	the	the	DET
chd-221	22	20	emerging	emerge	VERB
chd-221	22	21	areas	area	NOUN
chd-221	22	22	of	of	ADP
chd-221	22	23	pca	pca	PROPN
chd-221	22	24	research	research	NOUN
chd-221	22	25	.	.	PUNCT
chd-221	23	1	the	the	DET
chd-221	23	2	consortium	consortium	ADJ
chd-221	23	3	sub	sub	NOUN
chd-221	23	4	-	-	NOUN
chd-221	23	5	network	network	NOUN
chd-221	23	6	got	get	VERB
chd-221	23	7	their	their	PRON
chd-221	23	8	first	first	ADJ
chd-221	23	9	publication	publication	NOUN
chd-221	23	10	in	in	ADP
chd-221	23	11	2020	2020	NUM
chd-221	23	12	in	in	ADP
chd-221	23	13	pca	pca	NOUN
chd-221	23	14	genomics	genomic	NOUN
chd-221	23	15	from	from	ADP
chd-221	23	16	their	their	PRON
chd-221	23	17	pilot	pilot	NOUN
chd-221	23	18	analysis	analysis	NOUN
chd-221	23	19	of	of	ADP
chd-221	23	20	sequencing	sequence	VERB
chd-221	23	21	(	(	PUNCT
chd-221	23	22	gupta	gupta	PROPN
chd-221	23	23	et	et	PROPN
chd-221	23	24	al	al	PROPN
chd-221	23	25	.	.	PROPN
chd-221	23	26	,	,	PUNCT
chd-221	23	27	2020	2020	NUM
chd-221	23	28	)	)	PUNCT
chd-221	23	29	.	.	PUNCT
chd-221	24	1	from	from	ADP
chd-221	24	2	the	the	DET
chd-221	24	3	first	first	ADJ
chd-221	24	4	few	few	ADJ
chd-221	24	5	meetings	meeting	NOUN
chd-221	24	6	that	that	PRON
chd-221	24	7	were	be	AUX
chd-221	24	8	setup	setup	NOUN
chd-221	24	9	,	,	PUNCT
chd-221	24	10	the	the	DET
chd-221	24	11	network	network	NOUN
chd-221	24	12	peers	peer	NOUN
chd-221	24	13	discussed	discuss	VERB
chd-221	24	14	the	the	DET
chd-221	24	15	need	need	NOUN
chd-221	24	16	for	for	ADP
chd-221	24	17	bringing	bring	VERB
chd-221	24	18	india	india	PROPN
chd-221	24	19	specific	specific	ADJ
chd-221	24	20	phenotypes	phenotype	NOUN
chd-221	24	21	for	for	ADP
chd-221	24	22	which	which	PRON
chd-221	24	23	samples	sample	NOUN
chd-221	24	24	would	would	AUX
chd-221	24	25	steadfastly	steadfastly	ADV
chd-221	24	26	be	be	AUX
chd-221	24	27	used	use	VERB
chd-221	24	28	for	for	ADP
chd-221	24	29	sequencing	sequence	VERB
chd-221	24	30	,	,	PUNCT
chd-221	24	31	genotyping	genotyping	NOUN
chd-221	24	32	that	that	PRON
chd-221	24	33	are	be	AUX
chd-221	24	34	largely	largely	ADV
chd-221	24	35	focused	focus	VERB
chd-221	24	36	in	in	ADP
chd-221	24	37	the	the	DET
chd-221	24	38	areas	area	NOUN
chd-221	24	39	of	of	ADP
chd-221	24	40	indolent	indolent	ADJ
chd-221	24	41	tumors	tumor	NOUN
chd-221	24	42	,	,	PUNCT
chd-221	24	43	benign	benign	ADJ
chd-221	24	44	prostatic	prostatic	ADJ
chd-221	24	45	hyperplasia	hyperplasia	NOUN
chd-221	24	46	(	(	PUNCT
chd-221	24	47	bph	bph	NOUN
chd-221	24	48	)	)	PUNCT
chd-221	24	49	,	,	PUNCT
chd-221	24	50	malignant	malignant	ADJ
chd-221	24	51	and	and	CCONJ
chd-221	24	52	radical	radical	ADJ
chd-221	24	53	prostatectomy	prostatectomy	NOUN
chd-221	24	54	.	.	PUNCT
chd-221	25	1	we	we	PRON
chd-221	25	2	agreed	agree	VERB
chd-221	25	3	to	to	PART
chd-221	25	4	come	come	VERB
chd-221	25	5	up	up	ADP
chd-221	25	6	and	and	CCONJ
chd-221	25	7	emerge	emerge	VERB
chd-221	25	8	as	as	ADP
chd-221	25	9	a	a	DET
chd-221	25	10	consortium	consortium	NOUN
chd-221	25	11	of	of	ADP
chd-221	25	12	cross	cross	ADJ
chd-221	25	13	-	-	ADJ
chd-221	25	14	network	network	ADJ
chd-221	25	15	initiatives	initiative	NOUN
chd-221	25	16	through	through	ADP
chd-221	25	17	a	a	DET
chd-221	25	18	community	community	NOUN
chd-221	25	19	consultation	consultation	NOUN
chd-221	25	20	.	.	PUNCT
chd-221	26	1	we	we	PRON
chd-221	26	2	further	far	ADV
chd-221	26	3	discussed	discuss	VERB
chd-221	26	4	expanding	expand	VERB
chd-221	26	5	the	the	DET
chd-221	26	6	network	network	NOUN
chd-221	26	7	of	of	ADP
chd-221	26	8	all	all	DET
chd-221	26	9	regions	region	NOUN
chd-221	26	10	and	and	CCONJ
chd-221	26	11	states	state	NOUN
chd-221	26	12	in	in	ADP
chd-221	26	13	india	india	PROPN
chd-221	26	14	by	by	ADP
chd-221	26	15	maintaining	maintain	VERB
chd-221	26	16	the	the	DET
chd-221	26	17	diversity	diversity	NOUN
chd-221	26	18	of	of	ADP
chd-221	26	19	pca	pca	PROPN
chd-221	26	20	phenotypes	phenotype	NOUN
chd-221	26	21	(	(	PUNCT
chd-221	26	22	figure1	figure1	PROPN
chd-221	26	23	)	)	PUNCT
chd-221	26	24	.	.	PUNCT
chd-221	27	1	currently	currently	ADV
chd-221	27	2	,	,	PUNCT
chd-221	27	3	over	over	ADP
chd-221	27	4	30	30	NUM
chd-221	27	5	scientists	scientist	NOUN
chd-221	27	6	and	and	CCONJ
chd-221	27	7	clinicians	clinician	NOUN
chd-221	27	8	are	be	AUX
chd-221	27	9	a	a	DET
chd-221	27	10	part	part	NOUN
chd-221	27	11	of	of	ADP
chd-221	27	12	this	this	DET
chd-221	27	13	cohesive	cohesive	ADJ
chd-221	27	14	group	group	NOUN
chd-221	27	15	as	as	SCONJ
chd-221	27	16	we	we	PRON
chd-221	27	17	convene	convene	VERB
chd-221	27	18	four	four	NUM
chd-221	27	19	times	time	NOUN
chd-221	27	20	a	a	DET
chd-221	27	21	year	year	NOUN
chd-221	27	22	.	.	PUNCT
chd-221	28	1	over	over	ADP
chd-221	28	2	the	the	DET
chd-221	28	3	last	last	ADJ
chd-221	28	4	few	few	ADJ
chd-221	28	5	years	year	NOUN
chd-221	28	6	,	,	PUNCT
chd-221	28	7	diminutive	diminutive	ADJ
chd-221	28	8	knowledge	knowledge	NOUN
chd-221	28	9	about	about	ADP
chd-221	28	10	the	the	DET
chd-221	28	11	etiology	etiology	NOUN
chd-221	28	12	of	of	ADP
chd-221	28	13	pca	pca	PROPN
chd-221	28	14	has	have	AUX
chd-221	28	15	largely	largely	ADV
chd-221	28	16	been	be	AUX
chd-221	28	17	known	know	VERB
chd-221	28	18	.	.	PUNCT
chd-221	29	1	the	the	DET
chd-221	29	2	patient	patient	ADJ
chd-221	29	3	risk	risk	NOUN
chd-221	29	4	group	group	NOUN
chd-221	29	5	is	be	AUX
chd-221	29	6	clearly	clearly	ADV
chd-221	29	7	articulated	articulate	VERB
chd-221	29	8	largely	largely	ADV
chd-221	29	9	for	for	ADP
chd-221	29	10	elderly	elderly	ADJ
chd-221	29	11	men	man	NOUN
chd-221	29	12	,	,	PUNCT
chd-221	29	13	albeit	albeit	SCONJ
chd-221	29	14	consequently	consequently	ADV
chd-221	29	15	majority	majority	NOUN
chd-221	29	16	of	of	ADP
chd-221	29	17	therapies	therapy	NOUN
chd-221	29	18	and	and	CCONJ
chd-221	29	19	aetiological	aetiological	ADJ
chd-221	29	20	disquisitions	disquisition	NOUN
chd-221	29	21	have	have	AUX
chd-221	29	22	centered	center	VERB
chd-221	29	23	on	on	ADP
chd-221	29	24	male	male	ADJ
chd-221	29	25	sex	sex	NOUN
chd-221	29	26	hormones	hormone	NOUN
chd-221	29	27	(	(	PUNCT
chd-221	29	28	patel	patel	PROPN
chd-221	29	29	&	&	CCONJ
chd-221	29	30	klein	klein	PROPN
chd-221	29	31	,	,	PUNCT
chd-221	29	32	2009	2009	NUM
chd-221	29	33	)	)	PUNCT
chd-221	29	34	.	.	PUNCT
chd-221	30	1	after	after	ADP
chd-221	30	2	an	an	DET
chd-221	30	3	initial	initial	ADJ
chd-221	30	4	positive	positive	ADJ
chd-221	30	5	response	response	NOUN
chd-221	30	6	to	to	ADP
chd-221	30	7	these	these	DET
chd-221	30	8	treatments	treatment	NOUN
chd-221	30	9	,	,	PUNCT
chd-221	30	10	pca	pca	PROPN
chd-221	30	11	eventually	eventually	ADV
chd-221	30	12	progresses	progress	VERB
chd-221	30	13	to	to	ADP
chd-221	30	14	a	a	DET
chd-221	30	15	more	more	ADV
chd-221	30	16	resistant	resistant	ADJ
chd-221	30	17	and	and	CCONJ
chd-221	30	18	androgen	androgen	NOUN
chd-221	30	19	independent	independent	ADJ
chd-221	30	20	form	form	NOUN
chd-221	30	21	,	,	PUNCT
chd-221	30	22	which	which	PRON
chd-221	30	23	is	be	AUX
chd-221	30	24	usually	usually	ADV
chd-221	30	25	untreatable	untreatable	ADJ
chd-221	30	26	and	and	CCONJ
chd-221	30	27	lethal	lethal	ADJ
chd-221	30	28	within	within	ADP
chd-221	30	29	2	2	NUM
chd-221	30	30	years	year	NOUN
chd-221	30	31	of	of	ADP
chd-221	30	32	recurrence	recurrence	NOUN
chd-221	30	33	on	on	ADP
chd-221	30	34	average	average	ADJ
chd-221	30	35	.	.	PUNCT
chd-221	31	1	india	india	PROPN
chd-221	31	2	has	have	AUX
chd-221	31	3	largely	largely	ADV
chd-221	31	4	seen	see	VERB
chd-221	31	5	a	a	DET
chd-221	31	6	steep	steep	ADJ
chd-221	31	7	increase	increase	NOUN
chd-221	31	8	in	in	ADP
chd-221	31	9	incidence	incidence	NOUN
chd-221	31	10	of	of	ADP
chd-221	31	11	pca	pca	NOUN
chd-221	31	12	and	and	CCONJ
chd-221	31	13	palliative	palliative	ADJ
chd-221	31	14	care	care	NOUN
chd-221	31	15	during	during	ADP
chd-221	31	16	the	the	DET
chd-221	31	17	past	past	ADJ
chd-221	31	18	two	two	NUM
chd-221	31	19	decades	decade	NOUN
chd-221	31	20	(	(	PUNCT
chd-221	31	21	vlachostergios	vlachostergio	NOUN
chd-221	31	22	et	et	PROPN
chd-221	31	23	al	al	PROPN
chd-221	31	24	.	.	PROPN
chd-221	31	25	,	,	PUNCT
chd-221	31	26	2017	2017	NUM
chd-221	31	27	)	)	PUNCT
chd-221	31	28	.	.	PUNCT
chd-221	32	1	the	the	DET
chd-221	32	2	population	population	NOUN
chd-221	32	3	based	base	VERB
chd-221	32	4	cancer	cancer	NOUN
chd-221	32	5	registry	registry	NOUN
chd-221	32	6	for	for	ADP
chd-221	32	7	2020	2020	NUM
chd-221	32	8	shows	show	VERB
chd-221	32	9	ca	ca	NOUN
chd-221	32	10	.	.	PROPN
chd-221	33	1	48,000	48,000	NUM
chd-221	33	2	casualties	casualty	NOUN
chd-221	33	3	and	and	CCONJ
chd-221	33	4	as	as	ADV
chd-221	33	5	many	many	ADJ
chd-221	33	6	http://www.bioclues.org/capci	http://www.bioclues.org/capci	PROPN
chd-221	33	7	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-221	33	8	e4	e4	PROPN
chd-221	33	9	cancer	cancer	NOUN
chd-221	33	10	health	health	NOUN
chd-221	33	11	disparities	disparity	NOUN
chd-221	33	12	as	as	ADP
chd-221	33	13	a	a	DET
chd-221	33	14	million	million	NUM
chd-221	33	15	cases	case	NOUN
chd-221	33	16	pan	pan	NOUN
chd-221	33	17	-	-	ADJ
chd-221	33	18	india	india	ADJ
chd-221	33	19	(	(	PUNCT
chd-221	33	20	global	global	ADJ
chd-221	33	21	cancer	cancer	NOUN
chd-221	33	22	observatory	observatory	NOUN
chd-221	33	23	,	,	PUNCT
chd-221	33	24	n.d	n.d	PROPN
chd-221	33	25	.	.	PROPN
chd-221	33	26	)	)	PUNCT
chd-221	33	27	..	..	PUNCT
chd-221	34	1	given	give	VERB
chd-221	34	2	the	the	DET
chd-221	34	3	paradigm	paradigm	NOUN
chd-221	34	4	shifts	shift	NOUN
chd-221	34	5	in	in	ADP
chd-221	34	6	incidence	incidence	NOUN
chd-221	34	7	and	and	CCONJ
chd-221	34	8	casualties	casualty	NOUN
chd-221	34	9	,	,	PUNCT
chd-221	34	10	multi	multi	ADJ
chd-221	34	11	-	-	ADJ
chd-221	34	12	centric	centric	ADJ
chd-221	34	13	collaborative	collaborative	ADJ
chd-221	34	14	efforts	effort	NOUN
chd-221	34	15	are	be	AUX
chd-221	34	16	required	require	VERB
chd-221	34	17	to	to	PART
chd-221	34	18	bring	bring	VERB
chd-221	34	19	about	about	ADP
chd-221	34	20	a	a	DET
chd-221	34	21	change	change	NOUN
chd-221	34	22	in	in	ADP
chd-221	34	23	patient	patient	ADJ
chd-221	34	24	detection	detection	NOUN
chd-221	34	25	,	,	PUNCT
chd-221	34	26	treatment	treatment	NOUN
chd-221	34	27	,	,	PUNCT
chd-221	34	28	and	and	CCONJ
chd-221	34	29	care	care	NOUN
chd-221	34	30	,	,	PUNCT
chd-221	34	31	and	and	CCONJ
chd-221	34	32	this	this	PRON
chd-221	34	33	is	be	AUX
chd-221	34	34	where	where	SCONJ
chd-221	34	35	we	we	PRON
chd-221	34	36	believe	believe	VERB
chd-221	34	37	the	the	DET
chd-221	34	38	capci	capci	NOUN
chd-221	34	39	add	add	VERB
chd-221	34	40	values	value	NOUN
chd-221	34	41	.	.	PUNCT
chd-221	35	1	indian	indian	ADJ
chd-221	35	2	context	context	NOUN
chd-221	35	3	of	of	ADP
chd-221	35	4	human	human	ADJ
chd-221	35	5	genome	genome	NOUN
chd-221	35	6	project	project	NOUN
chd-221	35	7	the	the	DET
chd-221	35	8	human	human	ADJ
chd-221	35	9	genome	genome	NOUN
chd-221	35	10	project	project	NOUN
chd-221	35	11	(	(	PUNCT
chd-221	35	12	hgp	hgp	PROPN
chd-221	35	13	)	)	PUNCT
chd-221	35	14	is	be	AUX
chd-221	35	15	one	one	NUM
chd-221	35	16	of	of	ADP
chd-221	35	17	the	the	DET
chd-221	35	18	significant	significant	ADJ
chd-221	35	19	projects	project	NOUN
chd-221	35	20	in	in	ADP
chd-221	35	21	biological	biological	ADJ
chd-221	35	22	sciences	science	NOUN
chd-221	35	23	and	and	CCONJ
chd-221	35	24	clinical	clinical	ADJ
chd-221	35	25	medicine	medicine	NOUN
chd-221	35	26	with	with	ADP
chd-221	35	27	a	a	DET
chd-221	35	28	major	major	ADJ
chd-221	35	29	impact	impact	NOUN
chd-221	35	30	on	on	ADP
chd-221	35	31	clinical	clinical	ADJ
chd-221	35	32	medicine	medicine	NOUN
chd-221	35	33	in	in	ADP
chd-221	35	34	understanding	understand	VERB
chd-221	35	35	the	the	DET
chd-221	35	36	molecular	molecular	ADJ
chd-221	35	37	and	and	CCONJ
chd-221	35	38	biochemical	biochemical	ADJ
chd-221	35	39	interactions	interaction	NOUN
chd-221	35	40	of	of	ADP
chd-221	35	41	every	every	DET
chd-221	35	42	individual	individual	ADJ
chd-221	35	43	(	(	PUNCT
chd-221	35	44	emmert	emmert	NOUN
chd-221	35	45	-	-	PUNCT
chd-221	35	46	streib	streib	PROPN
chd-221	35	47	et	et	PROPN
chd-221	35	48	al	al	PROPN
chd-221	35	49	.	.	PROPN
chd-221	35	50	,	,	PUNCT
chd-221	35	51	2017	2017	NUM
chd-221	35	52	)	)	PUNCT
chd-221	35	53	.	.	PUNCT
chd-221	36	1	in	in	ADP
chd-221	36	2	particular	particular	ADJ
chd-221	36	3	,	,	PUNCT
chd-221	36	4	it	it	PRON
chd-221	36	5	has	have	AUX
chd-221	36	6	given	give	VERB
chd-221	36	7	us	we	PRON
chd-221	36	8	an	an	DET
chd-221	36	9	impetus	impetus	NOUN
chd-221	36	10	to	to	PART
chd-221	36	11	understand	understand	VERB
chd-221	36	12	the	the	DET
chd-221	36	13	diversity	diversity	NOUN
chd-221	36	14	as	as	SCONJ
chd-221	36	15	reflected	reflect	VERB
chd-221	36	16	by	by	ADP
chd-221	36	17	the	the	DET
chd-221	36	18	various	various	ADJ
chd-221	36	19	polymorphisms	polymorphism	NOUN
chd-221	36	20	occurring	occur	VERB
chd-221	36	21	in	in	ADP
chd-221	36	22	genes	gene	NOUN
chd-221	36	23	of	of	ADP
chd-221	36	24	our	our	PRON
chd-221	36	25	genome	genome	NOUN
chd-221	36	26	.	.	PUNCT
chd-221	37	1	the	the	DET
chd-221	37	2	chance	chance	NOUN
chd-221	37	3	of	of	ADP
chd-221	37	4	acquiring	acquire	VERB
chd-221	37	5	a	a	DET
chd-221	37	6	polymorphism	polymorphism	NOUN
chd-221	37	7	is	be	AUX
chd-221	37	8	one	one	NUM
chd-221	37	9	in	in	ADP
chd-221	37	10	1000	1000	NUM
chd-221	37	11	/	/	SYM
chd-221	37	12	base	base	NOUN
chd-221	37	13	pairs	pair	NOUN
chd-221	37	14	in	in	ADP
chd-221	37	15	the	the	DET
chd-221	37	16	genome	genome	NOUN
chd-221	37	17	,	,	PUNCT
chd-221	37	18	single	single	ADJ
chd-221	37	19	nucleotide	nucleotide	ADJ
chd-221	37	20	polymorphisms	polymorphism	NOUN
chd-221	37	21	(	(	PUNCT
chd-221	37	22	snps	snps	PROPN
chd-221	37	23	)	)	PUNCT
chd-221	37	24	being	be	AUX
chd-221	37	25	the	the	DET
chd-221	37	26	most	most	ADV
chd-221	37	27	common	common	ADJ
chd-221	37	28	.	.	PUNCT
chd-221	38	1	on	on	ADP
chd-221	38	2	an	an	DET
chd-221	38	3	average	average	ADJ
chd-221	38	4	,	,	PUNCT
chd-221	38	5	4	4	NUM
chd-221	38	6	to	to	PART
chd-221	38	7	8	8	NUM
chd-221	38	8	snps	snps	NOUN
chd-221	38	9	can	can	AUX
chd-221	38	10	be	be	AUX
chd-221	38	11	located	locate	VERB
chd-221	38	12	in	in	ADP
chd-221	38	13	any	any	DET
chd-221	38	14	gene	gene	NOUN
chd-221	38	15	whether	whether	SCONJ
chd-221	38	16	it	it	PRON
chd-221	38	17	is	be	AUX
chd-221	38	18	in	in	ADP
chd-221	38	19	the	the	DET
chd-221	38	20	exonic	exonic	ADJ
chd-221	38	21	region	region	NOUN
chd-221	38	22	or	or	CCONJ
chd-221	38	23	in	in	ADP
chd-221	38	24	the	the	DET
chd-221	38	25	exon	exon	NOUN
chd-221	38	26	-	-	PUNCT
chd-221	38	27	intron	intron	NOUN
chd-221	38	28	boundary	boundary	NOUN
chd-221	38	29	.	.	PUNCT
chd-221	39	1	these	these	DET
chd-221	39	2	snps	snps	PROPN
chd-221	39	3	are	be	AUX
chd-221	39	4	now	now	ADV
chd-221	39	5	used	use	VERB
chd-221	39	6	to	to	PART
chd-221	39	7	target	target	VERB
chd-221	39	8	and	and	CCONJ
chd-221	39	9	track	track	VERB
chd-221	39	10	the	the	DET
chd-221	39	11	gene	gene	NOUN
chd-221	39	12	of	of	ADP
chd-221	39	13	interest	interest	NOUN
chd-221	39	14	through	through	ADP
chd-221	39	15	whole	whole	ADJ
chd-221	39	16	genome	genome	NOUN
chd-221	39	17	studies	study	NOUN
chd-221	39	18	.	.	PUNCT
chd-221	40	1	this	this	PRON
chd-221	40	2	has	have	AUX
chd-221	40	3	led	lead	VERB
chd-221	40	4	us	we	PRON
chd-221	40	5	to	to	PART
chd-221	40	6	understand	understand	VERB
chd-221	40	7	how	how	SCONJ
chd-221	40	8	altered	altered	ADJ
chd-221	40	9	gene	gene	NOUN
chd-221	40	10	expression	expression	NOUN
chd-221	40	11	and	and	CCONJ
chd-221	40	12	its	its	PRON
chd-221	40	13	altered	altered	ADJ
chd-221	40	14	regulation	regulation	NOUN
chd-221	40	15	play	play	VERB
chd-221	40	16	a	a	DET
chd-221	40	17	role	role	NOUN
chd-221	40	18	in	in	ADP
chd-221	40	19	disease	disease	NOUN
chd-221	40	20	manifestation	manifestation	NOUN
chd-221	40	21	.	.	PUNCT
chd-221	41	1	such	such	DET
chd-221	41	2	a	a	DET
chd-221	41	3	molecular	molecular	ADJ
chd-221	41	4	level	level	NOUN
chd-221	41	5	of	of	ADP
chd-221	41	6	understanding	understanding	NOUN
chd-221	41	7	makes	make	VERB
chd-221	41	8	it	it	PRON
chd-221	41	9	possible	possible	ADJ
chd-221	41	10	for	for	ADP
chd-221	41	11	us	we	PRON
chd-221	41	12	in	in	ADP
chd-221	41	13	present	present	ADJ
chd-221	41	14	times	time	NOUN
chd-221	41	15	to	to	PART
chd-221	41	16	design	design	VERB
chd-221	41	17	potential	potential	ADJ
chd-221	41	18	therapies	therapy	NOUN
chd-221	41	19	for	for	ADP
chd-221	41	20	different	different	ADJ
chd-221	41	21	ailments	ailment	NOUN
chd-221	41	22	and	and	CCONJ
chd-221	41	23	their	their	PRON
chd-221	41	24	classifications	classification	NOUN
chd-221	41	25	(	(	PUNCT
chd-221	41	26	lele	lele	NOUN
chd-221	41	27	,	,	PUNCT
chd-221	41	28	2003	2003	NUM
chd-221	41	29	)	)	PUNCT
chd-221	41	30	.	.	PUNCT
chd-221	42	1	hence	hence	ADV
chd-221	42	2	,	,	PUNCT
chd-221	42	3	after	after	ADP
chd-221	42	4	the	the	DET
chd-221	42	5	hgp	hgp	PROPN
chd-221	42	6	,	,	PUNCT
chd-221	42	7	for	for	ADP
chd-221	42	8	the	the	DET
chd-221	42	9	first	first	ADJ
chd-221	42	10	time	time	NOUN
chd-221	42	11	ever	ever	ADV
chd-221	42	12	,	,	PUNCT
chd-221	42	13	there	there	PRON
chd-221	42	14	are	be	VERB
chd-221	42	15	a	a	DET
chd-221	42	16	whole	whole	ADJ
chd-221	42	17	lot	lot	NOUN
chd-221	42	18	of	of	ADP
chd-221	42	19	repositories	repository	NOUN
chd-221	42	20	on	on	ADP
chd-221	42	21	genetic	genetic	ADJ
chd-221	42	22	variation	variation	NOUN
chd-221	42	23	of	of	ADP
chd-221	42	24	diseases	disease	NOUN
chd-221	42	25	,	,	PUNCT
chd-221	42	26	pan	pan	NOUN
chd-221	42	27	-	-	ADJ
chd-221	42	28	cancer	cancer	ADJ
chd-221	42	29	genomes	genome	NOUN
chd-221	42	30	etc	etc	X
chd-221	42	31	.	.	X
chd-221	42	32	and	and	CCONJ
chd-221	42	33	all	all	DET
chd-221	42	34	the	the	DET
chd-221	42	35	diseases	disease	NOUN
chd-221	42	36	.	.	PUNCT
chd-221	43	1	while	while	SCONJ
chd-221	43	2	this	this	PRON
chd-221	43	3	has	have	AUX
chd-221	43	4	led	lead	VERB
chd-221	43	5	to	to	ADP
chd-221	43	6	growth	growth	NOUN
chd-221	43	7	in	in	ADP
chd-221	43	8	computational	computational	ADJ
chd-221	43	9	biology	biology	NOUN
chd-221	43	10	,	,	PUNCT
chd-221	43	11	managing	manage	VERB
chd-221	43	12	huge	huge	ADJ
chd-221	43	13	amounts	amount	NOUN
chd-221	43	14	of	of	ADP
chd-221	43	15	genomic	genomic	ADJ
chd-221	43	16	data	datum	NOUN
chd-221	43	17	across	across	ADP
chd-221	43	18	the	the	DET
chd-221	43	19	world	world	NOUN
chd-221	43	20	has	have	AUX
chd-221	43	21	set	set	VERB
chd-221	43	22	a	a	DET
chd-221	43	23	big	big	ADJ
chd-221	43	24	data	data	NOUN
chd-221	43	25	challenge	challenge	NOUN
chd-221	43	26	(	(	PUNCT
chd-221	43	27	gibbs	gibbs	PROPN
chd-221	43	28	,	,	PUNCT
chd-221	43	29	2020	2020	NUM
chd-221	43	30	)	)	PUNCT
chd-221	43	31	.	.	PUNCT
chd-221	44	1	on	on	ADP
chd-221	44	2	the	the	DET
chd-221	44	3	other	other	ADJ
chd-221	44	4	hand	hand	NOUN
chd-221	44	5	,	,	PUNCT
chd-221	44	6	it	it	PRON
chd-221	44	7	has	have	AUX
chd-221	44	8	brought	bring	VERB
chd-221	44	9	changes	change	NOUN
chd-221	44	10	in	in	ADP
chd-221	44	11	indian	indian	ADJ
chd-221	44	12	research	research	NOUN
chd-221	44	13	from	from	ADP
chd-221	44	14	the	the	DET
chd-221	44	15	last	last	ADJ
chd-221	44	16	decade	decade	NOUN
chd-221	44	17	,	,	PUNCT
chd-221	44	18	as	as	SCONJ
chd-221	44	19	growth	growth	NOUN
chd-221	44	20	of	of	ADP
chd-221	44	21	the	the	DET
chd-221	44	22	biotechnology	biotechnology	NOUN
chd-221	44	23	industry	industry	NOUN
chd-221	44	24	for	for	ADP
chd-221	44	25	designing	design	VERB
chd-221	44	26	personalized	personalized	ADJ
chd-221	44	27	medicine	medicine	NOUN
chd-221	44	28	is	be	AUX
chd-221	44	29	more	more	ADV
chd-221	44	30	intended	intended	ADJ
chd-221	44	31	(	(	PUNCT
chd-221	44	32	nogrady	nogrady	ADJ
chd-221	44	33	,	,	PUNCT
chd-221	44	34	2018	2018	NUM
chd-221	44	35	)	)	PUNCT
chd-221	44	36	.	.	PUNCT
chd-221	45	1	india	india	PROPN
chd-221	45	2	harbors	harbor	VERB
chd-221	45	3	not	not	PART
chd-221	45	4	only	only	ADV
chd-221	45	5	cultural	cultural	ADJ
chd-221	45	6	diversity	diversity	NOUN
chd-221	45	7	but	but	CCONJ
chd-221	45	8	also	also	ADV
chd-221	45	9	genetic	genetic	ADJ
chd-221	45	10	diversity	diversity	NOUN
chd-221	45	11	as	as	ADP
chd-221	45	12	a	a	DET
chd-221	45	13	result	result	NOUN
chd-221	45	14	of	of	ADP
chd-221	45	15	a	a	DET
chd-221	45	16	heterogeneous	heterogeneous	ADJ
chd-221	45	17	population	population	NOUN
chd-221	45	18	.	.	PUNCT
chd-221	46	1	the	the	DET
chd-221	46	2	indian	indian	ADJ
chd-221	46	3	population	population	NOUN
chd-221	46	4	structure	structure	NOUN
chd-221	46	5	is	be	AUX
chd-221	46	6	basically	basically	ADV
chd-221	46	7	reflected	reflect	VERB
chd-221	46	8	by	by	ADP
chd-221	46	9	set	set	VERB
chd-221	46	10	marriage	marriage	NOUN
chd-221	46	11	patterns	pattern	NOUN
chd-221	46	12	and	and	CCONJ
chd-221	46	13	consanguinity	consanguinity	NOUN
chd-221	46	14	practices	practice	NOUN
chd-221	46	15	..	..	PUNCT
chd-221	46	16	as	as	ADP
chd-221	46	17	a	a	DET
chd-221	46	18	result	result	NOUN
chd-221	46	19	,	,	PUNCT
chd-221	46	20	the	the	DET
chd-221	46	21	burden	burden	NOUN
chd-221	46	22	of	of	ADP
chd-221	46	23	rare	rare	ADJ
chd-221	46	24	or	or	CCONJ
chd-221	46	25	even	even	ADV
chd-221	46	26	extremely	extremely	ADV
chd-221	46	27	rare	rare	ADJ
chd-221	46	28	disorders	disorder	NOUN
chd-221	46	29	is	be	AUX
chd-221	46	30	increasing	increase	VERB
chd-221	46	31	in	in	ADP
chd-221	46	32	india	india	PROPN
chd-221	46	33	.	.	PUNCT
chd-221	47	1	genomics	genomic	NOUN
chd-221	47	2	based	base	VERB
chd-221	47	3	approaches	approach	NOUN
chd-221	47	4	are	be	AUX
chd-221	47	5	capable	capable	ADJ
chd-221	47	6	of	of	ADP
chd-221	47	7	speeding	speed	VERB
chd-221	47	8	up	up	ADP
chd-221	47	9	the	the	DET
chd-221	47	10	diagnosis	diagnosis	NOUN
chd-221	47	11	and	and	CCONJ
chd-221	47	12	management	management	NOUN
chd-221	47	13	of	of	ADP
chd-221	47	14	such	such	ADJ
chd-221	47	15	rare	rare	ADJ
chd-221	47	16	conditions	condition	NOUN
chd-221	47	17	.	.	PUNCT
chd-221	48	1	for	for	ADP
chd-221	48	2	such	such	ADJ
chd-221	48	3	technologies	technology	NOUN
chd-221	48	4	,	,	PUNCT
chd-221	48	5	the	the	DET
chd-221	48	6	genomics	genomic	NOUN
chd-221	48	7	for	for	ADP
chd-221	48	8	understanding	understand	VERB
chd-221	48	9	rare	rare	ADJ
chd-221	48	10	diseases	disease	NOUN
chd-221	48	11	:	:	PUNCT
chd-221	48	12	india	india	PROPN
chd-221	48	13	alliance	alliance	PROPN
chd-221	48	14	network	network	PROPN
chd-221	48	15	(	(	PUNCT
chd-221	48	16	guardian	guardian	PROPN
chd-221	48	17	)	)	PUNCT
chd-221	48	18	consortium	consortium	NOUN
chd-221	48	19	was	be	AUX
chd-221	48	20	formed	form	VERB
chd-221	48	21	to	to	PART
chd-221	48	22	provide	provide	VERB
chd-221	48	23	genomics	genomics	NOUN
chd-221	48	24	solutions	solution	NOUN
chd-221	48	25	in	in	ADP
chd-221	48	26	india	india	PROPN
chd-221	48	27	(	(	PUNCT
chd-221	48	28	sivasubbu	sivasubbu	PROPN
chd-221	48	29	and	and	CCONJ
chd-221	48	30	scaria	scaria	NOUN
chd-221	48	31	,	,	PUNCT
chd-221	48	32	2019	2019	NUM
chd-221	48	33	)	)	PUNCT
chd-221	48	34	.	.	PUNCT
chd-221	49	1	in	in	ADP
chd-221	49	2	2020	2020	NUM
chd-221	49	3	department	department	NOUN
chd-221	49	4	of	of	ADP
chd-221	49	5	biotechnology	biotechnology	NOUN
chd-221	49	6	(	(	PUNCT
chd-221	49	7	dbt	dbt	PROPN
chd-221	49	8	)	)	PUNCT
chd-221	49	9	has	have	AUX
chd-221	49	10	launched	launch	VERB
chd-221	49	11	a	a	DET
chd-221	49	12	project	project	NOUN
chd-221	49	13	‘	'	PUNCT
chd-221	49	14	genome	genome	NOUN
chd-221	49	15	india	india	PROPN
chd-221	49	16	project	project	NOUN
chd-221	49	17	’	'	PUNCT
chd-221	49	18	(	(	PUNCT
chd-221	49	19	gip	gip	NOUN
chd-221	49	20	)	)	PUNCT
chd-221	49	21	for	for	ADP
chd-221	49	22	creating	create	VERB
chd-221	49	23	indian	indian	ADJ
chd-221	49	24	reference	reference	NOUN
chd-221	49	25	genome	genome	NOUN
chd-221	49	26	.	.	PUNCT
chd-221	50	1	such	such	DET
chd-221	50	2	an	an	DET
chd-221	50	3	initiative	initiative	NOUN
chd-221	50	4	shows	show	VERB
chd-221	50	5	india	india	PROPN
chd-221	50	6	’s	’s	PART
chd-221	50	7	growth	growth	NOUN
chd-221	50	8	in	in	ADP
chd-221	50	9	gene	gene	NOUN
chd-221	50	10	therapies	therapy	NOUN
chd-221	50	11	and	and	CCONJ
chd-221	50	12	is	be	AUX
chd-221	50	13	a	a	DET
chd-221	50	14	step	step	NOUN
chd-221	50	15	towards	towards	ADP
chd-221	50	16	raising	raise	VERB
chd-221	50	17	next	next	ADJ
chd-221	50	18	generation	generation	NOUN
chd-221	50	19	medicine	medicine	NOUN
chd-221	50	20	(	(	PUNCT
chd-221	50	21	bajaj	bajaj	PROPN
chd-221	50	22	.	.	PUNCT
chd-221	50	23	2020	2020	NUM
chd-221	50	24	)	)	PUNCT
chd-221	50	25	.	.	PUNCT
chd-221	51	1	under	under	ADP
chd-221	51	2	an	an	DET
chd-221	51	3	‘	'	PUNCT
chd-221	51	4	indigen	indigen	NOUN
chd-221	51	5	’	'	PUNCT
chd-221	51	6	program	program	NOUN
chd-221	51	7	,	,	PUNCT
chd-221	51	8	whole	whole	ADJ
chd-221	51	9	genome	genome	NOUN
chd-221	51	10	studies	study	NOUN
chd-221	51	11	were	be	AUX
chd-221	51	12	carried	carry	VERB
chd-221	51	13	out	out	ADP
chd-221	51	14	and	and	CCONJ
chd-221	51	15	publicly	publicly	ADV
chd-221	51	16	available	available	ADJ
chd-221	51	17	population	population	NOUN
chd-221	51	18	databases	database	NOUN
chd-221	51	19	called	call	VERB
chd-221	51	20	‘	'	PUNCT
chd-221	51	21	indigenomes	indigenome	NOUN
chd-221	51	22	’	'	PUNCT
chd-221	51	23	were	be	AUX
chd-221	51	24	created	create	VERB
chd-221	51	25	which	which	PRON
chd-221	51	26	are	be	AUX
chd-221	51	27	not	not	PART
chd-221	51	28	only	only	ADV
chd-221	51	29	at	at	ADP
chd-221	51	30	the	the	DET
chd-221	51	31	population	population	NOUN
chd-221	51	32	level	level	NOUN
chd-221	51	33	but	but	CCONJ
chd-221	51	34	also	also	ADV
chd-221	51	35	at	at	ADP
chd-221	51	36	the	the	DET
chd-221	51	37	individual	individual	ADJ
chd-221	51	38	level	level	NOUN
chd-221	51	39	.	.	PUNCT
chd-221	52	1	this	this	DET
chd-221	52	2	database	database	NOUN
chd-221	52	3	has	have	AUX
chd-221	52	4	already	already	ADV
chd-221	52	5	helped	help	VERB
chd-221	52	6	both	both	DET
chd-221	52	7	researchers	researcher	NOUN
chd-221	52	8	and	and	CCONJ
chd-221	52	9	clinicians	clinician	NOUN
chd-221	52	10	identify	identify	VERB
chd-221	52	11	causal	causal	ADJ
chd-221	52	12	genetic	genetic	ADJ
chd-221	52	13	factors	factor	NOUN
chd-221	52	14	for	for	ADP
chd-221	52	15	any	any	DET
chd-221	52	16	condition	condition	NOUN
chd-221	52	17	.	.	PUNCT
chd-221	53	1	as	as	ADP
chd-221	53	2	an	an	DET
chd-221	53	3	all	all	ADV
chd-221	53	4	-	-	PUNCT
chd-221	53	5	inclusive	inclusive	ADJ
chd-221	53	6	resource	resource	NOUN
chd-221	53	7	for	for	ADP
chd-221	53	8	a	a	DET
chd-221	53	9	total	total	NOUN
chd-221	53	10	of	of	ADP
chd-221	53	11	about	about	ADV
chd-221	53	12	18	18	NUM
chd-221	53	13	million	million	NUM
chd-221	53	14	genetic	genetic	ADJ
chd-221	53	15	variants	variant	NOUN
chd-221	53	16	of	of	ADP
chd-221	53	17	indian	indian	ADJ
chd-221	53	18	population	population	NOUN
chd-221	53	19	specifically	specifically	ADV
chd-221	53	20	,	,	PUNCT
chd-221	53	21	it	it	PRON
chd-221	53	22	includes	include	VERB
chd-221	53	23	single	single	ADJ
chd-221	53	24	allelic	allelic	ADJ
chd-221	53	25	genetic	genetic	ADJ
chd-221	53	26	variants	variant	NOUN
chd-221	53	27	from	from	ADP
chd-221	53	28	genomes	genome	NOUN
chd-221	53	29	of	of	ADP
chd-221	53	30	geographically	geographically	ADV
chd-221	53	31	distinct	distinct	ADJ
chd-221	53	32	populations	population	NOUN
chd-221	53	33	,	,	PUNCT
chd-221	53	34	allele	allele	NOUN
chd-221	53	35	frequency	frequency	NOUN
chd-221	53	36	,	,	PUNCT
chd-221	53	37	allele	allele	NOUN
chd-221	53	38	count	count	NOUN
chd-221	53	39	,	,	PUNCT
chd-221	53	40	allele	allele	NOUN
chd-221	53	41	number	number	NOUN
chd-221	53	42	,	,	PUNCT
chd-221	53	43	number	number	NOUN
chd-221	53	44	of	of	ADP
chd-221	53	45	heterozygous	heterozygous	ADJ
chd-221	53	46	and	and	CCONJ
chd-221	53	47	homozygous	homozygous	ADJ
chd-221	53	48	were	be	AUX
chd-221	53	49	also	also	ADV
chd-221	53	50	calculated	calculate	VERB
chd-221	53	51	(	(	PUNCT
chd-221	53	52	jain	jain	PROPN
chd-221	53	53	et	et	PROPN
chd-221	53	54	al	al	PROPN
chd-221	53	55	.	.	PROPN
chd-221	53	56	,	,	PUNCT
chd-221	53	57	2021	2021	NUM
chd-221	53	58	)	)	PUNCT
chd-221	53	59	.	.	PUNCT
chd-221	54	1	however	however	ADV
chd-221	54	2	,	,	PUNCT
chd-221	54	3	given	give	VERB
chd-221	54	4	this	this	DET
chd-221	54	5	paucity	paucity	NOUN
chd-221	54	6	of	of	ADP
chd-221	54	7	data	datum	NOUN
chd-221	54	8	on	on	ADP
chd-221	54	9	pca	pca	PROPN
chd-221	54	10	,	,	PUNCT
chd-221	54	11	there	there	PRON
chd-221	54	12	are	be	VERB
chd-221	54	13	no	no	DET
chd-221	54	14	reported	report	VERB
chd-221	54	15	variants	variant	NOUN
chd-221	54	16	specific	specific	ADJ
chd-221	54	17	to	to	ADP
chd-221	54	18	indian	indian	PROPN
chd-221	54	19	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-221	54	20	e5	e5	PROPN
chd-221	54	21	cancer	cancer	NOUN
chd-221	54	22	health	health	NOUN
chd-221	54	23	disparities	disparity	NOUN
chd-221	54	24	phenotype	phenotype	NOUN
chd-221	54	25	until	until	SCONJ
chd-221	54	26	we	we	PRON
chd-221	54	27	explored	explore	VERB
chd-221	54	28	through	through	ADP
chd-221	54	29	our	our	PRON
chd-221	54	30	pilot	pilot	NOUN
chd-221	54	31	study	study	NOUN
chd-221	54	32	.	.	PUNCT
chd-221	55	1	given	give	VERB
chd-221	55	2	the	the	DET
chd-221	55	3	number	number	NOUN
chd-221	55	4	of	of	ADP
chd-221	55	5	sporadic	sporadic	ADJ
chd-221	55	6	and	and	CCONJ
chd-221	55	7	hereditary	hereditary	ADJ
chd-221	55	8	pca	pca	NOUN
chd-221	55	9	cases	case	NOUN
chd-221	55	10	that	that	PRON
chd-221	55	11	might	might	AUX
chd-221	55	12	be	be	AUX
chd-221	55	13	associated	associate	VERB
chd-221	55	14	,	,	PUNCT
chd-221	55	15	we	we	PRON
chd-221	55	16	therefore	therefore	ADV
chd-221	55	17	believe	believe	VERB
chd-221	55	18	capci	capci	PROPN
chd-221	55	19	could	could	AUX
chd-221	55	20	bring	bring	VERB
chd-221	55	21	a	a	DET
chd-221	55	22	pivotal	pivotal	ADJ
chd-221	55	23	change	change	NOUN
chd-221	55	24	in	in	ADP
chd-221	55	25	exploring	explore	VERB
chd-221	55	26	these	these	DET
chd-221	55	27	understudied	understudied	ADJ
chd-221	55	28	avenues	avenue	NOUN
chd-221	55	29	.	.	PUNCT
chd-221	56	1	international	international	ADJ
chd-221	56	2	consortia	consortium	NOUN
chd-221	56	3	on	on	ADP
chd-221	56	4	pca	pca	PROPN
chd-221	56	5	the	the	DET
chd-221	56	6	national	national	PROPN
chd-221	56	7	institute	institute	PROPN
chd-221	56	8	of	of	ADP
chd-221	56	9	health	health	PROPN
chd-221	56	10	(	(	PUNCT
chd-221	56	11	nih	nih	PROPN
chd-221	56	12	)	)	PUNCT
chd-221	56	13	funded	fund	VERB
chd-221	56	14	postgwas	postgwas	ADJ
chd-221	56	15	initiatives	initiative	NOUN
chd-221	56	16	with	with	ADP
chd-221	56	17	the	the	DET
chd-221	56	18	establishment	establishment	NOUN
chd-221	56	19	of	of	ADP
chd-221	56	20	elucidating	elucidating	NOUN
chd-221	56	21	loci	locus	NOUN
chd-221	56	22	involved	involve	VERB
chd-221	56	23	in	in	ADP
chd-221	56	24	prostate	prostate	NOUN
chd-221	56	25	cancer	cancer	NOUN
chd-221	56	26	susceptibility	susceptibility	NOUN
chd-221	56	27	(	(	PUNCT
chd-221	56	28	ellipse	ellipse	NOUN
chd-221	56	29	)	)	PUNCT
chd-221	56	30	(	(	PUNCT
chd-221	56	31	dbgap	dbgap	PROPN
chd-221	56	32	,	,	PUNCT
chd-221	56	33	https://www.ncbi.nlm.nih.gov/projects/gap/cgibin/study.cgi?study_id=phs001081.v1.p1	https://www.ncbi.nlm.nih.gov/projects/gap/cgibin/study.cgi?study_id=phs001081.v1.p1	PROPN
chd-221	56	34	)	)	PUNCT
chd-221	56	35	.	.	PUNCT
chd-221	57	1	as	as	ADP
chd-221	57	2	part	part	NOUN
chd-221	57	3	of	of	ADP
chd-221	57	4	this	this	PRON
chd-221	57	5	,	,	PUNCT
chd-221	57	6	the	the	DET
chd-221	57	7	clinical	clinical	ADJ
chd-221	57	8	ellipse	ellipse	NOUN
chd-221	57	9	consortium	consortium	NOUN
chd-221	57	10	(	(	PUNCT
chd-221	57	11	cec	cec	PROPN
chd-221	57	12	)	)	PUNCT
chd-221	57	13	was	be	AUX
chd-221	57	14	formed	form	VERB
chd-221	57	15	to	to	PART
chd-221	57	16	develop	develop	VERB
chd-221	57	17	risk	risk	NOUN
chd-221	57	18	models	model	NOUN
chd-221	57	19	,	,	PUNCT
chd-221	57	20	analyze	analyze	VERB
chd-221	57	21	risk	risk	NOUN
chd-221	57	22	profiles	profile	NOUN
chd-221	57	23	and	and	CCONJ
chd-221	57	24	investigate	investigate	VERB
chd-221	57	25	clinical	clinical	ADJ
chd-221	57	26	applications	application	NOUN
chd-221	57	27	.	.	PUNCT
chd-221	58	1	other	other	ADJ
chd-221	58	2	consortia	consortium	NOUN
chd-221	58	3	include	include	VERB
chd-221	58	4	the	the	DET
chd-221	58	5	prostate	prostate	NOUN
chd-221	58	6	cancer	cancer	NOUN
chd-221	58	7	association	association	PROPN
chd-221	58	8	group	group	NOUN
chd-221	58	9	to	to	PART
chd-221	58	10	investigate	investigate	VERB
chd-221	58	11	cancer	cancer	NOUN
chd-221	58	12	associated	associate	VERB
chd-221	58	13	alterations	alteration	NOUN
chd-221	58	14	in	in	ADP
chd-221	58	15	the	the	DET
chd-221	58	16	genome	genome	NOUN
chd-221	58	17	(	(	PUNCT
chd-221	58	18	practical	practical	ADJ
chd-221	58	19	)	)	PUNCT
chd-221	58	20	which	which	PRON
chd-221	58	21	is	be	AUX
chd-221	58	22	a	a	DET
chd-221	58	23	section	section	NOUN
chd-221	58	24	of	of	ADP
chd-221	58	25	the	the	DET
chd-221	58	26	collaborative	collaborative	ADJ
chd-221	58	27	oncological	oncological	ADJ
chd-221	58	28	gene	gene	NOUN
chd-221	58	29	environment	environment	NOUN
chd-221	58	30	study	study	NOUN
chd-221	58	31	(	(	PUNCT
chd-221	58	32	cogs	cog	NOUN
chd-221	58	33	)	)	PUNCT
chd-221	58	34	along	along	ADP
chd-221	58	35	with	with	ADP
chd-221	58	36	other	other	ADJ
chd-221	58	37	three	three	NUM
chd-221	58	38	cancer	cancer	NOUN
chd-221	58	39	genetics	genetic	NOUN
chd-221	58	40	consortium	consortium	NOUN
chd-221	58	41	of	of	ADP
chd-221	58	42	breast	breast	NOUN
chd-221	58	43	,	,	PUNCT
chd-221	58	44	ovarian	ovarian	ADJ
chd-221	58	45	and	and	CCONJ
chd-221	58	46	brca1/2	brca1/2	ADJ
chd-221	58	47	mutation	mutation	NOUN
chd-221	58	48	carriers	carrier	NOUN
chd-221	58	49	(	(	PUNCT
chd-221	58	50	szulkin	szulkin	X
chd-221	58	51	et	et	PROPN
chd-221	58	52	al	al	PROPN
chd-221	58	53	.	.	PROPN
chd-221	58	54	,	,	PUNCT
chd-221	58	55	2015	2015	NUM
chd-221	58	56	)	)	PUNCT
chd-221	58	57	.	.	PUNCT
chd-221	59	1	to	to	PART
chd-221	59	2	provide	provide	VERB
chd-221	59	3	specific	specific	ADJ
chd-221	59	4	prevention	prevention	NOUN
chd-221	59	5	and	and	CCONJ
chd-221	59	6	screening	screen	VERB
chd-221	59	7	approaches	approach	NOUN
chd-221	59	8	for	for	ADP
chd-221	59	9	those	those	DET
chd-221	59	10	men	man	NOUN
chd-221	59	11	who	who	PRON
chd-221	59	12	are	be	AUX
chd-221	59	13	at	at	ADP
chd-221	59	14	higher	high	ADJ
chd-221	59	15	risk	risk	NOUN
chd-221	59	16	,	,	PUNCT
chd-221	59	17	snps	snps	PROPN
chd-221	59	18	were	be	AUX
chd-221	59	19	shown	show	VERB
chd-221	59	20	more	more	ADV
chd-221	59	21	promising	promising	ADJ
chd-221	59	22	to	to	PART
chd-221	59	23	use	use	VERB
chd-221	59	24	for	for	ADP
chd-221	59	25	genetic	genetic	ADJ
chd-221	59	26	risk	risk	NOUN
chd-221	59	27	profiling	profiling	NOUN
chd-221	59	28	(	(	PUNCT
chd-221	59	29	martens	marten	NOUN
chd-221	59	30	et	et	PROPN
chd-221	59	31	al	al	PROPN
chd-221	59	32	.	.	PROPN
chd-221	59	33	,	,	PUNCT
chd-221	59	34	2016).the	2016).the	DET
chd-221	59	35	consortia	consortia	NOUN
chd-221	59	36	efforts	effort	NOUN
chd-221	59	37	resulted	result	VERB
chd-221	59	38	in	in	ADP
chd-221	59	39	making	make	VERB
chd-221	59	40	the	the	DET
chd-221	59	41	prostatespecific	prostatespecific	ADJ
chd-221	59	42	antigen	antigen	NOUN
chd-221	59	43	(	(	PUNCT
chd-221	59	44	psa	psa	NOUN
chd-221	59	45	)	)	PUNCT
chd-221	59	46	testing	testing	NOUN
chd-221	59	47	as	as	ADP
chd-221	59	48	not	not	PART
chd-221	59	49	the	the	DET
chd-221	59	50	only	only	ADJ
chd-221	59	51	essential	essential	ADJ
chd-221	59	52	or	or	CCONJ
chd-221	59	53	sensitive	sensitive	ADJ
chd-221	59	54	test	test	NOUN
chd-221	59	55	regimen	regiman	NOUN
chd-221	59	56	avoiding	avoid	VERB
chd-221	59	57	the	the	DET
chd-221	59	58	apparent	apparent	ADJ
chd-221	59	59	conflicting	conflicting	ADJ
chd-221	59	60	results	result	NOUN
chd-221	59	61	from	from	ADP
chd-221	59	62	two	two	NUM
chd-221	59	63	of	of	ADP
chd-221	59	64	the	the	DET
chd-221	59	65	largest	large	ADJ
chd-221	59	66	screening	screening	NOUN
chd-221	59	67	trials	trial	NOUN
chd-221	59	68	,	,	PUNCT
chd-221	59	69	the	the	DET
chd-221	59	70	european	european	ADJ
chd-221	59	71	randomized	randomized	ADJ
chd-221	59	72	study	study	NOUN
chd-221	59	73	of	of	ADP
chd-221	59	74	screening	screen	VERB
chd-221	59	75	for	for	ADP
chd-221	59	76	prostate	prostate	NOUN
chd-221	59	77	cancer	cancer	NOUN
chd-221	59	78	(	(	PUNCT
chd-221	59	79	erspc	erspc	PROPN
chd-221	59	80	)	)	PUNCT
chd-221	59	81	and	and	CCONJ
chd-221	59	82	prostate	prostate	NOUN
chd-221	59	83	,	,	PUNCT
chd-221	59	84	lung	lung	NOUN
chd-221	59	85	,	,	PUNCT
chd-221	59	86	colorectal	colorectal	NOUN
chd-221	59	87	,	,	PUNCT
chd-221	59	88	and	and	CCONJ
chd-221	59	89	ovarian	ovarian	ADJ
chd-221	59	90	(	(	PUNCT
chd-221	59	91	plco	plco	NOUN
chd-221	59	92	)	)	PUNCT
chd-221	59	93	cancer	cancer	NOUN
chd-221	59	94	screening	screen	VERB
chd-221	59	95	trial	trial	NOUN
chd-221	59	96	have	have	AUX
chd-221	59	97	elicited	elicit	VERB
chd-221	59	98	a	a	DET
chd-221	59	99	strong	strong	ADJ
chd-221	59	100	debate	debate	NOUN
chd-221	59	101	among	among	ADP
chd-221	59	102	the	the	DET
chd-221	59	103	experts	expert	NOUN
chd-221	59	104	.	.	PUNCT
chd-221	60	1	the	the	DET
chd-221	60	2	national	national	PROPN
chd-221	60	3	cancer	cancer	PROPN
chd-221	60	4	institute	institute	PROPN
chd-221	60	5	(	(	PUNCT
chd-221	60	6	nci	nci	PROPN
chd-221	60	7	)	)	PUNCT
chd-221	60	8	mouse	mouse	NOUN
chd-221	60	9	models	model	NOUN
chd-221	60	10	of	of	ADP
chd-221	60	11	human	human	ADJ
chd-221	60	12	cancers	cancer	NOUN
chd-221	60	13	consortium	consortium	NOUN
chd-221	60	14	(	(	PUNCT
chd-221	60	15	mmhcc	mmhcc	PROPN
chd-221	60	16	)	)	PUNCT
chd-221	60	17	has	have	AUX
chd-221	60	18	also	also	ADV
chd-221	60	19	assembled	assemble	VERB
chd-221	60	20	a	a	DET
chd-221	60	21	group	group	NOUN
chd-221	60	22	of	of	ADP
chd-221	60	23	pathologists	pathologist	NOUN
chd-221	60	24	from	from	ADP
chd-221	60	25	both	both	CCONJ
chd-221	60	26	human	human	ADJ
chd-221	60	27	and	and	CCONJ
chd-221	60	28	veterinary	veterinary	ADJ
chd-221	60	29	departments	department	NOUN
chd-221	60	30	to	to	PART
chd-221	60	31	inspect	inspect	VERB
chd-221	60	32	and	and	CCONJ
chd-221	60	33	discuss	discuss	VERB
chd-221	60	34	the	the	DET
chd-221	60	35	present	present	ADJ
chd-221	60	36	animal	animal	NOUN
chd-221	60	37	models	model	NOUN
chd-221	60	38	for	for	ADP
chd-221	60	39	their	their	PRON
chd-221	60	40	recommendations	recommendation	NOUN
chd-221	60	41	in	in	ADP
chd-221	60	42	pathological	pathological	ADJ
chd-221	60	43	analysis	analysis	NOUN
chd-221	60	44	(	(	PUNCT
chd-221	60	45	ittmann	ittmann	PROPN
chd-221	60	46	et	et	PROPN
chd-221	60	47	al	al	PROPN
chd-221	60	48	.	.	PROPN
chd-221	60	49	,	,	PUNCT
chd-221	60	50	2013	2013	NUM
chd-221	60	51	)	)	PUNCT
chd-221	60	52	.	.	PUNCT
chd-221	61	1	on	on	ADP
chd-221	61	2	the	the	DET
chd-221	61	3	other	other	ADJ
chd-221	61	4	hand	hand	NOUN
chd-221	61	5	,	,	PUNCT
chd-221	61	6	the	the	DET
chd-221	61	7	international	international	ADJ
chd-221	61	8	consortium	consortium	NOUN
chd-221	61	9	of	of	ADP
chd-221	61	10	prostate	prostate	NOUN
chd-221	61	11	cancer	cancer	NOUN
chd-221	61	12	genetics	genetic	NOUN
chd-221	61	13	(	(	PUNCT
chd-221	61	14	icpcg	icpcg	PROPN
chd-221	61	15	)	)	PUNCT
chd-221	61	16	brought	bring	VERB
chd-221	61	17	together	together	ADV
chd-221	61	18	the	the	DET
chd-221	61	19	genome	genome	NOUN
chd-221	61	20	wide	wide	ADJ
chd-221	61	21	linkage	linkage	NOUN
chd-221	61	22	data	datum	NOUN
chd-221	61	23	taken	take	VERB
chd-221	61	24	from	from	ADP
chd-221	61	25	11	11	NUM
chd-221	61	26	different	different	ADJ
chd-221	61	27	international	international	ADJ
chd-221	61	28	prostate	prostate	NOUN
chd-221	61	29	cancer	cancer	NOUN
chd-221	61	30	research	research	NOUN
chd-221	61	31	(	(	PUNCT
chd-221	61	32	prca	prca	NOUN
chd-221	61	33	)	)	PUNCT
chd-221	61	34	groups	group	NOUN
chd-221	61	35	(	(	PUNCT
chd-221	61	36	camp	camp	NOUN
chd-221	61	37	et	et	NOUN
chd-221	61	38	al	al	PROPN
chd-221	61	39	.	.	PROPN
chd-221	61	40	,	,	PUNCT
chd-221	61	41	2007	2007	NUM
chd-221	61	42	;	;	PUNCT
chd-221	61	43	schaid	schaid	PROPN
chd-221	61	44	&	&	CCONJ
chd-221	61	45	chang	chang	PROPN
chd-221	61	46	,	,	PUNCT
chd-221	61	47	2005	2005	NUM
chd-221	61	48	)	)	PUNCT
chd-221	61	49	.	.	PUNCT
chd-221	62	1	the	the	DET
chd-221	62	2	prostate	prostate	NOUN
chd-221	62	3	cancer	cancer	NOUN
chd-221	62	4	consortium	consortium	NOUN
chd-221	62	5	in	in	ADP
chd-221	62	6	europe	europe	PROPN
chd-221	62	7	(	(	PUNCT
chd-221	62	8	peace	peace	NOUN
chd-221	62	9	)	)	PUNCT
chd-221	62	10	assisted	assist	VERB
chd-221	62	11	europeans	european	NOUN
chd-221	62	12	in	in	ADP
chd-221	62	13	gaining	gain	VERB
chd-221	62	14	faster	fast	ADJ
chd-221	62	15	access	access	NOUN
chd-221	62	16	to	to	ADP
chd-221	62	17	the	the	DET
chd-221	62	18	most	most	ADV
chd-221	62	19	recent	recent	ADJ
chd-221	62	20	treatment	treatment	NOUN
chd-221	62	21	options	option	NOUN
chd-221	62	22	and	and	CCONJ
chd-221	62	23	data	datum	NOUN
chd-221	62	24	generation	generation	NOUN
chd-221	62	25	in	in	ADP
chd-221	62	26	the	the	DET
chd-221	62	27	fight	fight	NOUN
chd-221	62	28	against	against	ADP
chd-221	62	29	pca	pca	PROPN
chd-221	62	30	(	(	PUNCT
chd-221	62	31	fizazi	fizazi	PROPN
chd-221	62	32	et	et	PROPN
chd-221	62	33	al	al	PROPN
chd-221	62	34	.	.	PROPN
chd-221	62	35	,	,	PUNCT
chd-221	62	36	2015	2015	NUM
chd-221	62	37	)	)	PUNCT
chd-221	62	38	.	.	PUNCT
chd-221	63	1	chinese	chinese	ADJ
chd-221	63	2	prostate	prostate	NOUN
chd-221	63	3	cancer	cancer	NOUN
chd-221	63	4	consortium	consortium	NOUN
chd-221	63	5	-	-	PUNCT
chd-221	63	6	risk	risk	NOUN
chd-221	63	7	calculator	calculator	NOUN
chd-221	63	8	(	(	PUNCT
chd-221	63	9	cpcc	cpcc	PROPN
chd-221	63	10	-	-	PUNCT
chd-221	63	11	rc	rc	PROPN
chd-221	63	12	)	)	PUNCT
chd-221	63	13	(	(	PUNCT
chd-221	63	14	chen	chen	PROPN
chd-221	63	15	et	et	PROPN
chd-221	63	16	al	al	PROPN
chd-221	63	17	.	.	PROPN
chd-221	63	18	,	,	PUNCT
chd-221	63	19	2014	2014	NUM
chd-221	63	20	)	)	PUNCT
chd-221	63	21	,	,	PUNCT
chd-221	63	22	was	be	AUX
chd-221	63	23	designed	design	VERB
chd-221	63	24	in	in	ADP
chd-221	63	25	2016	2016	NUM
chd-221	63	26	based	base	VERB
chd-221	63	27	on	on	ADP
chd-221	63	28	gleason	gleason	PROPN
chd-221	63	29	grade	grade	NOUN
chd-221	63	30	cancer	cancer	NOUN
chd-221	63	31	(	(	PUNCT
chd-221	63	32	7	7	NUM
chd-221	63	33	or	or	CCONJ
chd-221	63	34	above	above	ADV
chd-221	63	35	)	)	PUNCT
chd-221	63	36	in	in	ADP
chd-221	63	37	chinese	chinese	ADJ
chd-221	63	38	or	or	CCONJ
chd-221	63	39	other	other	ADJ
chd-221	63	40	asian	asian	ADJ
chd-221	63	41	countries	country	NOUN
chd-221	63	42	who	who	PRON
chd-221	63	43	are	be	AUX
chd-221	63	44	exposed	expose	VERB
chd-221	63	45	to	to	ADP
chd-221	63	46	the	the	DET
chd-221	63	47	same	same	ADJ
chd-221	63	48	genetic	genetic	ADJ
chd-221	63	49	and	and	CCONJ
chd-221	63	50	environmental	environmental	ADJ
chd-221	63	51	background	background	NOUN
chd-221	63	52	.	.	PUNCT
chd-221	64	1	furthermore	furthermore	ADV
chd-221	64	2	,	,	PUNCT
chd-221	64	3	to	to	PART
chd-221	64	4	address	address	VERB
chd-221	64	5	the	the	DET
chd-221	64	6	pca	pca	NOUN
chd-221	64	7	burden	burden	NOUN
chd-221	64	8	in	in	ADP
chd-221	64	9	black	black	ADJ
chd-221	64	10	men	man	NOUN
chd-221	64	11	,	,	PUNCT
chd-221	64	12	a	a	DET
chd-221	64	13	consortium	consortium	NOUN
chd-221	64	14	named	name	VERB
chd-221	64	15	“	"	PUNCT
chd-221	64	16	the	the	DET
chd-221	64	17	prostate	prostate	NOUN
chd-221	64	18	cancer	cancer	NOUN
chd-221	64	19	transatlantic	transatlantic	ADJ
chd-221	64	20	consortium	consortium	NOUN
chd-221	64	21	(	(	PUNCT
chd-221	64	22	captc	captc	NOUN
chd-221	64	23	)	)	PUNCT
chd-221	64	24	”	"	PUNCT
chd-221	64	25	was	be	AUX
chd-221	64	26	formed	form	VERB
chd-221	64	27	in	in	ADP
chd-221	64	28	2005	2005	NUM
chd-221	64	29	(	(	PUNCT
chd-221	64	30	https://epi.grants.cancer.gov/captc/	https://epi.grants.cancer.gov/captc/	NOUN
chd-221	64	31	)	)	PUNCT
chd-221	64	32	.	.	PUNCT
chd-221	65	1	this	this	PRON
chd-221	65	2	is	be	AUX
chd-221	65	3	an	an	DET
chd-221	65	4	open	open	ADJ
chd-221	65	5	consortium	consortium	NOUN
chd-221	65	6	,	,	PUNCT
chd-221	65	7	which	which	PRON
chd-221	65	8	has	have	VERB
chd-221	65	9	a	a	DET
chd-221	65	10	group	group	NOUN
chd-221	65	11	of	of	ADP
chd-221	65	12	pca	pca	PROPN
chd-221	65	13	scientists	scientist	NOUN
chd-221	65	14	,	,	PUNCT
chd-221	65	15	clinicians	clinician	NOUN
chd-221	65	16	,	,	PUNCT
chd-221	65	17	legal	legal	ADJ
chd-221	65	18	personnel	personnel	NOUN
chd-221	65	19	and	and	CCONJ
chd-221	65	20	survivors	survivor	NOUN
chd-221	65	21	from	from	ADP
chd-221	65	22	all	all	ADV
chd-221	65	23	across	across	ADP
chd-221	65	24	europe	europe	PROPN
chd-221	65	25	,	,	PUNCT
chd-221	65	26	north	north	PROPN
chd-221	65	27	america	america	PROPN
chd-221	65	28	,	,	PUNCT
chd-221	65	29	the	the	DET
chd-221	65	30	caribbean	caribbean	ADJ
chd-221	65	31	islands	island	NOUN
chd-221	65	32	,	,	PUNCT
chd-221	65	33	and	and	CCONJ
chd-221	65	34	west	west	PROPN
chd-221	65	35	africa	africa	PROPN
chd-221	65	36	.	.	PUNCT
chd-221	66	1	the	the	DET
chd-221	66	2	main	main	ADJ
chd-221	66	3	aim	aim	NOUN
chd-221	66	4	of	of	ADP
chd-221	66	5	captc	captc	NOUN
chd-221	66	6	is	be	AUX
chd-221	66	7	to	to	PART
chd-221	66	8	explore	explore	VERB
chd-221	66	9	differences	difference	NOUN
chd-221	66	10	in	in	ADP
chd-221	66	11	morbidity	morbidity	NOUN
chd-221	66	12	and	and	CCONJ
chd-221	66	13	mortality	mortality	NOUN
chd-221	66	14	among	among	ADP
chd-221	66	15	black	black	ADJ
chd-221	66	16	men	man	NOUN
chd-221	66	17	and	and	CCONJ
chd-221	66	18	further	further	ADJ
chd-221	66	19	study	study	VERB
chd-221	66	20	reliable	reliable	ADJ
chd-221	66	21	biomarkers	biomarker	NOUN
chd-221	66	22	in	in	ADP
chd-221	66	23	addition	addition	NOUN
chd-221	66	24	to	to	ADP
chd-221	66	25	developing	develop	VERB
chd-221	66	26	sensitive	sensitive	ADJ
chd-221	66	27	diagnostics	diagnostic	NOUN
chd-221	66	28	approaches	approach	NOUN
chd-221	66	29	to	to	PART
chd-221	66	30	remove	remove	VERB
chd-221	66	31	the	the	DET
chd-221	66	32	global	global	ADJ
chd-221	66	33	disparity	disparity	NOUN
chd-221	66	34	associated	associate	VERB
chd-221	66	35	with	with	ADP
chd-221	66	36	pca	pca	PROPN
chd-221	66	37	in	in	ADP
chd-221	66	38	black	black	ADJ
chd-221	66	39	men	man	NOUN
chd-221	66	40	(	(	PUNCT
chd-221	66	41	oladoyinbo	oladoyinbo	INTJ
chd-221	66	42	et	et	PROPN
chd-221	66	43	al	al	PROPN
chd-221	66	44	.	.	PROPN
chd-221	66	45	,	,	PUNCT
chd-221	66	46	2020	2020	NUM
chd-221	66	47	)	)	PUNCT
chd-221	66	48	.	.	PUNCT
chd-221	67	1	capci	capci	PROPN
chd-221	67	2	organization	organization	PROPN
chd-221	67	3	,	,	PUNCT
chd-221	67	4	goals	goal	NOUN
chd-221	67	5	and	and	CCONJ
chd-221	67	6	objectives	objective	VERB
chd-221	67	7	the	the	DET
chd-221	67	8	main	main	ADJ
chd-221	67	9	goal	goal	NOUN
chd-221	67	10	of	of	ADP
chd-221	67	11	capci	capci	PROPN
chd-221	67	12	is	be	AUX
chd-221	67	13	to	to	PART
chd-221	67	14	promote	promote	VERB
chd-221	67	15	collaboration	collaboration	NOUN
chd-221	67	16	between	between	ADP
chd-221	67	17	clinicians	clinician	NOUN
chd-221	67	18	and	and	CCONJ
chd-221	67	19	academic	academic	ADJ
chd-221	67	20	researchers	researcher	NOUN
chd-221	67	21	which	which	PRON
chd-221	67	22	will	will	AUX
chd-221	67	23	also	also	ADV
chd-221	67	24	help	help	VERB
chd-221	67	25	in	in	ADP
chd-221	67	26	knowledge	knowledge	NOUN
chd-221	67	27	exchange	exchange	NOUN
chd-221	67	28	between	between	ADP
chd-221	67	29	these	these	DET
chd-221	67	30	two	two	NUM
chd-221	67	31	groups	group	NOUN
chd-221	67	32	.	.	PUNCT
chd-221	68	1	the	the	DET
chd-221	68	2	capci	capci	NOUN
chd-221	68	3	is	be	AUX
chd-221	68	4	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-221	68	5	e6	e6	NOUN
chd-221	68	6	cancer	cancer	NOUN
chd-221	68	7	health	health	NOUN
chd-221	68	8	disparities	disparity	NOUN
chd-221	68	9	dedicated	dedicate	VERB
chd-221	68	10	to	to	ADP
chd-221	68	11	developing	develop	VERB
chd-221	68	12	programs	program	NOUN
chd-221	68	13	that	that	PRON
chd-221	68	14	will	will	AUX
chd-221	68	15	lead	lead	VERB
chd-221	68	16	to	to	ADP
chd-221	68	17	better	well	ADJ
chd-221	68	18	approaches	approach	NOUN
chd-221	68	19	for	for	ADP
chd-221	68	20	prevention	prevention	NOUN
chd-221	68	21	,	,	PUNCT
chd-221	68	22	diagnosis	diagnosis	NOUN
chd-221	68	23	,	,	PUNCT
chd-221	68	24	and	and	CCONJ
chd-221	68	25	management	management	NOUN
chd-221	68	26	of	of	ADP
chd-221	68	27	cancer	cancer	NOUN
chd-221	68	28	,	,	PUNCT
chd-221	68	29	besides	besides	SCONJ
chd-221	68	30	contributing	contribute	VERB
chd-221	68	31	to	to	ADP
chd-221	68	32	the	the	DET
chd-221	68	33	broader	broad	ADJ
chd-221	68	34	agenda	agenda	NOUN
chd-221	68	35	of	of	ADP
chd-221	68	36	pca	pca	PROPN
chd-221	68	37	control	control	NOUN
chd-221	68	38	in	in	ADP
chd-221	68	39	the	the	DET
chd-221	68	40	country	country	NOUN
chd-221	68	41	(	(	PUNCT
chd-221	68	42	figure1	figure1	PROPN
chd-221	68	43	)	)	PUNCT
chd-221	68	44	.	.	PUNCT
chd-221	69	1	although	although	SCONJ
chd-221	69	2	early	early	ADJ
chd-221	69	3	linkage	linkage	NOUN
chd-221	69	4	analyses	analysis	NOUN
chd-221	69	5	and	and	CCONJ
chd-221	69	6	candidate	candidate	NOUN
chd-221	69	7	gene	gene	NOUN
chd-221	69	8	approaches	approach	NOUN
chd-221	69	9	are	be	AUX
chd-221	69	10	used	use	VERB
chd-221	69	11	to	to	PART
chd-221	69	12	identify	identify	VERB
chd-221	69	13	variants	variant	NOUN
chd-221	69	14	,	,	PUNCT
chd-221	69	15	this	this	DET
chd-221	69	16	coordination	coordination	NOUN
chd-221	69	17	would	would	AUX
chd-221	69	18	be	be	AUX
chd-221	69	19	of	of	ADP
chd-221	69	20	great	great	ADJ
chd-221	69	21	importance	importance	NOUN
chd-221	69	22	when	when	SCONJ
chd-221	69	23	we	we	PRON
chd-221	69	24	discuss	discuss	VERB
chd-221	69	25	adequate	adequate	ADJ
chd-221	69	26	sample	sample	NOUN
chd-221	69	27	sizes	size	NOUN
chd-221	69	28	,	,	PUNCT
chd-221	69	29	investigate	investigate	VERB
chd-221	69	30	the	the	DET
chd-221	69	31	genetic	genetic	ADJ
chd-221	69	32	–	–	PUNCT
chd-221	69	33	clinical	clinical	ADJ
chd-221	69	34	interactions	interaction	NOUN
chd-221	69	35	.	.	PUNCT
chd-221	70	1	even	even	ADV
chd-221	70	2	though	though	SCONJ
chd-221	70	3	authentic	authentic	ADJ
chd-221	70	4	statistics	statistic	NOUN
chd-221	70	5	of	of	ADP
chd-221	70	6	associated	associated	ADJ
chd-221	70	7	risk	risk	NOUN
chd-221	70	8	and	and	CCONJ
chd-221	70	9	combined	combined	ADJ
chd-221	70	10	relationship	relationship	NOUN
chd-221	70	11	of	of	ADP
chd-221	70	12	these	these	DET
chd-221	70	13	snps	snps	PROPN
chd-221	70	14	could	could	AUX
chd-221	70	15	be	be	AUX
chd-221	70	16	established	establish	VERB
chd-221	70	17	on	on	ADP
chd-221	70	18	a	a	DET
chd-221	70	19	large	large	ADJ
chd-221	70	20	-	-	PUNCT
chd-221	70	21	scale	scale	NOUN
chd-221	70	22	case	case	NOUN
chd-221	70	23	-	-	PUNCT
chd-221	70	24	control	control	NOUN
chd-221	70	25	evaluation	evaluation	NOUN
chd-221	70	26	,	,	PUNCT
chd-221	70	27	as	as	SCONJ
chd-221	70	28	previously	previously	ADV
chd-221	70	29	described	describe	VERB
chd-221	70	30	(	(	PUNCT
chd-221	70	31	kote	kote	VERB
chd-221	70	32	-	-	PUNCT
chd-221	70	33	jarai	jarai	VERB
chd-221	70	34	et	et	PROPN
chd-221	70	35	al	al	PROPN
chd-221	70	36	.	.	PROPN
chd-221	70	37	,	,	PUNCT
chd-221	70	38	2008	2008	NUM
chd-221	70	39	)	)	PUNCT
chd-221	70	40	,	,	PUNCT
chd-221	70	41	these	these	DET
chd-221	70	42	cases	case	NOUN
chd-221	70	43	have	have	VERB
chd-221	70	44	important	important	ADJ
chd-221	70	45	implications	implication	NOUN
chd-221	70	46	for	for	ADP
chd-221	70	47	public	public	ADJ
chd-221	70	48	health	health	NOUN
chd-221	70	49	as	as	ADV
chd-221	70	50	well	well	ADV
chd-221	70	51	as	as	ADP
chd-221	70	52	individualized	individualized	ADJ
chd-221	70	53	pca	pca	NOUN
chd-221	70	54	management	management	NOUN
chd-221	70	55	strategies	strategy	NOUN
chd-221	70	56	.	.	PUNCT
chd-221	71	1	having	having	AUX
chd-221	71	2	said	say	VERB
chd-221	71	3	this	this	PRON
chd-221	71	4	,	,	PUNCT
chd-221	71	5	broader	broad	ADJ
chd-221	71	6	scientific	scientific	ADJ
chd-221	71	7	collaborations	collaboration	NOUN
chd-221	71	8	are	be	AUX
chd-221	71	9	needed	need	VERB
chd-221	71	10	for	for	ADP
chd-221	71	11	better	well	ADJ
chd-221	71	12	organization	organization	NOUN
chd-221	71	13	of	of	ADP
chd-221	71	14	data	datum	NOUN
chd-221	71	15	quality	quality	NOUN
chd-221	71	16	and	and	CCONJ
chd-221	71	17	to	to	PART
chd-221	71	18	protect	protect	VERB
chd-221	71	19	confidentiality	confidentiality	NOUN
chd-221	71	20	of	of	ADP
chd-221	71	21	participants	participant	NOUN
chd-221	71	22	as	as	ADV
chd-221	71	23	well	well	ADV
chd-221	71	24	.	.	PUNCT
chd-221	72	1	india	india	PROPN
chd-221	72	2	has	have	AUX
chd-221	72	3	seen	see	VERB
chd-221	72	4	varied	varied	ADJ
chd-221	72	5	phenotypes	phenotype	NOUN
chd-221	72	6	of	of	ADP
chd-221	72	7	diabetes	diabetes	NOUN
chd-221	72	8	as	as	ADP
chd-221	72	9	a	a	DET
chd-221	72	10	lifestyle	lifestyle	NOUN
chd-221	72	11	disease	disease	NOUN
chd-221	72	12	.	.	PUNCT
chd-221	73	1	it	it	PRON
chd-221	73	2	is	be	AUX
chd-221	73	3	surprising	surprising	ADJ
chd-221	73	4	that	that	SCONJ
chd-221	73	5	though	though	SCONJ
chd-221	73	6	india	india	PROPN
chd-221	73	7	receives	receive	VERB
chd-221	73	8	splendid	splendid	ADJ
chd-221	73	9	sunshine	sunshine	NOUN
chd-221	73	10	and	and	CCONJ
chd-221	73	11	is	be	AUX
chd-221	73	12	one	one	NUM
chd-221	73	13	of	of	ADP
chd-221	73	14	the	the	DET
chd-221	73	15	largest	large	ADJ
chd-221	73	16	milk	milk	NOUN
chd-221	73	17	producers	producer	NOUN
chd-221	73	18	,	,	PUNCT
chd-221	73	19	the	the	DET
chd-221	73	20	vitamin	vitamin	NOUN
chd-221	73	21	d	d	NOUN
chd-221	73	22	deficiency	deficiency	NOUN
chd-221	73	23	is	be	AUX
chd-221	73	24	immense	immense	ADJ
chd-221	73	25	and	and	CCONJ
chd-221	73	26	what	what	PRON
chd-221	73	27	is	be	AUX
chd-221	73	28	more	more	ADV
chd-221	73	29	concerning	concern	VERB
chd-221	73	30	is	be	AUX
chd-221	73	31	that	that	SCONJ
chd-221	73	32	these	these	PRON
chd-221	73	33	are	be	AUX
chd-221	73	34	susceptible	susceptible	ADJ
chd-221	73	35	to	to	ADP
chd-221	73	36	urogenital	urogenital	ADJ
chd-221	73	37	cancers	cancer	NOUN
chd-221	73	38	/	/	SYM
chd-221	73	39	pca	pca	PROPN
chd-221	73	40	.	.	PUNCT
chd-221	74	1	furthermore	furthermore	ADV
chd-221	74	2	,	,	PUNCT
chd-221	74	3	the	the	DET
chd-221	74	4	diet	diet	NOUN
chd-221	74	5	based	base	VERB
chd-221	74	6	mutations	mutation	NOUN
chd-221	74	7	associated	associate	VERB
chd-221	74	8	with	with	ADP
chd-221	74	9	pca	pca	PROPN
chd-221	74	10	risk	risk	NOUN
chd-221	74	11	from	from	ADP
chd-221	74	12	our	our	PRON
chd-221	74	13	pilot	pilot	NOUN
chd-221	74	14	study	study	NOUN
chd-221	74	15	(	(	PUNCT
chd-221	74	16	gupta	gupta	PROPN
chd-221	74	17	et	et	PROPN
chd-221	74	18	al	al	PROPN
chd-221	74	19	.	.	PROPN
chd-221	74	20	2020	2020	NUM
chd-221	74	21	)	)	PUNCT
chd-221	74	22	further	far	ADV
chd-221	74	23	augments	augment	VERB
chd-221	74	24	the	the	DET
chd-221	74	25	hypothesis	hypothesis	NOUN
chd-221	74	26	that	that	SCONJ
chd-221	74	27	there	there	PRON
chd-221	74	28	are	be	VERB
chd-221	74	29	a	a	DET
chd-221	74	30	growing	grow	VERB
chd-221	74	31	number	number	NOUN
chd-221	74	32	of	of	ADP
chd-221	74	33	genetic	genetic	ADJ
chd-221	74	34	contributions	contribution	NOUN
chd-221	74	35	not	not	PART
chd-221	74	36	just	just	ADV
chd-221	74	37	associated	associate	VERB
chd-221	74	38	with	with	ADP
chd-221	74	39	disparities	disparity	NOUN
chd-221	74	40	but	but	CCONJ
chd-221	74	41	also	also	ADV
chd-221	74	42	from	from	ADP
chd-221	74	43	epigenetics	epigenetic	NOUN
chd-221	74	44	,	,	PUNCT
chd-221	74	45	environment	environment	NOUN
chd-221	74	46	and	and	CCONJ
chd-221	74	47	socio	socio	NOUN
chd-221	74	48	-	-	PUNCT
chd-221	74	49	economic	economic	ADJ
chd-221	74	50	status	status	NOUN
chd-221	74	51	which	which	PRON
chd-221	74	52	motivates	motivate	VERB
chd-221	74	53	us	we	PRON
chd-221	74	54	to	to	PART
chd-221	74	55	assess	assess	VERB
chd-221	74	56	the	the	DET
chd-221	74	57	objectives	objective	NOUN
chd-221	74	58	based	base	VERB
chd-221	74	59	on	on	ADP
chd-221	74	60	the	the	DET
chd-221	74	61	varied	varied	ADJ
chd-221	74	62	phenotypes	phenotype	NOUN
chd-221	74	63	.	.	PUNCT
chd-221	75	1	1	1	X
chd-221	75	2	.	.	X
chd-221	75	3	to	to	PART
chd-221	75	4	establish	establish	VERB
chd-221	75	5	pca	pca	PROPN
chd-221	75	6	as	as	ADP
chd-221	75	7	a	a	DET
chd-221	75	8	public	public	ADJ
chd-221	75	9	health	health	NOUN
chd-221	75	10	priority	priority	NOUN
chd-221	75	11	and	and	CCONJ
chd-221	75	12	a	a	DET
chd-221	75	13	leading	lead	VERB
chd-221	75	14	healthcare	healthcare	NOUN
chd-221	75	15	disparity	disparity	NOUN
chd-221	75	16	in	in	ADP
chd-221	75	17	the	the	DET
chd-221	75	18	indian	indian	ADJ
chd-221	75	19	context	context	NOUN
chd-221	75	20	.	.	PUNCT
chd-221	76	1	2	2	X
chd-221	76	2	.	.	X
chd-221	76	3	to	to	PART
chd-221	76	4	aid	aid	VERB
chd-221	76	5	in	in	ADP
chd-221	76	6	research	research	NOUN
chd-221	76	7	and	and	CCONJ
chd-221	76	8	development	development	NOUN
chd-221	76	9	,	,	PUNCT
chd-221	76	10	education	education	NOUN
chd-221	76	11	,	,	PUNCT
chd-221	76	12	data	datum	NOUN
chd-221	76	13	storage	storage	NOUN
chd-221	76	14	,	,	PUNCT
chd-221	76	15	curation	curation	NOUN
chd-221	76	16	,	,	PUNCT
chd-221	76	17	and	and	CCONJ
chd-221	76	18	public	public	ADJ
chd-221	76	19	awareness	awareness	NOUN
chd-221	76	20	in	in	ADP
chd-221	76	21	the	the	DET
chd-221	76	22	direction	direction	NOUN
chd-221	76	23	of	of	ADP
chd-221	76	24	saving	save	VERB
chd-221	76	25	lives	life	NOUN
chd-221	76	26	and	and	CCONJ
chd-221	76	27	improving	improve	VERB
chd-221	76	28	patient	patient	ADJ
chd-221	76	29	outcomes	outcome	NOUN
chd-221	76	30	3	3	NUM
chd-221	76	31	.	.	PUNCT
chd-221	76	32	to	to	PART
chd-221	76	33	collect	collect	VERB
chd-221	76	34	data	datum	NOUN
chd-221	76	35	for	for	ADP
chd-221	76	36	inherent	inherent	ADJ
chd-221	76	37	storage	storage	NOUN
chd-221	76	38	,	,	PUNCT
chd-221	76	39	entry	entry	NOUN
chd-221	76	40	and	and	CCONJ
chd-221	76	41	downstream	downstream	ADJ
chd-221	76	42	data	datum	NOUN
chd-221	76	43	curation	curation	NOUN
chd-221	76	44	patient	patient	ADJ
chd-221	76	45	longitudinal	longitudinal	ADJ
chd-221	76	46	follow	follow	NOUN
chd-221	76	47	-	-	PUNCT
chd-221	76	48	ups	up	NOUN
chd-221	76	49	the	the	DET
chd-221	76	50	most	most	ADV
chd-221	76	51	important	important	ADJ
chd-221	76	52	things	thing	NOUN
chd-221	76	53	to	to	PART
chd-221	76	54	consider	consider	VERB
chd-221	76	55	for	for	ADP
chd-221	76	56	disease	disease	NOUN
chd-221	76	57	classification	classification	NOUN
chd-221	76	58	studies	study	NOUN
chd-221	76	59	are	be	AUX
chd-221	76	60	a	a	DET
chd-221	76	61	proper	proper	ADJ
chd-221	76	62	sample	sample	NOUN
chd-221	76	63	size	size	NOUN
chd-221	76	64	and	and	CCONJ
chd-221	76	65	statistical	statistical	ADJ
chd-221	76	66	evaluation	evaluation	NOUN
chd-221	76	67	.	.	PUNCT
chd-221	77	1	any	any	DET
chd-221	77	2	influence	influence	NOUN
chd-221	77	3	of	of	ADP
chd-221	77	4	age	age	NOUN
chd-221	77	5	on	on	ADP
chd-221	77	6	the	the	DET
chd-221	77	7	study	study	NOUN
chd-221	77	8	population	population	NOUN
chd-221	77	9	and	and	CCONJ
chd-221	77	10	specific	specific	ADJ
chd-221	77	11	demographics	demographic	NOUN
chd-221	77	12	should	should	AUX
chd-221	77	13	be	be	AUX
chd-221	77	14	taken	take	VERB
chd-221	77	15	into	into	ADP
chd-221	77	16	account	account	NOUN
chd-221	77	17	.	.	PUNCT
chd-221	78	1	use	use	NOUN
chd-221	78	2	of	of	ADP
chd-221	78	3	archival	archival	NOUN
chd-221	78	4	samples	sample	NOUN
chd-221	78	5	can	can	AUX
chd-221	78	6	be	be	AUX
chd-221	78	7	challenging	challenge	VERB
chd-221	78	8	because	because	SCONJ
chd-221	78	9	of	of	ADP
chd-221	78	10	potential	potential	ADJ
chd-221	78	11	dna	dna	PROPN
chd-221	78	12	/	/	SYM
chd-221	78	13	rna	rna	NOUN
chd-221	78	14	damage	damage	NOUN
chd-221	78	15	(	(	PUNCT
chd-221	78	16	gaffney	gaffney	NOUN
chd-221	78	17	et	et	PROPN
chd-221	78	18	al	al	PROPN
chd-221	78	19	,	,	PUNCT
chd-221	78	20	2018	2018	NUM
chd-221	78	21	;	;	PUNCT
chd-221	78	22	jackson	jackson	PROPN
chd-221	78	23	et	et	PROPN
chd-221	78	24	al	al	PROPN
chd-221	78	25	.	.	PROPN
chd-221	78	26	,	,	PUNCT
chd-221	78	27	2012	2012	NUM
chd-221	78	28	)	)	PUNCT
chd-221	78	29	.	.	PUNCT
chd-221	79	1	regular	regular	ADJ
chd-221	79	2	check	check	NOUN
chd-221	79	3	-	-	PUNCT
chd-221	79	4	ups	up	NOUN
chd-221	79	5	of	of	ADP
chd-221	79	6	subjects	subject	NOUN
chd-221	79	7	in	in	ADP
chd-221	79	8	the	the	DET
chd-221	79	9	case	case	NOUN
chd-221	79	10	of	of	ADP
chd-221	79	11	longitudinal	longitudinal	ADJ
chd-221	79	12	cohort	cohort	NOUN
chd-221	79	13	studies	study	NOUN
chd-221	79	14	may	may	AUX
chd-221	79	15	increase	increase	VERB
chd-221	79	16	a	a	DET
chd-221	79	17	candidate	candidate	NOUN
chd-221	79	18	's	's	PART
chd-221	79	19	health	health	NOUN
chd-221	79	20	when	when	SCONJ
chd-221	79	21	information	information	NOUN
chd-221	79	22	is	be	AUX
chd-221	79	23	fed	feed	VERB
chd-221	79	24	back	back	ADV
chd-221	79	25	to	to	ADP
chd-221	79	26	them	they	PRON
chd-221	79	27	.	.	PUNCT
chd-221	80	1	screening	screen	VERB
chd-221	80	2	for	for	ADP
chd-221	80	3	pca	pca	NOUN
chd-221	80	4	for	for	ADP
chd-221	80	5	those	those	PRON
chd-221	80	6	with	with	ADP
chd-221	80	7	normal	normal	ADJ
chd-221	80	8	psa	psa	NOUN
chd-221	80	9	(	(	PUNCT
chd-221	80	10	<	<	X
chd-221	80	11	4ng	4ng	X
chd-221	80	12	/	/	SYM
chd-221	80	13	ml	ml	VERB
chd-221	80	14	)	)	PUNCT
chd-221	80	15	must	must	AUX
chd-221	80	16	be	be	AUX
chd-221	80	17	done	do	VERB
chd-221	80	18	in	in	ADP
chd-221	80	19	conjunction	conjunction	NOUN
chd-221	80	20	with	with	ADP
chd-221	80	21	(	(	PUNCT
chd-221	80	22	a	a	X
chd-221	80	23	)	)	PUNCT
chd-221	80	24	annual	annual	ADJ
chd-221	80	25	digital	digital	ADJ
chd-221	80	26	rectal	rectal	ADJ
chd-221	80	27	examination	examination	NOUN
chd-221	80	28	(	(	PUNCT
chd-221	80	29	dre	dre	PROPN
chd-221	80	30	)	)	PUNCT
chd-221	80	31	beginning	begin	VERB
chd-221	80	32	at	at	ADP
chd-221	80	33	the	the	DET
chd-221	80	34	age	age	NOUN
chd-221	80	35	of	of	ADP
chd-221	80	36	50	50	NUM
chd-221	80	37	(	(	PUNCT
chd-221	80	38	b	b	NOUN
chd-221	80	39	)	)	PUNCT
chd-221	80	40	psa	psa	VERB
chd-221	80	41	screening	screen	VERB
chd-221	80	42	with	with	ADP
chd-221	80	43	4k	4k	PRON
chd-221	80	44	(	(	PUNCT
chd-221	80	45	kallikrein	kallikrein	VERB
chd-221	80	46	tests	test	NOUN
chd-221	80	47	)	)	PUNCT
chd-221	80	48	and	and	CCONJ
chd-221	80	49	discussed	discuss	VERB
chd-221	80	50	with	with	ADP
chd-221	80	51	a	a	DET
chd-221	80	52	health	health	NOUN
chd-221	80	53	care	care	NOUN
chd-221	80	54	provider	provider	NOUN
chd-221	80	55	as	as	ADP
chd-221	80	56	a	a	DET
chd-221	80	57	yearly	yearly	ADJ
chd-221	80	58	test	test	NOUN
chd-221	80	59	amidst	amidst	ADP
chd-221	80	60	ages	age	NOUN
chd-221	80	61	of	of	ADP
chd-221	80	62	5569	5569	NUM
chd-221	80	63	.	.	PUNCT
chd-221	81	1	(	(	PUNCT
chd-221	81	2	c	c	X
chd-221	81	3	)	)	PUNCT
chd-221	81	4	procuring	procure	VERB
chd-221	81	5	a	a	DET
chd-221	81	6	positive	positive	ADJ
chd-221	81	7	family	family	NOUN
chd-221	81	8	history	history	NOUN
chd-221	81	9	,	,	PUNCT
chd-221	81	10	screening	screen	VERB
chd-221	81	11	intended	intend	VERB
chd-221	81	12	to	to	PART
chd-221	81	13	be	be	AUX
chd-221	81	14	divulged	divulge	VERB
chd-221	81	15	amongst	amongst	ADP
chd-221	81	16	a	a	DET
chd-221	81	17	healthcare	healthcare	NOUN
chd-221	81	18	benefactor	benefactor	NOUN
chd-221	81	19	,	,	PUNCT
chd-221	81	20	starting	start	VERB
chd-221	81	21	at	at	ADP
chd-221	81	22	age	age	NOUN
chd-221	81	23	40	40	NUM
chd-221	81	24	(	(	PUNCT
chd-221	81	25	catalona	catalona	NOUN
chd-221	81	26	and	and	CCONJ
chd-221	81	27	loeb	loeb	PROPN
chd-221	81	28	,	,	PUNCT
chd-221	81	29	2010	2010	NUM
chd-221	81	30	)	)	PUNCT
chd-221	81	31	.	.	PUNCT
chd-221	82	1	if	if	SCONJ
chd-221	82	2	psa	psa	NOUN
chd-221	82	3	/	/	SYM
chd-221	82	4	dre	dre	PROPN
chd-221	82	5	results	result	NOUN
chd-221	82	6	are	be	AUX
chd-221	82	7	alarming	alarming	ADJ
chd-221	82	8	,	,	PUNCT
chd-221	82	9	they	they	PRON
chd-221	82	10	can	can	AUX
chd-221	82	11	be	be	AUX
chd-221	82	12	supported	support	VERB
chd-221	82	13	by	by	ADP
chd-221	82	14	prostate	prostate	NOUN
chd-221	82	15	ultrasound	ultrasound	NOUN
chd-221	82	16	and	and	CCONJ
chd-221	82	17	biopsy	biopsy	NOUN
chd-221	82	18	(	(	PUNCT
chd-221	82	19	schroder	schroder	NOUN
chd-221	82	20	et	et	PROPN
chd-221	82	21	al	al	PROPN
chd-221	82	22	,	,	PUNCT
chd-221	82	23	2001	2001	NUM
chd-221	82	24	)	)	PUNCT
chd-221	82	25	.	.	PUNCT
chd-221	83	1	active	active	ADJ
chd-221	83	2	surveillance	surveillance	NOUN
chd-221	83	3	(	(	PUNCT
chd-221	83	4	as	as	ADP
chd-221	83	5	)	)	PUNCT
chd-221	83	6	of	of	ADP
chd-221	83	7	notably	notably	ADV
chd-221	83	8	low	low	ADJ
chd-221	83	9	risk	risk	NOUN
chd-221	83	10	pca	pca	NOUN
chd-221	83	11	is	be	AUX
chd-221	83	12	recommended	recommend	VERB
chd-221	83	13	,	,	PUNCT
chd-221	83	14	in	in	ADP
chd-221	83	15	which	which	PRON
chd-221	83	16	psa	psa	NOUN
chd-221	83	17	is	be	AUX
chd-221	83	18	screened	screen	VERB
chd-221	83	19	every	every	DET
chd-221	83	20	6	6	NUM
chd-221	83	21	months	month	NOUN
chd-221	83	22	,	,	PUNCT
chd-221	83	23	dre	dre	PROPN
chd-221	83	24	performed	perform	VERB
chd-221	83	25	every	every	DET
chd-221	83	26	12	12	NUM
chd-221	83	27	months	month	NOUN
chd-221	83	28	,	,	PUNCT
chd-221	83	29	and	and	CCONJ
chd-221	83	30	repeat	repeat	NOUN
chd-221	83	31	biopsy	biopsy	NOUN
chd-221	83	32	approximately	approximately	ADV
chd-221	83	33	every	every	DET
chd-221	83	34	12	12	NUM
chd-221	83	35	months	month	NOUN
chd-221	83	36	(	(	PUNCT
chd-221	83	37	nieboer	nieboer	NOUN
chd-221	83	38	et	et	NOUN
chd-221	83	39	al	al	PROPN
chd-221	83	40	,	,	PUNCT
chd-221	83	41	2018	2018	NUM
chd-221	83	42	)	)	PUNCT
chd-221	83	43	.	.	PUNCT
chd-221	84	1	on	on	ADP
chd-221	84	2	the	the	DET
chd-221	84	3	other	other	ADJ
chd-221	84	4	hand	hand	NOUN
chd-221	84	5	,	,	PUNCT
chd-221	84	6	approximately	approximately	ADV
chd-221	84	7	30	30	NUM
chd-221	84	8	%	%	NOUN
chd-221	84	9	of	of	ADP
chd-221	84	10	men	man	NOUN
chd-221	84	11	are	be	AUX
chd-221	84	12	found	find	VERB
chd-221	84	13	to	to	PART
chd-221	84	14	have	have	VERB
chd-221	84	15	higher	high	ADJ
chd-221	84	16	grade	grade	NOUN
chd-221	84	17	pca	pca	NOUN
chd-221	84	18	at	at	ADP
chd-221	84	19	repeat	repeat	NOUN
chd-221	84	20	biopsy	biopsy	NOUN
chd-221	84	21	.	.	PUNCT
chd-221	85	1	post	post	NOUN
chd-221	85	2	recovery	recovery	NOUN
chd-221	85	3	from	from	ADP
chd-221	85	4	pca	pca	PROPN
chd-221	85	5	is	be	AUX
chd-221	85	6	also	also	ADV
chd-221	85	7	statutory	statutory	ADJ
chd-221	85	8	as	as	ADP
chd-221	85	9	multifarious	multifarious	ADJ
chd-221	85	10	therapy	therapy	NOUN
chd-221	85	11	has	have	VERB
chd-221	85	12	side	side	ADJ
chd-221	85	13	effects	effect	NOUN
chd-221	85	14	such	such	ADJ
chd-221	85	15	as	as	ADP
chd-221	85	16	hormone	hormone	NOUN
chd-221	85	17	therapy	therapy	NOUN
chd-221	85	18	(	(	PUNCT
chd-221	85	19	castration	castration	NOUN
chd-221	85	20	therapy	therapy	NOUN
chd-221	85	21	)	)	PUNCT
chd-221	85	22	resulting	result	VERB
chd-221	85	23	in	in	ADP
chd-221	85	24	low	low	ADJ
chd-221	85	25	testosterone	testosterone	NOUN
chd-221	85	26	,	,	PUNCT
chd-221	85	27	hot	hot	ADJ
chd-221	85	28	flashes	flash	NOUN
chd-221	85	29	,	,	PUNCT
chd-221	85	30	osteoporosis	osteoporosis	NOUN
chd-221	85	31	,	,	PUNCT
chd-221	85	32	loss	loss	NOUN
chd-221	85	33	of	of	ADP
chd-221	85	34	muscle	muscle	NOUN
chd-221	85	35	mass	mass	PROPN
chd-221	85	36	,	,	PUNCT
chd-221	85	37	weight	weight	NOUN
chd-221	85	38	gain	gain	NOUN
chd-221	85	39	,	,	PUNCT
chd-221	85	40	erectile	erectile	ADJ
chd-221	85	41	dysfunction	dysfunction	NOUN
chd-221	85	42	,	,	PUNCT
chd-221	85	43	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-221	85	44	e7	e7	PROPN
chd-221	85	45	cancer	cancer	NOUN
chd-221	85	46	health	health	NOUN
chd-221	85	47	disparities	disparity	NOUN
chd-221	85	48	decrease	decrease	VERB
chd-221	85	49	mental	mental	ADJ
chd-221	85	50	sharpness	sharpness	NOUN
chd-221	85	51	,	,	PUNCT
chd-221	85	52	depression	depression	NOUN
chd-221	85	53	,	,	PUNCT
chd-221	85	54	fatigue	fatigue	NOUN
chd-221	85	55	and	and	CCONJ
chd-221	85	56	increased	increase	VERB
chd-221	85	57	cholesterol	cholesterol	NOUN
chd-221	85	58	levels	level	NOUN
chd-221	85	59	.	.	PUNCT
chd-221	86	1	monitoring	monitor	VERB
chd-221	86	2	psa	psa	VERB
chd-221	86	3	and	and	CCONJ
chd-221	86	4	dre	dre	PROPN
chd-221	86	5	after	after	ADP
chd-221	86	6	definitive	definitive	ADJ
chd-221	86	7	therapy	therapy	NOUN
chd-221	86	8	is	be	AUX
chd-221	86	9	compulsory	compulsory	ADJ
chd-221	86	10	,	,	PUNCT
chd-221	86	11	if	if	SCONJ
chd-221	86	12	the	the	DET
chd-221	86	13	risk	risk	NOUN
chd-221	86	14	of	of	ADP
chd-221	86	15	recurrence	recurrence	NOUN
chd-221	86	16	is	be	AUX
chd-221	86	17	high	high	ADJ
chd-221	86	18	(	(	PUNCT
chd-221	86	19	loeb	loeb	PROPN
chd-221	86	20	et	et	PROPN
chd-221	86	21	al	al	PROPN
chd-221	86	22	.	.	PROPN
chd-221	86	23	2007	2007	NUM
chd-221	86	24	)	)	PUNCT
chd-221	86	25	.	.	PUNCT
chd-221	87	1	the	the	DET
chd-221	87	2	dre	dre	PROPN
chd-221	87	3	could	could	AUX
chd-221	87	4	be	be	AUX
chd-221	87	5	performed	perform	VERB
chd-221	87	6	early	early	ADV
chd-221	87	7	,	,	PUNCT
chd-221	87	8	regardless	regardless	ADV
chd-221	87	9	of	of	ADP
chd-221	87	10	whether	whether	SCONJ
chd-221	87	11	the	the	DET
chd-221	87	12	psa	psa	NOUN
chd-221	87	13	is	be	AUX
chd-221	87	14	undetectable	undetectable	ADJ
chd-221	87	15	as	as	SCONJ
chd-221	87	16	patients	patient	NOUN
chd-221	87	17	treated	treat	VERB
chd-221	87	18	with	with	ADP
chd-221	87	19	radiation	radiation	NOUN
chd-221	87	20	therapy	therapy	NOUN
chd-221	87	21	have	have	VERB
chd-221	87	22	a	a	DET
chd-221	87	23	truncated	truncate	VERB
chd-221	87	24	,	,	PUNCT
chd-221	87	25	but	but	CCONJ
chd-221	87	26	measurable	measurable	ADJ
chd-221	87	27	psa	psa	NOUN
chd-221	87	28	.	.	PUNCT
chd-221	88	1	prevalence	prevalence	NOUN
chd-221	88	2	of	of	ADP
chd-221	88	3	some	some	DET
chd-221	88	4	psychological	psychological	ADJ
chd-221	88	5	morbidity	morbidity	NOUN
chd-221	88	6	(	(	PUNCT
chd-221	88	7	distress	distress	NOUN
chd-221	88	8	,	,	PUNCT
chd-221	88	9	anxiety	anxiety	NOUN
chd-221	88	10	and	and	CCONJ
chd-221	88	11	depression	depression	NOUN
chd-221	88	12	)	)	PUNCT
chd-221	88	13	is	be	AUX
chd-221	88	14	also	also	ADV
chd-221	88	15	reported	report	VERB
chd-221	88	16	in	in	ADP
chd-221	88	17	pca	pca	NOUN
chd-221	88	18	patients	patient	NOUN
chd-221	88	19	who	who	PRON
chd-221	88	20	can	can	AUX
chd-221	88	21	both	both	CCONJ
chd-221	88	22	directly	directly	ADV
chd-221	88	23	or	or	CCONJ
chd-221	88	24	indirectly	indirectly	ADV
chd-221	88	25	influence	influence	VERB
chd-221	88	26	the	the	DET
chd-221	88	27	patient	patient	NOUN
chd-221	88	28	's	's	PART
chd-221	88	29	outcomes	outcome	NOUN
chd-221	88	30	(	(	PUNCT
chd-221	88	31	quality	quality	NOUN
chd-221	88	32	of	of	ADP
chd-221	88	33	life	life	NOUN
chd-221	88	34	)	)	PUNCT
chd-221	88	35	.	.	PUNCT
chd-221	89	1	earlier	early	ADV
chd-221	89	2	mental	mental	ADJ
chd-221	89	3	status	status	NOUN
chd-221	89	4	in	in	ADP
chd-221	89	5	these	these	DET
chd-221	89	6	patients	patient	NOUN
chd-221	89	7	was	be	AUX
chd-221	89	8	given	give	VERB
chd-221	89	9	less	less	ADJ
chd-221	89	10	attention	attention	NOUN
chd-221	89	11	;	;	PUNCT
chd-221	89	12	however	however	ADV
chd-221	89	13	nowadays	nowadays	ADV
chd-221	89	14	it	it	PRON
chd-221	89	15	has	have	AUX
chd-221	89	16	been	be	AUX
chd-221	89	17	critically	critically	ADV
chd-221	89	18	included	include	VERB
chd-221	89	19	as	as	ADP
chd-221	89	20	a	a	DET
chd-221	89	21	part	part	NOUN
chd-221	89	22	of	of	ADP
chd-221	89	23	high	high	ADJ
chd-221	89	24	quality	quality	NOUN
chd-221	89	25	cancer	cancer	NOUN
chd-221	89	26	care	care	NOUN
chd-221	89	27	during	during	ADP
chd-221	89	28	longitudinal	longitudinal	ADJ
chd-221	89	29	follow	follow	NOUN
chd-221	89	30	ups	up	NOUN
chd-221	89	31	(	(	PUNCT
chd-221	89	32	kershaw	kershaw	PROPN
chd-221	89	33	et	et	PROPN
chd-221	89	34	al	al	PROPN
chd-221	89	35	.	.	PROPN
chd-221	89	36	,	,	PUNCT
chd-221	89	37	2008	2008	NUM
chd-221	89	38	)	)	PUNCT
chd-221	89	39	(	(	PUNCT
chd-221	89	40	punnen	punnen	NOUN
chd-221	89	41	et	et	PROPN
chd-221	89	42	al	al	PROPN
chd-221	89	43	.	.	PROPN
chd-221	89	44	,	,	PUNCT
chd-221	89	45	2013	2013	NUM
chd-221	89	46	)	)	PUNCT
chd-221	89	47	.	.	PUNCT
chd-221	90	1	figure	figure	VERB
chd-221	90	2	1	1	NUM
chd-221	90	3	:	:	PUNCT
chd-221	90	4	a	a	DET
chd-221	90	5	pictorial	pictorial	ADJ
chd-221	90	6	representation	representation	NOUN
chd-221	90	7	of	of	ADP
chd-221	90	8	capci	capci	PROPN
chd-221	90	9	inception	inception	NOUN
chd-221	90	10	,	,	PUNCT
chd-221	90	11	current	current	ADJ
chd-221	90	12	developments	development	NOUN
chd-221	90	13	and	and	CCONJ
chd-221	90	14	future	future	ADJ
chd-221	90	15	goals	goal	NOUN
chd-221	90	16	overcoming	overcome	VERB
chd-221	90	17	sample	sample	NOUN
chd-221	90	18	conundrum	conundrum	NOUN
chd-221	90	19	for	for	ADP
chd-221	90	20	isolation	isolation	NOUN
chd-221	90	21	of	of	ADP
chd-221	90	22	biomolecules	biomolecule	NOUN
chd-221	90	23	for	for	ADP
chd-221	90	24	next	next	ADJ
chd-221	90	25	generation	generation	NOUN
chd-221	90	26	sequencing	sequence	VERB
chd-221	90	27	over	over	ADP
chd-221	90	28	the	the	DET
chd-221	90	29	years	year	NOUN
chd-221	90	30	,	,	PUNCT
chd-221	90	31	several	several	ADJ
chd-221	90	32	genome	genome	NOUN
chd-221	90	33	wide	wide	ADJ
chd-221	90	34	association	association	NOUN
chd-221	90	35	studies	study	NOUN
chd-221	90	36	(	(	PUNCT
chd-221	90	37	gwas	gwas	PROPN
chd-221	90	38	)	)	PUNCT
chd-221	90	39	have	have	AUX
chd-221	90	40	yielded	yield	VERB
chd-221	90	41	substantial	substantial	ADJ
chd-221	90	42	pca	pca	NOUN
chd-221	90	43	risk	risk	NOUN
chd-221	90	44	alleles	allele	NOUN
chd-221	90	45	/	/	SYM
chd-221	90	46	snps	snps	NOUN
chd-221	90	47	in	in	ADP
chd-221	90	48	various	various	ADJ
chd-221	90	49	populations	population	NOUN
chd-221	90	50	.	.	PUNCT
chd-221	91	1	by	by	ADP
chd-221	91	2	and	and	CCONJ
chd-221	91	3	large	large	ADJ
chd-221	91	4	,	,	PUNCT
chd-221	91	5	the	the	DET
chd-221	91	6	african	african	ADJ
chd-221	91	7	american	american	PROPN
chd-221	91	8	(	(	PUNCT
chd-221	91	9	aa	aa	PROPN
chd-221	91	10	)	)	PUNCT
chd-221	91	11	population	population	NOUN
chd-221	91	12	is	be	AUX
chd-221	91	13	largely	largely	ADV
chd-221	91	14	affected	affect	VERB
chd-221	91	15	followed	follow	VERB
chd-221	91	16	by	by	ADP
chd-221	91	17	european	european	PROPN
chd-221	91	18	american	american	PROPN
chd-221	91	19	(	(	PUNCT
chd-221	91	20	ea	ea	NOUN
chd-221	91	21	)	)	PUNCT
chd-221	91	22	when	when	SCONJ
chd-221	91	23	compared	compare	VERB
chd-221	91	24	to	to	ADP
chd-221	91	25	other	other	ADJ
chd-221	91	26	sub	sub	NOUN
chd-221	91	27	-	-	NOUN
chd-221	91	28	population	population	NOUN
chd-221	91	29	across	across	ADP
chd-221	91	30	the	the	DET
chd-221	91	31	world	world	NOUN
chd-221	91	32	.	.	PUNCT
chd-221	92	1	however	however	ADV
chd-221	92	2	,	,	PUNCT
chd-221	92	3	a	a	DET
chd-221	92	4	very	very	ADV
chd-221	92	5	limited	limited	ADJ
chd-221	92	6	number	number	NOUN
chd-221	92	7	of	of	ADP
chd-221	92	8	next	next	ADJ
chd-221	92	9	-	-	PUNCT
chd-221	92	10	generation	generation	NOUN
chd-221	92	11	sequencing	sequencing	NOUN
chd-221	92	12	(	(	PUNCT
chd-221	92	13	ngs	ng	NOUN
chd-221	92	14	)	)	PUNCT
chd-221	92	15	strategies	strategy	NOUN
chd-221	92	16	have	have	AUX
chd-221	92	17	been	be	AUX
chd-221	92	18	done	do	VERB
chd-221	92	19	to	to	PART
chd-221	92	20	ascertain	ascertain	VERB
chd-221	92	21	the	the	DET
chd-221	92	22	risk	risk	NOUN
chd-221	92	23	of	of	ADP
chd-221	92	24	pca	pca	PROPN
chd-221	92	25	.	.	PUNCT
chd-221	93	1	we	we	PRON
chd-221	93	2	at	at	ADP
chd-221	93	3	capci	capci	PROPN
chd-221	93	4	foresee	foresee	NOUN
chd-221	93	5	that	that	SCONJ
chd-221	93	6	it	it	PRON
chd-221	93	7	is	be	AUX
chd-221	93	8	inevitable	inevitable	ADJ
chd-221	93	9	to	to	ADP
chd-221	93	10	sequence	sequence	NOUN
chd-221	93	11	as	as	ADP
chd-221	93	12	many	many	ADJ
chd-221	93	13	samples	sample	NOUN
chd-221	93	14	to	to	PART
chd-221	93	15	identify	identify	VERB
chd-221	93	16	risk	risk	NOUN
chd-221	93	17	alleles	allele	NOUN
chd-221	93	18	associated	associate	VERB
chd-221	93	19	with	with	ADP
chd-221	93	20	the	the	DET
chd-221	93	21	genetic	genetic	ADJ
chd-221	93	22	contribution	contribution	NOUN
chd-221	93	23	of	of	ADP
chd-221	93	24	pca	pca	PROPN
chd-221	93	25	.	.	PUNCT
chd-221	94	1	this	this	PRON
chd-221	94	2	is	be	AUX
chd-221	94	3	also	also	ADV
chd-221	94	4	due	due	ADJ
chd-221	94	5	to	to	ADP
chd-221	94	6	the	the	DET
chd-221	94	7	supporting	support	VERB
chd-221	94	8	evidence	evidence	NOUN
chd-221	94	9	that	that	SCONJ
chd-221	94	10	the	the	DET
chd-221	94	11	gwas	gwas	NOUN
chd-221	94	12	has	have	AUX
chd-221	94	13	probably	probably	ADV
chd-221	94	14	not	not	PART
chd-221	94	15	identified	identify	VERB
chd-221	94	16	the	the	DET
chd-221	94	17	snps	snps	PROPN
chd-221	94	18	associated	associate	VERB
chd-221	94	19	with	with	ADP
chd-221	94	20	pca	pca	PROPN
chd-221	94	21	risk	risk	NOUN
chd-221	94	22	,	,	PUNCT
chd-221	94	23	accounting	account	VERB
chd-221	94	24	for	for	ADP
chd-221	94	25	the	the	DET
chd-221	94	26	lack	lack	NOUN
chd-221	94	27	of	of	ADP
chd-221	94	28	psa	psa	NOUN
chd-221	94	29	in	in	ADP
chd-221	94	30	the	the	DET
chd-221	94	31	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-221	94	32	e8	e8	PROPN
chd-221	94	33	cancer	cancer	NOUN
chd-221	94	34	health	health	NOUN
chd-221	94	35	disparities	disparitie	VERB
chd-221	94	36	african	african	ADJ
chd-221	94	37	population	population	NOUN
chd-221	94	38	which	which	PRON
chd-221	94	39	leads	lead	VERB
chd-221	94	40	us	we	PRON
chd-221	94	41	to	to	PART
chd-221	94	42	study	study	VERB
chd-221	94	43	this	this	PRON
chd-221	94	44	in	in	ADP
chd-221	94	45	developing	develop	VERB
chd-221	94	46	countries	country	NOUN
chd-221	94	47	including	include	VERB
chd-221	94	48	india	india	PROPN
chd-221	94	49	.	.	PUNCT
chd-221	95	1	the	the	DET
chd-221	95	2	ngs	ng	NOUN
chd-221	95	3	would	would	AUX
chd-221	95	4	allow	allow	VERB
chd-221	95	5	us	we	PRON
chd-221	95	6	to	to	PART
chd-221	95	7	identify	identify	VERB
chd-221	95	8	a	a	DET
chd-221	95	9	number	number	NOUN
chd-221	95	10	of	of	ADP
chd-221	95	11	variants	variant	NOUN
chd-221	95	12	in	in	ADP
chd-221	95	13	tumor	tumor	NOUN
chd-221	95	14	samples	sample	NOUN
chd-221	95	15	in	in	ADP
chd-221	95	16	a	a	DET
chd-221	95	17	clinical	clinical	ADJ
chd-221	95	18	setting	setting	NOUN
chd-221	95	19	.	.	PUNCT
chd-221	96	1	whole	whole	ADJ
chd-221	96	2	genome	genome	NOUN
chd-221	96	3	sequencing	sequence	VERB
chd-221	96	4	(	(	PUNCT
chd-221	96	5	wgs	wgs	NOUN
chd-221	96	6	)	)	PUNCT
chd-221	96	7	or	or	CCONJ
chd-221	96	8	whole	whole	ADJ
chd-221	96	9	exome	exome	NOUN
chd-221	96	10	sequencing	sequence	VERB
chd-221	96	11	(	(	PUNCT
chd-221	96	12	wes	wes	PROPN
chd-221	96	13	)	)	PUNCT
chd-221	96	14	could	could	AUX
chd-221	96	15	serve	serve	VERB
chd-221	96	16	as	as	ADP
chd-221	96	17	a	a	DET
chd-221	96	18	diagnostic	diagnostic	ADJ
chd-221	96	19	determinant	determinant	ADJ
chd-221	96	20	in	in	ADP
chd-221	96	21	identifying	identify	VERB
chd-221	96	22	new	new	ADJ
chd-221	96	23	mutations	mutation	NOUN
chd-221	96	24	.	.	PUNCT
chd-221	97	1	this	this	PRON
chd-221	97	2	is	be	AUX
chd-221	97	3	ably	ably	ADV
chd-221	97	4	supported	support	VERB
chd-221	97	5	and	and	CCONJ
chd-221	97	6	followed	follow	VERB
chd-221	97	7	by	by	ADP
chd-221	97	8	sanger	sanger	PROPN
chd-221	97	9	sequencing	sequencing	NOUN
chd-221	97	10	which	which	PRON
chd-221	97	11	validates	validate	VERB
chd-221	97	12	the	the	DET
chd-221	97	13	analyzed	analyze	VERB
chd-221	97	14	regions	region	NOUN
chd-221	97	15	to	to	PART
chd-221	97	16	accomplish	accomplish	VERB
chd-221	97	17	sufficient	sufficient	ADJ
chd-221	97	18	depth	depth	NOUN
chd-221	97	19	of	of	ADP
chd-221	97	20	coverage	coverage	NOUN
chd-221	97	21	or	or	CCONJ
chd-221	97	22	to	to	PART
chd-221	97	23	create	create	VERB
chd-221	97	24	data	datum	NOUN
chd-221	97	25	of	of	ADP
chd-221	97	26	superior	superior	ADJ
chd-221	97	27	quality	quality	NOUN
chd-221	97	28	and	and	CCONJ
chd-221	97	29	further	further	ADJ
chd-221	97	30	checks	check	NOUN
chd-221	97	31	for	for	ADP
chd-221	97	32	downstream	downstream	ADJ
chd-221	97	33	validation	validation	NOUN
chd-221	97	34	(	(	PUNCT
chd-221	97	35	li	li	PROPN
chd-221	97	36	et	et	PROPN
chd-221	97	37	al	al	PROPN
chd-221	97	38	.	.	PROPN
chd-221	97	39	,	,	PUNCT
chd-221	97	40	2020	2020	NUM
chd-221	97	41	)	)	PUNCT
chd-221	97	42	.	.	PUNCT
chd-221	98	1	in	in	ADP
chd-221	98	2	addition	addition	NOUN
chd-221	98	3	,	,	PUNCT
chd-221	98	4	the	the	DET
chd-221	98	5	capci	capci	NOUN
chd-221	98	6	aims	aim	VERB
chd-221	98	7	to	to	PART
chd-221	98	8	establish	establish	VERB
chd-221	98	9	a	a	DET
chd-221	98	10	new	new	ADJ
chd-221	98	11	collaborative	collaborative	ADJ
chd-221	98	12	site	site	NOUN
chd-221	98	13	for	for	ADP
chd-221	98	14	the	the	DET
chd-221	98	15	collection	collection	NOUN
chd-221	98	16	of	of	ADP
chd-221	98	17	tissues	tissue	NOUN
chd-221	98	18	for	for	ADP
chd-221	98	19	research	research	NOUN
chd-221	98	20	that	that	PRON
chd-221	98	21	would	would	AUX
chd-221	98	22	be	be	AUX
chd-221	98	23	essential	essential	ADJ
chd-221	98	24	for	for	ADP
chd-221	98	25	pca	pca	NOUN
chd-221	98	26	screening	screening	NOUN
chd-221	98	27	.	.	PUNCT
chd-221	99	1	from	from	ADP
chd-221	99	2	our	our	PRON
chd-221	99	3	prior	prior	ADJ
chd-221	99	4	experience	experience	NOUN
chd-221	99	5	in	in	ADP
chd-221	99	6	handling	handle	VERB
chd-221	99	7	the	the	DET
chd-221	99	8	samples	sample	NOUN
chd-221	99	9	,	,	PUNCT
chd-221	99	10	we	we	PRON
chd-221	99	11	hope	hope	VERB
chd-221	99	12	to	to	PART
chd-221	99	13	document	document	VERB
chd-221	99	14	sustainable	sustainable	ADJ
chd-221	99	15	goals	goal	NOUN
chd-221	99	16	for	for	ADP
chd-221	99	17	isolation	isolation	NOUN
chd-221	99	18	should	should	AUX
chd-221	99	19	be	be	AUX
chd-221	99	20	performed	perform	VERB
chd-221	99	21	.	.	PUNCT
chd-221	100	1	in	in	ADP
chd-221	100	2	biomedical	biomedical	ADJ
chd-221	100	3	research	research	NOUN
chd-221	100	4	,	,	PUNCT
chd-221	100	5	to	to	PART
chd-221	100	6	ensure	ensure	VERB
chd-221	100	7	effortless	effortless	ADJ
chd-221	100	8	identification	identification	NOUN
chd-221	100	9	of	of	ADP
chd-221	100	10	specimens	specimen	NOUN
chd-221	100	11	,	,	PUNCT
chd-221	100	12	correct	correct	ADJ
chd-221	100	13	labeling	labeling	NOUN
chd-221	100	14	and	and	CCONJ
chd-221	100	15	barcoding	barcoding	NOUN
chd-221	100	16	of	of	ADP
chd-221	100	17	each	each	DET
chd-221	100	18	specimen	speciman	NOUN
chd-221	100	19	of	of	ADP
chd-221	100	20	tissue	tissue	NOUN
chd-221	100	21	is	be	AUX
chd-221	100	22	paramount	paramount	ADJ
chd-221	100	23	.	.	PUNCT
chd-221	101	1	unlabeled	unlabeled	PROPN
chd-221	101	2	and/or	and/or	CCONJ
chd-221	101	3	mislabeled	mislabele	VERB
chd-221	101	4	(	(	PUNCT
chd-221	101	5	e.g.	e.g.	ADJ
chd-221	101	6	,	,	PUNCT
chd-221	101	7	illegible	illegible	ADJ
chd-221	101	8	handwriting	handwriting	NOUN
chd-221	101	9	)	)	PUNCT
chd-221	101	10	specimens	specimen	NOUN
chd-221	101	11	might	might	AUX
chd-221	101	12	present	present	VERB
chd-221	101	13	a	a	DET
chd-221	101	14	great	great	ADJ
chd-221	101	15	clinical	clinical	ADJ
chd-221	101	16	risk	risk	NOUN
chd-221	101	17	,	,	PUNCT
chd-221	101	18	which	which	PRON
chd-221	101	19	can	can	AUX
chd-221	101	20	be	be	AUX
chd-221	101	21	prevented	prevent	VERB
chd-221	101	22	by	by	ADP
chd-221	101	23	using	use	VERB
chd-221	101	24	a	a	DET
chd-221	101	25	proper	proper	ADJ
chd-221	101	26	and	and	CCONJ
chd-221	101	27	defined	define	VERB
chd-221	101	28	method	method	NOUN
chd-221	101	29	of	of	ADP
chd-221	101	30	labeling	labeling	NOUN
chd-221	101	31	.	.	PUNCT
chd-221	102	1	holistically	holistically	ADV
chd-221	102	2	,	,	PUNCT
chd-221	102	3	barcodes	barcode	NOUN
chd-221	102	4	can	can	AUX
chd-221	102	5	be	be	AUX
chd-221	102	6	an	an	DET
chd-221	102	7	efficient	efficient	ADJ
chd-221	102	8	way	way	NOUN
chd-221	102	9	of	of	ADP
chd-221	102	10	labeling	labeling	NOUN
chd-221	102	11	.	.	PUNCT
chd-221	103	1	developing	develop	VERB
chd-221	103	2	and	and	CCONJ
chd-221	103	3	implementing	implement	VERB
chd-221	103	4	a	a	DET
chd-221	103	5	barcode	barcode	NOUN
chd-221	103	6	system	system	NOUN
chd-221	103	7	will	will	AUX
chd-221	103	8	allow	allow	VERB
chd-221	103	9	links	link	NOUN
chd-221	103	10	to	to	PART
chd-221	103	11	construct	construct	VERB
chd-221	103	12	high	high	ADJ
chd-221	103	13	-	-	PUNCT
chd-221	103	14	throughput	throughput	NOUN
chd-221	103	15	analysis	analysis	NOUN
chd-221	103	16	of	of	ADP
chd-221	103	17	tissue	tissue	NOUN
chd-221	103	18	microarrays	microarray	NOUN
chd-221	103	19	(	(	PUNCT
chd-221	103	20	tmas	tma	NOUN
chd-221	103	21	)	)	PUNCT
chd-221	103	22	.	.	PUNCT
chd-221	104	1	tmas	tma	NOUN
chd-221	104	2	are	be	AUX
chd-221	104	3	basically	basically	ADV
chd-221	104	4	tissue	tissue	NOUN
chd-221	104	5	“	"	PUNCT
chd-221	104	6	archives	archive	NOUN
chd-221	104	7	”	"	PUNCT
chd-221	104	8	developed	develop	VERB
chd-221	104	9	by	by	ADP
chd-221	104	10	the	the	DET
chd-221	104	11	recurring	recur	VERB
chd-221	104	12	transfer	transfer	NOUN
chd-221	104	13	of	of	ADP
chd-221	104	14	small	small	ADJ
chd-221	104	15	tissue	tissue	NOUN
chd-221	104	16	cores	core	NOUN
chd-221	104	17	,	,	PUNCT
chd-221	104	18	from	from	ADP
chd-221	104	19	paraffin	paraffin	NOUN
chd-221	104	20	embedded	embed	VERB
chd-221	104	21	‘	'	PUNCT
chd-221	104	22	donor	donor	NOUN
chd-221	104	23	’	'	PUNCT
chd-221	104	24	blocks	block	NOUN
chd-221	104	25	into	into	ADP
chd-221	104	26	a	a	DET
chd-221	104	27	single	single	ADJ
chd-221	104	28	tma	tma	PROPN
chd-221	104	29	‘	'	PUNCT
chd-221	104	30	recipient	recipient	NOUN
chd-221	104	31	’	'	PUNCT
chd-221	104	32	block	block	NOUN
chd-221	104	33	.	.	PUNCT
chd-221	105	1	the	the	DET
chd-221	105	2	tmas	tma	NOUN
chd-221	105	3	represent	represent	VERB
chd-221	105	4	a	a	DET
chd-221	105	5	unique	unique	ADJ
chd-221	105	6	approach	approach	NOUN
chd-221	105	7	of	of	ADP
chd-221	105	8	simultaneous	simultaneous	ADJ
chd-221	105	9	analysis	analysis	NOUN
chd-221	105	10	of	of	ADP
chd-221	105	11	up	up	ADP
chd-221	105	12	to	to	PART
chd-221	105	13	1000	1000	NUM
chd-221	105	14	different	different	ADJ
chd-221	105	15	tissue	tissue	NOUN
chd-221	105	16	samples	sample	NOUN
chd-221	105	17	at	at	ADP
chd-221	105	18	the	the	DET
chd-221	105	19	dna	dna	PROPN
chd-221	105	20	,	,	PUNCT
chd-221	105	21	rna	rna	NOUN
chd-221	105	22	or	or	CCONJ
chd-221	105	23	protein	protein	NOUN
chd-221	105	24	level	level	NOUN
chd-221	105	25	by	by	ADP
chd-221	105	26	immunohistochemistry	immunohistochemistry	NOUN
chd-221	105	27	(	(	PUNCT
chd-221	105	28	ihc	ihc	PROPN
chd-221	105	29	)	)	PUNCT
chd-221	105	30	,	,	PUNCT
chd-221	105	31	in	in	ADP
chd-221	105	32	situ	situ	ADJ
chd-221	105	33	hybridization	hybridization	NOUN
chd-221	105	34	(	(	PUNCT
chd-221	105	35	ish	ish	PROPN
chd-221	105	36	)	)	PUNCT
chd-221	105	37	,	,	PUNCT
chd-221	105	38	or	or	CCONJ
chd-221	105	39	immunofluorescence	immunofluorescence	NOUN
chd-221	105	40	(	(	PUNCT
chd-221	105	41	if	if	SCONJ
chd-221	105	42	)	)	PUNCT
chd-221	105	43	.	.	PUNCT
chd-221	106	1	tmas	tmas	PROPN
chd-221	106	2	could	could	AUX
chd-221	106	3	be	be	AUX
chd-221	106	4	obtained	obtain	VERB
chd-221	106	5	from	from	ADP
chd-221	106	6	tissue	tissue	NOUN
chd-221	106	7	repositories	repository	NOUN
chd-221	106	8	which	which	PRON
chd-221	106	9	provide	provide	VERB
chd-221	106	10	a	a	DET
chd-221	106	11	section	section	NOUN
chd-221	106	12	of	of	ADP
chd-221	106	13	tmas	tma	NOUN
chd-221	106	14	to	to	ADP
chd-221	106	15	investigators	investigator	NOUN
chd-221	106	16	and	and	CCONJ
chd-221	106	17	preserve	preserve	VERB
chd-221	106	18	precious	precious	ADJ
chd-221	106	19	raw	raw	ADJ
chd-221	106	20	material	material	NOUN
chd-221	106	21	(	(	PUNCT
chd-221	106	22	archived	archive	VERB
chd-221	106	23	tissue	tissue	NOUN
chd-221	106	24	samples	sample	NOUN
chd-221	106	25	)	)	PUNCT
chd-221	106	26	.	.	PUNCT
chd-221	107	1	we	we	PRON
chd-221	107	2	have	have	AUX
chd-221	107	3	recently	recently	ADV
chd-221	107	4	tweaked	tweak	VERB
chd-221	107	5	a	a	DET
chd-221	107	6	protocol	protocol	NOUN
chd-221	107	7	for	for	ADP
chd-221	107	8	the	the	DET
chd-221	107	9	extraction	extraction	NOUN
chd-221	107	10	of	of	ADP
chd-221	107	11	biomolecules	biomolecule	NOUN
chd-221	107	12	from	from	ADP
chd-221	107	13	formalin	formalin	NOUN
chd-221	107	14	-	-	PUNCT
chd-221	107	15	fixed	fix	VERB
chd-221	107	16	,	,	PUNCT
chd-221	107	17	paraffin	paraffin	NOUN
chd-221	107	18	embedded	embed	VERB
chd-221	107	19	(	(	PUNCT
chd-221	107	20	ffpe	ffpe	NOUN
chd-221	107	21	)	)	PUNCT
chd-221	107	22	tissue	tissue	NOUN
chd-221	107	23	blocks	block	NOUN
chd-221	107	24	that	that	PRON
chd-221	107	25	would	would	AUX
chd-221	107	26	be	be	AUX
chd-221	107	27	used	use	VERB
chd-221	107	28	for	for	ADP
chd-221	107	29	downstream	downstream	ADJ
chd-221	107	30	sequencing	sequencing	NOUN
chd-221	107	31	analysis	analysis	NOUN
chd-221	107	32	(	(	PUNCT
chd-221	107	33	shukla	shukla	NOUN
chd-221	107	34	et	et	PROPN
chd-221	107	35	al	al	PROPN
chd-221	107	36	.	.	PROPN
chd-221	107	37	2021	2021	NUM
chd-221	107	38	)	)	PUNCT
chd-221	107	39	cell	cell	NOUN
chd-221	107	40	lines	line	NOUN
chd-221	107	41	in	in	ADP
chd-221	107	42	pca	pca	PROPN
chd-221	107	43	research	research	NOUN
chd-221	107	44	cancer	cancer	NOUN
chd-221	107	45	cell	cell	NOUN
chd-221	107	46	lines	line	NOUN
chd-221	107	47	are	be	AUX
chd-221	107	48	developed	develop	VERB
chd-221	107	49	as	as	ADP
chd-221	107	50	a	a	DET
chd-221	107	51	significant	significant	ADJ
chd-221	107	52	model	model	NOUN
chd-221	107	53	system	system	NOUN
chd-221	107	54	for	for	ADP
chd-221	107	55	research	research	NOUN
chd-221	107	56	based	base	VERB
chd-221	107	57	studies	study	NOUN
chd-221	107	58	into	into	ADP
chd-221	107	59	the	the	DET
chd-221	107	60	molecular	molecular	ADJ
chd-221	107	61	mechanisms	mechanism	NOUN
chd-221	107	62	underlying	underlie	VERB
chd-221	107	63	the	the	DET
chd-221	107	64	various	various	ADJ
chd-221	107	65	aspects	aspect	NOUN
chd-221	107	66	of	of	ADP
chd-221	107	67	pca	pca	PROPN
chd-221	107	68	.	.	PUNCT
chd-221	108	1	in	in	ADP
chd-221	108	2	vitro	vitro	X
chd-221	108	3	studies	study	NOUN
chd-221	108	4	with	with	ADP
chd-221	108	5	cancer	cancer	NOUN
chd-221	108	6	cell	cell	NOUN
chd-221	108	7	lines	line	NOUN
chd-221	108	8	can	can	AUX
chd-221	108	9	be	be	AUX
chd-221	108	10	used	use	VERB
chd-221	108	11	to	to	PART
chd-221	108	12	identify	identify	VERB
chd-221	108	13	novel	novel	ADJ
chd-221	108	14	gene	gene	NOUN
chd-221	108	15	candidates	candidate	NOUN
chd-221	108	16	and	and	CCONJ
chd-221	108	17	investigate	investigate	VERB
chd-221	108	18	different	different	ADJ
chd-221	108	19	molecular	molecular	ADJ
chd-221	108	20	mechanisms	mechanism	NOUN
chd-221	108	21	.	.	PUNCT
chd-221	109	1	pca	pca	PROPN
chd-221	109	2	resulting	result	VERB
chd-221	109	3	from	from	ADP
chd-221	109	4	different	different	ADJ
chd-221	109	5	cell	cell	NOUN
chd-221	109	6	sources	source	NOUN
chd-221	109	7	in	in	ADP
chd-221	109	8	the	the	DET
chd-221	109	9	prostate	prostate	NOUN
chd-221	109	10	lead	lead	NOUN
chd-221	109	11	to	to	ADP
chd-221	109	12	the	the	DET
chd-221	109	13	development	development	NOUN
chd-221	109	14	of	of	ADP
chd-221	109	15	a	a	DET
chd-221	109	16	large	large	ADJ
chd-221	109	17	number	number	NOUN
chd-221	109	18	of	of	ADP
chd-221	109	19	pca	pca	NOUN
chd-221	109	20	cell	cell	NOUN
chd-221	109	21	lines	line	NOUN
chd-221	109	22	.	.	PUNCT
chd-221	110	1	pca	pca	NOUN
chd-221	110	2	cell	cell	NOUN
chd-221	110	3	lines	line	NOUN
chd-221	110	4	can	can	AUX
chd-221	110	5	be	be	AUX
chd-221	110	6	of	of	ADP
chd-221	110	7	two	two	NUM
chd-221	110	8	types	type	NOUN
chd-221	110	9	i.e.	i.e.	X
chd-221	110	10	androgen	androgen	NOUN
chd-221	110	11	independent	independent	ADJ
chd-221	110	12	and	and	CCONJ
chd-221	110	13	androgen	androgen	NOUN
chd-221	110	14	dependent	dependent	ADJ
chd-221	110	15	.	.	PUNCT
chd-221	111	1	a	a	DET
chd-221	111	2	database	database	NOUN
chd-221	111	3	of	of	ADP
chd-221	111	4	the	the	DET
chd-221	111	5	great	great	ADJ
chd-221	111	6	number	number	NOUN
chd-221	111	7	of	of	ADP
chd-221	111	8	pca	pca	NOUN
chd-221	111	9	cell	cell	NOUN
chd-221	111	10	lines	line	NOUN
chd-221	111	11	has	have	AUX
chd-221	111	12	been	be	AUX
chd-221	111	13	provided	provide	VERB
chd-221	111	14	by	by	ADP
chd-221	111	15	british	british	PROPN
chd-221	111	16	columbia	columbia	PROPN
chd-221	111	17	cancer	cancer	NOUN
chd-221	111	18	agency	agency	PROPN
chd-221	111	19	(	(	PUNCT
chd-221	111	20	bcca	bcca	PROPN
chd-221	111	21	)	)	PUNCT
chd-221	111	22	and	and	CCONJ
chd-221	111	23	another	another	DET
chd-221	111	24	detailed	detailed	ADJ
chd-221	111	25	and	and	CCONJ
chd-221	111	26	comprehensive	comprehensive	ADJ
chd-221	111	27	compendium	compendium	NOUN
chd-221	111	28	of	of	ADP
chd-221	111	29	pca	pca	PROPN
chd-221	111	30	cell	cell	NOUN
chd-221	111	31	lines	line	NOUN
chd-221	111	32	is	be	AUX
chd-221	111	33	available	available	ADJ
chd-221	111	34	from	from	ADP
chd-221	111	35	sobel	sobel	NOUN
chd-221	111	36	and	and	CCONJ
chd-221	111	37	sadar	sadar	PROPN
chd-221	111	38	(	(	PUNCT
chd-221	111	39	russell	russell	PROPN
chd-221	111	40	&	&	CCONJ
chd-221	111	41	kingsley	kingsley	PROPN
chd-221	111	42	,	,	PUNCT
chd-221	111	43	2003	2003	NUM
chd-221	111	44	)	)	PUNCT
chd-221	111	45	.	.	PUNCT
chd-221	112	1	the	the	DET
chd-221	112	2	availability	availability	NOUN
chd-221	112	3	of	of	ADP
chd-221	112	4	different	different	ADJ
chd-221	112	5	prostate	prostate	NOUN
chd-221	112	6	cancer	cancer	NOUN
chd-221	112	7	cell	cell	NOUN
chd-221	112	8	lines	line	NOUN
chd-221	112	9	that	that	PRON
chd-221	112	10	mimic	mimic	VERB
chd-221	112	11	human	human	ADJ
chd-221	112	12	disease	disease	NOUN
chd-221	112	13	progression	progression	NOUN
chd-221	112	14	is	be	AUX
chd-221	112	15	a	a	DET
chd-221	112	16	challenging	challenging	ADJ
chd-221	112	17	task	task	NOUN
chd-221	112	18	.	.	PUNCT
chd-221	113	1	prostate	prostate	NOUN
chd-221	113	2	cell	cell	NOUN
chd-221	113	3	lines	line	NOUN
chd-221	113	4	developed	develop	VERB
chd-221	113	5	from	from	ADP
chd-221	113	6	patients	patient	NOUN
chd-221	113	7	have	have	AUX
chd-221	113	8	been	be	AUX
chd-221	113	9	instrumental	instrumental	ADJ
chd-221	113	10	in	in	ADP
chd-221	113	11	advancing	advance	VERB
chd-221	113	12	research	research	NOUN
chd-221	113	13	in	in	ADP
chd-221	113	14	understanding	understand	VERB
chd-221	113	15	mechanistic	mechanistic	ADJ
chd-221	113	16	details	detail	NOUN
chd-221	113	17	of	of	ADP
chd-221	113	18	cancer	cancer	NOUN
chd-221	113	19	progression	progression	NOUN
chd-221	113	20	.	.	PUNCT
chd-221	114	1	there	there	PRON
chd-221	114	2	are	be	VERB
chd-221	114	3	two	two	NUM
chd-221	114	4	types	type	NOUN
chd-221	114	5	of	of	ADP
chd-221	114	6	pca	pca	NOUN
chd-221	114	7	,	,	PUNCT
chd-221	114	8	hormone	hormone	NOUN
chd-221	114	9	-	-	PUNCT
chd-221	114	10	sensitive	sensitive	ADJ
chd-221	114	11	and	and	CCONJ
chd-221	114	12	hormone	hormone	NOUN
chd-221	114	13	-	-	PUNCT
chd-221	114	14	resistant	resistant	ADJ
chd-221	114	15	.	.	PUNCT
chd-221	115	1	hormone	hormone	NOUN
chd-221	115	2	-	-	PUNCT
chd-221	115	3	sensitive	sensitive	ADJ
chd-221	115	4	pca	pca	PROPN
chd-221	115	5	responds	respond	VERB
chd-221	115	6	well	well	ADV
chd-221	115	7	to	to	ADP
chd-221	115	8	androgen	androgen	NOUN
chd-221	115	9	deprivation	deprivation	NOUN
chd-221	115	10	therapy	therapy	NOUN
chd-221	115	11	(	(	PUNCT
chd-221	115	12	adt	adt	NOUN
chd-221	115	13	)	)	PUNCT
chd-221	115	14	,	,	PUNCT
chd-221	115	15	but	but	CCONJ
chd-221	115	16	most	most	ADJ
chd-221	115	17	patients	patient	NOUN
chd-221	115	18	relapse	relapse	VERB
chd-221	115	19	with	with	ADP
chd-221	115	20	aggressive	aggressive	ADJ
chd-221	115	21	hormone	hormone	NOUN
chd-221	115	22	-	-	PUNCT
chd-221	115	23	resistant	resistant	ADJ
chd-221	115	24	pca	pca	NOUN
chd-221	115	25	after	after	ADP
chd-221	115	26	an	an	DET
chd-221	115	27	initial	initial	ADJ
chd-221	115	28	therapeutic	therapeutic	ADJ
chd-221	115	29	response	response	NOUN
chd-221	115	30	.	.	PUNCT
chd-221	116	1	the	the	DET
chd-221	116	2	mechanism	mechanism	NOUN
chd-221	116	3	of	of	ADP
chd-221	116	4	hormone	hormone	NOUN
chd-221	116	5	resistance	resistance	NOUN
chd-221	116	6	is	be	AUX
chd-221	116	7	n’t	not	PART
chd-221	116	8	well	well	ADV
chd-221	116	9	understood	understand	VERB
chd-221	116	10	and	and	CCONJ
chd-221	116	11	therefore	therefore	ADV
chd-221	116	12	appropriate	appropriate	ADJ
chd-221	116	13	prostate	prostate	NOUN
chd-221	116	14	cell	cell	NOUN
chd-221	116	15	line	line	NOUN
chd-221	116	16	models	model	NOUN
chd-221	116	17	would	would	AUX
chd-221	116	18	assist	assist	VERB
chd-221	116	19	in	in	ADP
chd-221	116	20	delineation	delineation	NOUN
chd-221	116	21	of	of	ADP
chd-221	116	22	associated	associated	ADJ
chd-221	116	23	pathways	pathway	NOUN
chd-221	116	24	.	.	PUNCT
chd-221	117	1	the	the	DET
chd-221	117	2	most	most	ADV
chd-221	117	3	common	common	ADJ
chd-221	117	4	prostate	prostate	NOUN
chd-221	117	5	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-221	117	6	e9	e9	PROPN
chd-221	117	7	cancer	cancer	NOUN
chd-221	117	8	health	health	NOUN
chd-221	117	9	disparities	disparity	NOUN
chd-221	117	10	cell	cell	NOUN
chd-221	117	11	lines	line	NOUN
chd-221	117	12	include	include	VERB
chd-221	117	13	(	(	PUNCT
chd-221	117	14	i	i	NOUN
chd-221	117	15	)	)	PUNCT
chd-221	117	16	non	non	ADJ
chd-221	117	17	-	-	ADJ
chd-221	117	18	cancerous	cancerous	ADJ
chd-221	117	19	prostate	prostate	NOUN
chd-221	117	20	epithelial	epithelial	ADJ
chd-221	117	21	cell	cell	NOUN
chd-221	117	22	lines	line	NOUN
chd-221	117	23	including	include	VERB
chd-221	117	24	rwpe-1	rwpe-1	NOUN
chd-221	117	25	,	,	PUNCT
chd-221	117	26	bph-1	bph-1	NUM
chd-221	117	27	,	,	PUNCT
chd-221	117	28	prns-1	prns-1	PROPN
chd-221	117	29	-	-	PUNCT
chd-221	117	30	1	1	NUM
chd-221	117	31	,	,	PUNCT
chd-221	117	32	rc77n	rc77n	NOUN
chd-221	117	33	/	/	SYM
chd-221	117	34	e	e	NOUN
chd-221	117	35	,	,	PUNCT
chd-221	117	36	hprepc	hprepc	X
chd-221	117	37	etc	etc	X
chd-221	117	38	;	;	PUNCT
chd-221	117	39	(	(	PUNCT
chd-221	117	40	ii	ii	NOUN
chd-221	117	41	)	)	PUNCT
chd-221	117	42	hormone	hormone	NOUN
chd-221	117	43	sensitive	sensitive	ADJ
chd-221	117	44	prostate	prostate	NOUN
chd-221	117	45	cancer	cancer	NOUN
chd-221	117	46	cell	cell	NOUN
chd-221	117	47	lines	line	NOUN
chd-221	117	48	including	include	VERB
chd-221	117	49	lncap	lncap	NOUN
chd-221	117	50	,	,	PUNCT
chd-221	117	51	lapc-4	lapc-4	PROPN
chd-221	117	52	,	,	PUNCT
chd-221	117	53	lapc-9	lapc-9	NUM
chd-221	117	54	,	,	PUNCT
chd-221	117	55	vcap	vcap	NOUN
chd-221	117	56	,	,	PUNCT
chd-221	117	57	mda	mda	PROPN
chd-221	117	58	-	-	PUNCT
chd-221	117	59	pca	pca	PROPN
chd-221	117	60	2a/2b	2a/2b	NUM
chd-221	117	61	,	,	PUNCT
chd-221	117	62	lucap	lucap	NOUN
chd-221	117	63	23.1	23.1	NUM
chd-221	117	64	,	,	PUNCT
chd-221	117	65	rc-77t	rc-77t	PROPN
chd-221	117	66	/	/	SYM
chd-221	117	67	e	e	X
chd-221	117	68	etc	etc	X
chd-221	117	69	;	;	PUNCT
chd-221	117	70	(	(	PUNCT
chd-221	117	71	iii	iii	X
chd-221	117	72	)	)	PUNCT
chd-221	117	73	hormone	hormone	NOUN
chd-221	117	74	resistant	resistant	ADJ
chd-221	117	75	prostate	prostate	NOUN
chd-221	117	76	cancer	cancer	NOUN
chd-221	117	77	cell	cell	NOUN
chd-221	117	78	lines	line	NOUN
chd-221	117	79	including	include	VERB
chd-221	117	80	pc-3	pc-3	NOUN
chd-221	117	81	,	,	PUNCT
chd-221	117	82	du-145	du-145	PROPN
chd-221	117	83	,	,	PUNCT
chd-221	117	84	c4	c4	NOUN
chd-221	117	85	-	-	PUNCT
chd-221	117	86	2	2	NUM
chd-221	117	87	/	/	SYM
chd-221	117	88	c4	c4	NOUN
chd-221	117	89	-	-	PUNCT
chd-221	117	90	2b	2b	NOUN
chd-221	117	91	,	,	PUNCT
chd-221	117	92	22rv1	22rv1	NUM
chd-221	117	93	,	,	PUNCT
chd-221	117	94	arcap	arcap	NOUN
chd-221	117	95	etc	etc	X
chd-221	117	96	(	(	PUNCT
chd-221	117	97	saranyutanon	saranyutanon	X
chd-221	117	98	et	et	PROPN
chd-221	117	99	al	al	PROPN
chd-221	117	100	.	.	PROPN
chd-221	117	101	,	,	PUNCT
chd-221	117	102	2020	2020	NUM
chd-221	117	103	)	)	PUNCT
chd-221	117	104	.	.	PUNCT
chd-221	118	1	the	the	DET
chd-221	118	2	major	major	ADJ
chd-221	118	3	disadvantage	disadvantage	NOUN
chd-221	118	4	of	of	ADP
chd-221	118	5	existing	exist	VERB
chd-221	118	6	cell	cell	NOUN
chd-221	118	7	lines	line	NOUN
chd-221	118	8	is	be	AUX
chd-221	118	9	that	that	SCONJ
chd-221	118	10	they	they	PRON
chd-221	118	11	are	be	AUX
chd-221	118	12	either	either	ADV
chd-221	118	13	derived	derive	VERB
chd-221	118	14	from	from	ADP
chd-221	118	15	normal	normal	ADJ
chd-221	118	16	tissue	tissue	NOUN
chd-221	118	17	or	or	CCONJ
chd-221	118	18	malignant	malignant	ADJ
chd-221	118	19	tissue	tissue	NOUN
chd-221	118	20	and	and	CCONJ
chd-221	118	21	are	be	AUX
chd-221	118	22	established	establish	VERB
chd-221	118	23	by	by	ADP
chd-221	118	24	gene	gene	NOUN
chd-221	118	25	transduction	transduction	NOUN
chd-221	118	26	using	use	VERB
chd-221	118	27	human	human	ADJ
chd-221	118	28	telomerase	telomerase	NOUN
chd-221	118	29	reverse	reverse	NOUN
chd-221	118	30	transcriptase	transcriptase	NOUN
chd-221	118	31	(	(	PUNCT
chd-221	118	32	htert	htert	NOUN
chd-221	118	33	)	)	PUNCT
chd-221	118	34	(	(	PUNCT
chd-221	118	35	murofushi	murofushi	PROPN
chd-221	118	36	et	et	PROPN
chd-221	118	37	.	.	PROPN
chd-221	118	38	,	,	PUNCT
chd-221	118	39	2006	2006	NUM
chd-221	118	40	)	)	PUNCT
chd-221	118	41	.	.	PUNCT
chd-221	119	1	therefore	therefore	ADV
chd-221	119	2	,	,	PUNCT
chd-221	119	3	apart	apart	ADV
chd-221	119	4	from	from	ADP
chd-221	119	5	using	use	VERB
chd-221	119	6	established	establish	VERB
chd-221	119	7	cell	cell	NOUN
chd-221	119	8	lines	line	NOUN
chd-221	119	9	,	,	PUNCT
chd-221	119	10	an	an	DET
chd-221	119	11	effort	effort	NOUN
chd-221	119	12	will	will	AUX
chd-221	119	13	be	be	AUX
chd-221	119	14	made	make	VERB
chd-221	119	15	to	to	PART
chd-221	119	16	establish	establish	VERB
chd-221	119	17	patient	patient	NOUN
chd-221	119	18	-	-	PUNCT
chd-221	119	19	derived	derive	VERB
chd-221	119	20	pca	pca	NOUN
chd-221	119	21	cell	cell	NOUN
chd-221	119	22	lines	line	NOUN
chd-221	119	23	of	of	ADP
chd-221	119	24	epithelial	epithelial	ADJ
chd-221	119	25	and	and	CCONJ
chd-221	119	26	mesenchymal	mesenchymal	ADJ
chd-221	119	27	origin	origin	NOUN
chd-221	119	28	.	.	PUNCT
chd-221	120	1	the	the	DET
chd-221	120	2	acquisition	acquisition	NOUN
chd-221	120	3	of	of	ADP
chd-221	120	4	these	these	DET
chd-221	120	5	cell	cell	NOUN
chd-221	120	6	lines	line	NOUN
chd-221	120	7	would	would	AUX
chd-221	120	8	enable	enable	VERB
chd-221	120	9	a	a	DET
chd-221	120	10	thorough	thorough	ADJ
chd-221	120	11	study	study	NOUN
chd-221	120	12	of	of	ADP
chd-221	120	13	the	the	DET
chd-221	120	14	mechanisms	mechanism	NOUN
chd-221	120	15	underlying	underlie	VERB
chd-221	120	16	hormone	hormone	NOUN
chd-221	120	17	resistance	resistance	NOUN
chd-221	120	18	in	in	ADP
chd-221	120	19	prostate	prostate	NOUN
chd-221	120	20	cancer	cancer	NOUN
chd-221	120	21	(	(	PUNCT
chd-221	120	22	namekawa	namekawa	NOUN
chd-221	120	23	et	et	PROPN
chd-221	120	24	al	al	PROPN
chd-221	120	25	.	.	PROPN
chd-221	120	26	,	,	PUNCT
chd-221	120	27	2019	2019	NUM
chd-221	120	28	)	)	PUNCT
chd-221	120	29	.	.	PUNCT
chd-221	121	1	the	the	DET
chd-221	121	2	culture	culture	NOUN
chd-221	121	3	of	of	ADP
chd-221	121	4	human	human	ADJ
chd-221	121	5	cell	cell	NOUN
chd-221	121	6	lines	line	NOUN
chd-221	121	7	requires	require	VERB
chd-221	121	8	appropriate	appropriate	ADJ
chd-221	121	9	biosafety	biosafety	NOUN
chd-221	121	10	labs	lab	NOUN
chd-221	121	11	(	(	PUNCT
chd-221	121	12	bsl	bsl	PROPN
chd-221	121	13	)	)	PUNCT
chd-221	121	14	.	.	PUNCT
chd-221	122	1	bio	bio	PROPN
chd-221	122	2	safety	safety	PROPN
chd-221	122	3	cabinet	cabinet	PROPN
chd-221	122	4	is	be	AUX
chd-221	122	5	a	a	DET
chd-221	122	6	set	set	NOUN
chd-221	122	7	of	of	ADP
chd-221	122	8	biocontainment	biocontainment	ADJ
chd-221	122	9	facilities	facility	NOUN
chd-221	122	10	to	to	PART
chd-221	122	11	grow	grow	VERB
chd-221	122	12	and	and	CCONJ
chd-221	122	13	propagate	propagate	VERB
chd-221	122	14	biological	biological	ADJ
chd-221	122	15	agents	agent	NOUN
chd-221	122	16	.	.	PUNCT
chd-221	123	1	the	the	DET
chd-221	123	2	cell	cell	NOUN
chd-221	123	3	lines	line	NOUN
chd-221	123	4	that	that	PRON
chd-221	123	5	do	do	AUX
chd-221	123	6	not	not	PART
chd-221	123	7	contain	contain	VERB
chd-221	123	8	human	human	ADJ
chd-221	123	9	or	or	CCONJ
chd-221	123	10	animal	animal	NOUN
chd-221	123	11	pathogens	pathogen	NOUN
chd-221	123	12	are	be	AUX
chd-221	123	13	designated	designate	VERB
chd-221	123	14	bsl-1	bsl-1	ADP
chd-221	123	15	.	.	X
chd-221	123	16	bsl-1	bsl-1	NUM
chd-221	123	17	is	be	AUX
chd-221	123	18	selected	select	VERB
chd-221	123	19	for	for	ADP
chd-221	123	20	agents	agent	NOUN
chd-221	123	21	that	that	PRON
chd-221	123	22	present	present	VERB
chd-221	123	23	minimal	minimal	ADJ
chd-221	123	24	potential	potential	ADJ
chd-221	123	25	hazard	hazard	NOUN
chd-221	123	26	to	to	ADP
chd-221	123	27	personnel	personnel	NOUN
chd-221	123	28	and	and	CCONJ
chd-221	123	29	the	the	DET
chd-221	123	30	environment	environment	NOUN
chd-221	123	31	.	.	PUNCT
chd-221	124	1	however	however	ADV
chd-221	124	2	,	,	PUNCT
chd-221	124	3	primary	primary	ADJ
chd-221	124	4	cell	cell	NOUN
chd-221	124	5	lines	line	NOUN
chd-221	124	6	,	,	PUNCT
chd-221	124	7	cell	cell	NOUN
chd-221	124	8	lines	line	NOUN
chd-221	124	9	transformed	transform	VERB
chd-221	124	10	by	by	ADP
chd-221	124	11	human	human	ADJ
chd-221	124	12	oncogenic	oncogenic	ADJ
chd-221	124	13	viruses	virus	NOUN
chd-221	124	14	,	,	PUNCT
chd-221	124	15	fresh	fresh	ADJ
chd-221	124	16	or	or	CCONJ
chd-221	124	17	frozen	frozen	ADJ
chd-221	124	18	tissue	tissue	NOUN
chd-221	124	19	explants	explant	NOUN
chd-221	124	20	are	be	AUX
chd-221	124	21	required	require	VERB
chd-221	124	22	to	to	PART
chd-221	124	23	be	be	AUX
chd-221	124	24	handled	handle	VERB
chd-221	124	25	using	use	VERB
chd-221	124	26	bsl-2	bsl-2	PART
chd-221	124	27	facility	facility	NOUN
chd-221	124	28	.	.	PUNCT
chd-221	124	29	bsl-2	bsl-2	PUNCT
chd-221	124	30	is	be	AUX
chd-221	124	31	designated	designate	VERB
chd-221	124	32	for	for	ADP
chd-221	124	33	all	all	DET
chd-221	124	34	the	the	DET
chd-221	124	35	agents	agent	NOUN
chd-221	124	36	associated	associate	VERB
chd-221	124	37	with	with	ADP
chd-221	124	38	human	human	ADJ
chd-221	124	39	diseases	disease	NOUN
chd-221	124	40	that	that	PRON
chd-221	124	41	pose	pose	VERB
chd-221	124	42	a	a	DET
chd-221	124	43	moderate	moderate	ADJ
chd-221	124	44	health	health	NOUN
chd-221	124	45	hazard	hazard	NOUN
chd-221	124	46	.	.	PUNCT
chd-221	125	1	the	the	DET
chd-221	125	2	national	national	ADJ
chd-221	125	3	centre	centre	NOUN
chd-221	125	4	for	for	ADP
chd-221	125	5	cell	cell	NOUN
chd-221	125	6	sciences	science	NOUN
chd-221	125	7	(	(	PUNCT
chd-221	125	8	nccs	nccs	PROPN
chd-221	125	9	)	)	PUNCT
chd-221	125	10	,	,	PUNCT
chd-221	125	11	pune	pune	NOUN
chd-221	125	12	has	have	AUX
chd-221	125	13	been	be	AUX
chd-221	125	14	at	at	ADP
chd-221	125	15	the	the	DET
chd-221	125	16	center	center	NOUN
chd-221	125	17	of	of	ADP
chd-221	125	18	providing	provide	VERB
chd-221	125	19	such	such	ADJ
chd-221	125	20	cell	cell	NOUN
chd-221	125	21	lines	line	NOUN
chd-221	125	22	for	for	ADP
chd-221	125	23	multifarious	multifarious	ADJ
chd-221	125	24	fields	field	NOUN
chd-221	125	25	of	of	ADP
chd-221	125	26	cell	cell	NOUN
chd-221	125	27	biology	biology	NOUN
chd-221	125	28	,	,	PUNCT
chd-221	125	29	conspicuously	conspicuously	ADV
chd-221	125	30	those	those	PRON
chd-221	125	31	addressing	address	VERB
chd-221	125	32	imperative	imperative	ADJ
chd-221	125	33	human	human	PROPN
chd-221	125	34	health	health	NOUN
chd-221	125	35	affairs	affair	NOUN
chd-221	125	36	such	such	ADJ
chd-221	125	37	as	as	ADP
chd-221	125	38	cancer	cancer	NOUN
chd-221	125	39	,	,	PUNCT
chd-221	125	40	integrating	integrate	VERB
chd-221	125	41	modern	modern	ADJ
chd-221	125	42	and	and	CCONJ
chd-221	125	43	conventional	conventional	ADJ
chd-221	125	44	disciplines	discipline	NOUN
chd-221	125	45	including	include	VERB
chd-221	125	46	cell	cell	NOUN
chd-221	125	47	biology	biology	NOUN
chd-221	125	48	,	,	PUNCT
chd-221	125	49	cellular	cellular	ADJ
chd-221	125	50	signaling	signaling	NOUN
chd-221	125	51	,	,	PUNCT
chd-221	125	52	stem	stem	NOUN
chd-221	125	53	cell	cell	NOUN
chd-221	125	54	biology	biology	NOUN
chd-221	125	55	,	,	PUNCT
chd-221	125	56	immunology	immunology	NOUN
chd-221	125	57	,	,	PUNCT
chd-221	125	58	genomics	genomics	NOUN
chd-221	125	59	,	,	PUNCT
chd-221	125	60	proteomics	proteomic	NOUN
chd-221	125	61	and	and	CCONJ
chd-221	125	62	systems	system	NOUN
chd-221	125	63	biology	biology	NOUN
chd-221	125	64	.	.	PUNCT
chd-221	126	1	(	(	PUNCT
chd-221	126	2	national	national	ADJ
chd-221	126	3	centre	centre	NOUN
chd-221	126	4	for	for	ADP
chd-221	126	5	cell	cell	NOUN
chd-221	126	6	science	science	NOUN
chd-221	126	7	,	,	PUNCT
chd-221	126	8	n.d	n.d	PROPN
chd-221	126	9	.	.	PROPN
chd-221	126	10	)	)	PUNCT
chd-221	126	11	need	need	VERB
chd-221	126	12	for	for	ADP
chd-221	126	13	pca	pca	PROPN
chd-221	126	14	biobank	biobank	NOUN
chd-221	126	15	a	a	DET
chd-221	126	16	biobank	biobank	NOUN
chd-221	126	17	is	be	AUX
chd-221	126	18	a	a	DET
chd-221	126	19	biorepository	biorepository	NOUN
chd-221	126	20	that	that	PRON
chd-221	126	21	stores	store	VERB
chd-221	126	22	human	human	ADJ
chd-221	126	23	biological	biological	ADJ
chd-221	126	24	samples	sample	NOUN
chd-221	126	25	and	and	CCONJ
chd-221	126	26	provides	provide	VERB
chd-221	126	27	access	access	NOUN
chd-221	126	28	for	for	ADP
chd-221	126	29	scientific	scientific	ADJ
chd-221	126	30	research	research	NOUN
chd-221	126	31	.	.	PUNCT
chd-221	127	1	while	while	SCONJ
chd-221	127	2	research	research	NOUN
chd-221	127	3	on	on	ADP
chd-221	127	4	these	these	DET
chd-221	127	5	samples	sample	NOUN
chd-221	127	6	is	be	AUX
chd-221	127	7	non	non	ADJ
chd-221	127	8	-	-	ADJ
chd-221	127	9	therapeutic	therapeutic	ADJ
chd-221	127	10	,	,	PUNCT
chd-221	127	11	it	it	PRON
chd-221	127	12	is	be	AUX
chd-221	127	13	not	not	PART
chd-221	127	14	directly	directly	ADV
chd-221	127	15	applicable	applicable	ADJ
chd-221	127	16	to	to	ADP
chd-221	127	17	the	the	DET
chd-221	127	18	donor	donor	NOUN
chd-221	127	19	/	/	SYM
chd-221	127	20	patient	patient	NOUN
chd-221	127	21	.	.	PUNCT
chd-221	128	1	classification	classification	NOUN
chd-221	128	2	is	be	AUX
chd-221	128	3	based	base	VERB
chd-221	128	4	on	on	ADP
chd-221	128	5	either	either	CCONJ
chd-221	128	6	(	(	PUNCT
chd-221	128	7	a	a	X
chd-221	128	8	)	)	PUNCT
chd-221	128	9	specific	specific	ADJ
chd-221	128	10	disease	disease	NOUN
chd-221	128	11	or	or	CCONJ
chd-221	128	12	condition	condition	NOUN
chd-221	128	13	along	along	ADP
chd-221	128	14	with	with	ADP
chd-221	128	15	possible	possible	ADJ
chd-221	128	16	control	control	NOUN
chd-221	128	17	data	datum	NOUN
chd-221	128	18	collection	collection	NOUN
chd-221	128	19	specifically	specifically	ADV
chd-221	128	20	designed	design	VERB
chd-221	128	21	for	for	ADP
chd-221	128	22	non	non	ADJ
chd-221	128	23	-	-	ADJ
chd-221	128	24	therapeutic	therapeutic	ADJ
chd-221	128	25	research	research	NOUN
chd-221	128	26	or	or	CCONJ
chd-221	128	27	existing	exist	VERB
chd-221	128	28	collections	collection	NOUN
chd-221	128	29	with	with	ADP
chd-221	128	30	samples	sample	NOUN
chd-221	128	31	that	that	PRON
chd-221	128	32	were	be	AUX
chd-221	128	33	used	use	VERB
chd-221	128	34	for	for	ADP
chd-221	128	35	diagnosis	diagnosis	NOUN
chd-221	128	36	,	,	PUNCT
chd-221	128	37	or	or	CCONJ
chd-221	128	38	(	(	PUNCT
chd-221	128	39	b	b	NOUN
chd-221	128	40	)	)	PUNCT
chd-221	128	41	population	population	NOUN
chd-221	128	42	or	or	CCONJ
chd-221	128	43	cohort	cohort	NOUN
chd-221	128	44	studies	study	NOUN
chd-221	128	45	wherein	wherein	ADJ
chd-221	128	46	phenotypic	phenotypic	NOUN
chd-221	128	47	(	(	PUNCT
chd-221	128	48	lifestyle	lifestyle	NOUN
chd-221	128	49	/	/	SYM
chd-221	128	50	medical/	medical/	NUM
chd-221	128	51	environmental	environmental	ADJ
chd-221	128	52	)	)	PUNCT
chd-221	128	53	data	datum	NOUN
chd-221	128	54	associated	associate	VERB
chd-221	128	55	with	with	ADP
chd-221	128	56	genetic	genetic	ADJ
chd-221	128	57	data	datum	NOUN
chd-221	128	58	,	,	PUNCT
chd-221	128	59	would	would	AUX
chd-221	128	60	be	be	AUX
chd-221	128	61	used	use	VERB
chd-221	128	62	as	as	ADP
chd-221	128	63	a	a	DET
chd-221	128	64	resource	resource	NOUN
chd-221	128	65	for	for	ADP
chd-221	128	66	different	different	ADJ
chd-221	128	67	types	type	NOUN
chd-221	128	68	of	of	ADP
chd-221	128	69	research	research	NOUN
chd-221	128	70	.	.	PUNCT
chd-221	129	1	the	the	DET
chd-221	129	2	convenience	convenience	NOUN
chd-221	129	3	in	in	ADP
chd-221	129	4	the	the	DET
chd-221	129	5	latter	latter	NOUN
chd-221	129	6	is	be	AUX
chd-221	129	7	that	that	SCONJ
chd-221	129	8	it	it	PRON
chd-221	129	9	provides	provide	VERB
chd-221	129	10	a	a	DET
chd-221	129	11	better	well	ADJ
chd-221	129	12	understanding	understanding	NOUN
chd-221	129	13	of	of	ADP
chd-221	129	14	the	the	DET
chd-221	129	15	prevalence	prevalence	NOUN
chd-221	129	16	of	of	ADP
chd-221	129	17	gene	gene	NOUN
chd-221	129	18	variations	variation	NOUN
chd-221	129	19	and	and	CCONJ
chd-221	129	20	relation	relation	NOUN
chd-221	129	21	between	between	ADP
chd-221	129	22	phenotype	phenotype	NOUN
chd-221	129	23	and	and	CCONJ
chd-221	129	24	genotypes	genotype	NOUN
chd-221	129	25	.	.	PUNCT
chd-221	130	1	participating	participate	VERB
chd-221	130	2	in	in	ADP
chd-221	130	3	research	research	NOUN
chd-221	130	4	may	may	AUX
chd-221	130	5	pose	pose	VERB
chd-221	130	6	a	a	DET
chd-221	130	7	limited	limited	ADJ
chd-221	130	8	physical	physical	ADJ
chd-221	130	9	and	and	CCONJ
chd-221	130	10	emotional	emotional	ADJ
chd-221	130	11	risk	risk	NOUN
chd-221	130	12	...	...	PUNCT
chd-221	130	13	confidentiality	confidentiality	NOUN
chd-221	130	14	may	may	AUX
chd-221	130	15	be	be	AUX
chd-221	130	16	an	an	DET
chd-221	130	17	issue	issue	NOUN
chd-221	130	18	due	due	ADP
chd-221	130	19	to	to	ADP
chd-221	130	20	concerns	concern	NOUN
chd-221	130	21	that	that	SCONJ
chd-221	130	22	third	third	ADJ
chd-221	130	23	parties	party	NOUN
chd-221	130	24	(	(	PUNCT
chd-221	130	25	insurers	insurer	NOUN
chd-221	130	26	,	,	PUNCT
chd-221	130	27	employers	employer	NOUN
chd-221	130	28	,	,	PUNCT
chd-221	130	29	schools	school	NOUN
chd-221	130	30	,	,	PUNCT
chd-221	130	31	and	and	CCONJ
chd-221	130	32	the	the	DET
chd-221	130	33	government	government	NOUN
chd-221	130	34	)	)	PUNCT
chd-221	130	35	may	may	AUX
chd-221	130	36	gain	gain	VERB
chd-221	130	37	access	access	NOUN
chd-221	130	38	to	to	ADP
chd-221	130	39	data	datum	NOUN
chd-221	130	40	,	,	PUNCT
chd-221	130	41	the	the	DET
chd-221	130	42	risk	risk	NOUN
chd-221	130	43	of	of	ADP
chd-221	130	44	personal	personal	ADJ
chd-221	130	45	or	or	CCONJ
chd-221	130	46	group	group	NOUN
chd-221	130	47	stigma	stigma	NOUN
chd-221	130	48	,	,	PUNCT
chd-221	130	49	and	and	CCONJ
chd-221	130	50	the	the	DET
chd-221	130	51	sensitivity	sensitivity	NOUN
chd-221	130	52	of	of	ADP
chd-221	130	53	medical	medical	ADJ
chd-221	130	54	and	and	CCONJ
chd-221	130	55	genetic	genetic	ADJ
chd-221	130	56	data	datum	NOUN
chd-221	130	57	.	.	PUNCT
chd-221	131	1	a	a	DET
chd-221	131	2	stigmatization	stigmatization	NOUN
chd-221	131	3	for	for	ADP
chd-221	131	4	‘	'	PUNCT
chd-221	131	5	fair	fair	ADJ
chd-221	131	6	institutions	institution	NOUN
chd-221	131	7	’	'	PUNCT
chd-221	131	8	and	and	CCONJ
chd-221	131	9	societal	societal	ADJ
chd-221	131	10	access	access	NOUN
chd-221	131	11	,	,	PUNCT
chd-221	131	12	privacy	privacy	NOUN
chd-221	131	13	protection	protection	NOUN
chd-221	131	14	could	could	AUX
chd-221	131	15	be	be	AUX
chd-221	131	16	done	do	VERB
chd-221	131	17	by	by	ADP
chd-221	131	18	security	security	NOUN
chd-221	131	19	,	,	PUNCT
chd-221	131	20	anonymization	anonymization	NOUN
chd-221	131	21	or	or	CCONJ
chd-221	131	22	coding	coding	NOUN
chd-221	131	23	of	of	ADP
chd-221	131	24	identifiable	identifiable	ADJ
chd-221	131	25	samples	sample	NOUN
chd-221	131	26	which	which	PRON
chd-221	131	27	would	would	AUX
chd-221	131	28	also	also	ADV
chd-221	131	29	be	be	AUX
chd-221	131	30	beneficial	beneficial	ADJ
chd-221	131	31	for	for	ADP
chd-221	131	32	biological	biological	ADJ
chd-221	131	33	materials	material	NOUN
chd-221	131	34	that	that	PRON
chd-221	131	35	are	be	AUX
chd-221	131	36	traceable	traceable	ADJ
chd-221	131	37	.	.	PUNCT
chd-221	132	1	informed	informed	ADJ
chd-221	132	2	consent	consent	NOUN
chd-221	132	3	could	could	AUX
chd-221	132	4	include	include	VERB
chd-221	132	5	allowing	allow	VERB
chd-221	132	6	people	people	NOUN
chd-221	132	7	to	to	PART
chd-221	132	8	assess	assess	VERB
chd-221	132	9	the	the	DET
chd-221	132	10	risk	risk	NOUN
chd-221	132	11	for	for	ADP
chd-221	132	12	themselves	themselves	PRON
chd-221	132	13	,	,	PUNCT
chd-221	132	14	honoring	honor	VERB
chd-221	132	15	their	their	PRON
chd-221	132	16	participation	participation	NOUN
chd-221	132	17	,	,	PUNCT
chd-221	132	18	and	and	CCONJ
chd-221	132	19	stressing	stress	VERB
chd-221	132	20	the	the	DET
chd-221	132	21	divide	divide	NOUN
chd-221	132	22	between	between	ADP
chd-221	132	23	research	research	NOUN
chd-221	132	24	and	and	CCONJ
chd-221	132	25	medical	medical	ADJ
chd-221	132	26	care	care	NOUN
chd-221	132	27	.	.	PUNCT
chd-221	133	1	many	many	ADJ
chd-221	133	2	patients	patient	NOUN
chd-221	133	3	or	or	CCONJ
chd-221	133	4	donors	donor	NOUN
chd-221	133	5	are	be	AUX
chd-221	133	6	reluctant	reluctant	ADJ
chd-221	133	7	in	in	ADP
chd-221	133	8	some	some	DET
chd-221	133	9	complex	complex	ADJ
chd-221	133	10	consent	consent	NOUN
chd-221	133	11	procedures	procedure	NOUN
chd-221	133	12	.	.	PUNCT
chd-221	134	1	nevertheless	nevertheless	ADV
chd-221	134	2	,	,	PUNCT
chd-221	134	3	it	it	PRON
chd-221	134	4	could	could	AUX
chd-221	134	5	be	be	AUX
chd-221	134	6	useful	useful	ADJ
chd-221	134	7	if	if	SCONJ
chd-221	134	8	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-221	134	9	e10	e10	NUM
chd-221	134	10	cancer	cancer	NOUN
chd-221	134	11	health	health	NOUN
chd-221	134	12	disparities	disparity	NOUN
chd-221	134	13	disease	disease	NOUN
chd-221	134	14	/	/	SYM
chd-221	134	15	condition	condition	NOUN
chd-221	134	16	is	be	AUX
chd-221	134	17	treatable	treatable	ADJ
chd-221	134	18	and	and	CCONJ
chd-221	134	19	volunteers	volunteer	NOUN
chd-221	134	20	have	have	VERB
chd-221	134	21	a	a	DET
chd-221	134	22	right	right	NOUN
chd-221	134	23	to	to	ADP
chd-221	134	24	this	this	DET
chd-221	134	25	kind	kind	NOUN
chd-221	134	26	of	of	ADP
chd-221	134	27	information	information	NOUN
chd-221	134	28	.	.	PUNCT
chd-221	135	1	to	to	PART
chd-221	135	2	overcome	overcome	VERB
chd-221	135	3	this	this	PRON
chd-221	135	4	,	,	PUNCT
chd-221	135	5	commercial	commercial	ADJ
chd-221	135	6	companies	company	NOUN
chd-221	135	7	should	should	AUX
chd-221	135	8	share	share	VERB
chd-221	135	9	a	a	DET
chd-221	135	10	part	part	NOUN
chd-221	135	11	of	of	ADP
chd-221	135	12	the	the	DET
chd-221	135	13	profit	profit	NOUN
chd-221	135	14	with	with	ADP
chd-221	135	15	people	people	NOUN
chd-221	135	16	who	who	PRON
chd-221	135	17	need	need	VERB
chd-221	135	18	it	it	PRON
chd-221	135	19	the	the	DET
chd-221	135	20	most	most	ADJ
chd-221	135	21	(	(	PUNCT
chd-221	135	22	benefit	benefit	NOUN
chd-221	135	23	sharing	sharing	NOUN
chd-221	135	24	)	)	PUNCT
chd-221	135	25	.	.	PUNCT
chd-221	136	1	for	for	ADP
chd-221	136	2	example	example	NOUN
chd-221	136	3	,	,	PUNCT
chd-221	136	4	collections	collection	NOUN
chd-221	136	5	of	of	ADP
chd-221	136	6	blood	blood	NOUN
chd-221	136	7	spot	spot	NOUN
chd-221	136	8	cards	card	NOUN
chd-221	136	9	could	could	AUX
chd-221	136	10	be	be	AUX
chd-221	136	11	used	use	VERB
chd-221	136	12	to	to	PART
chd-221	136	13	study	study	VERB
chd-221	136	14	prevalence	prevalence	NOUN
chd-221	136	15	of	of	ADP
chd-221	136	16	cancer	cancer	NOUN
chd-221	136	17	susceptibility	susceptibility	NOUN
chd-221	136	18	genes	gene	NOUN
chd-221	136	19	.	.	PUNCT
chd-221	137	1	research	research	NOUN
chd-221	137	2	progress	progress	NOUN
chd-221	137	3	should	should	AUX
chd-221	137	4	be	be	AUX
chd-221	137	5	communicated	communicate	VERB
chd-221	137	6	with	with	ADP
chd-221	137	7	the	the	DET
chd-221	137	8	participants	participant	NOUN
chd-221	137	9	in	in	ADP
chd-221	137	10	a	a	DET
chd-221	137	11	detailed	detailed	ADJ
chd-221	137	12	and	and	CCONJ
chd-221	137	13	transparent	transparent	ADJ
chd-221	137	14	manner	manner	NOUN
chd-221	137	15	either	either	CCONJ
chd-221	137	16	via	via	ADP
chd-221	137	17	personal	personal	ADJ
chd-221	137	18	interaction	interaction	NOUN
chd-221	137	19	or	or	CCONJ
chd-221	137	20	website	website	NOUN
chd-221	137	21	/	/	SYM
chd-221	137	22	newsletter	newsletter	NOUN
chd-221	137	23	.	.	PUNCT
chd-221	138	1	there	there	PRON
chd-221	138	2	should	should	AUX
chd-221	138	3	be	be	AUX
chd-221	138	4	a	a	DET
chd-221	138	5	policy	policy	NOUN
chd-221	138	6	for	for	ADP
chd-221	138	7	providing	provide	VERB
chd-221	138	8	information	information	NOUN
chd-221	138	9	related	relate	VERB
chd-221	138	10	to	to	ADP
chd-221	138	11	preventable	preventable	ADJ
chd-221	138	12	diseases	disease	NOUN
chd-221	138	13	and	and	CCONJ
chd-221	138	14	those	those	DET
chd-221	138	15	details	detail	NOUN
chd-221	138	16	need	need	VERB
chd-221	138	17	to	to	PART
chd-221	138	18	be	be	AUX
chd-221	138	19	included	include	VERB
chd-221	138	20	in	in	ADP
chd-221	138	21	informed	informed	ADJ
chd-221	138	22	consent	consent	NOUN
chd-221	138	23	forms	form	NOUN
chd-221	138	24	.	.	PUNCT
chd-221	139	1	it	it	PRON
chd-221	139	2	would	would	AUX
chd-221	139	3	have	have	VERB
chd-221	139	4	the	the	DET
chd-221	139	5	right	right	NOUN
chd-221	139	6	to	to	PART
chd-221	139	7	entreat	entreat	VERB
chd-221	139	8	citizens	citizen	NOUN
chd-221	139	9	to	to	PART
chd-221	139	10	partake	partake	VERB
chd-221	139	11	in	in	ADP
chd-221	139	12	akin	akin	ADJ
chd-221	139	13	research	research	NOUN
chd-221	139	14	.	.	PUNCT
chd-221	140	1	on	on	ADP
chd-221	140	2	the	the	DET
chd-221	140	3	other	other	ADJ
chd-221	140	4	hand	hand	NOUN
chd-221	140	5	,	,	PUNCT
chd-221	140	6	pca	pca	NOUN
chd-221	140	7	biobanks	biobank	NOUN
chd-221	140	8	could	could	AUX
chd-221	140	9	allure	allure	VERB
chd-221	140	10	the	the	DET
chd-221	140	11	general	general	ADJ
chd-221	140	12	public	public	NOUN
chd-221	140	13	to	to	PART
chd-221	140	14	scrub	scrub	VERB
chd-221	140	15	in	in	ADP
chd-221	140	16	genetic	genetic	ADJ
chd-221	140	17	research	research	NOUN
chd-221	140	18	on	on	ADP
chd-221	140	19	the	the	DET
chd-221	140	20	kernel	kernel	NOUN
chd-221	140	21	of	of	ADP
chd-221	140	22	solidarity	solidarity	PROPN
chd-221	140	23	provided	provide	VERB
chd-221	140	24	the	the	DET
chd-221	140	25	aim	aim	NOUN
chd-221	140	26	of	of	ADP
chd-221	140	27	such	such	ADJ
chd-221	140	28	research	research	NOUN
chd-221	140	29	is	be	AUX
chd-221	140	30	to	to	PART
chd-221	140	31	aid	aid	VERB
chd-221	140	32	diagnosis	diagnosis	NOUN
chd-221	140	33	and	and	CCONJ
chd-221	140	34	treatment	treatment	NOUN
chd-221	140	35	of	of	ADP
chd-221	140	36	pca	pca	NOUN
chd-221	140	37	conditions	condition	NOUN
chd-221	140	38	.	.	PUNCT
chd-221	141	1	we	we	PRON
chd-221	141	2	aim	aim	VERB
chd-221	141	3	to	to	PART
chd-221	141	4	develop	develop	VERB
chd-221	141	5	this	this	PRON
chd-221	141	6	as	as	ADP
chd-221	141	7	an	an	DET
chd-221	141	8	extended	extended	ADJ
chd-221	141	9	program	program	NOUN
chd-221	141	10	with	with	ADP
chd-221	141	11	industry	industry	NOUN
chd-221	141	12	partners	partner	NOUN
chd-221	141	13	wherein	wherein	SCONJ
chd-221	141	14	a	a	DET
chd-221	141	15	biobank	biobank	NOUN
chd-221	141	16	containing	contain	VERB
chd-221	141	17	biospecimens	biospecimen	NOUN
chd-221	141	18	,	,	PUNCT
chd-221	141	19	coupled	couple	VERB
chd-221	141	20	with	with	ADP
chd-221	141	21	both	both	DET
chd-221	141	22	clinico	clinico	NOUN
chd-221	141	23	-	-	PUNCT
chd-221	141	24	pathological	pathological	ADJ
chd-221	141	25	and	and	CCONJ
chd-221	141	26	epidemiological	epidemiological	ADJ
chd-221	141	27	data	datum	NOUN
chd-221	141	28	would	would	AUX
chd-221	141	29	be	be	AUX
chd-221	141	30	used	use	VERB
chd-221	141	31	for	for	ADP
chd-221	141	32	collaboration	collaboration	NOUN
chd-221	141	33	of	of	ADP
chd-221	141	34	urologists	urologist	NOUN
chd-221	141	35	,	,	PUNCT
chd-221	141	36	scientists	scientist	NOUN
chd-221	141	37	,	,	PUNCT
chd-221	141	38	pathologists	pathologist	NOUN
chd-221	141	39	and	and	CCONJ
chd-221	141	40	research	research	NOUN
chd-221	141	41	personnel	personnel	NOUN
chd-221	141	42	.	.	PUNCT
chd-221	142	1	blood	blood	NOUN
chd-221	142	2	,	,	PUNCT
chd-221	142	3	urine	urine	NOUN
chd-221	142	4	and	and	CCONJ
chd-221	142	5	prostate	prostate	NOUN
chd-221	142	6	tissue	tissue	NOUN
chd-221	142	7	could	could	AUX
chd-221	142	8	be	be	AUX
chd-221	142	9	obtained	obtain	VERB
chd-221	142	10	,	,	PUNCT
chd-221	142	11	systematically	systematically	ADV
chd-221	142	12	processed	process	VERB
chd-221	142	13	in	in	ADP
chd-221	142	14	a	a	DET
chd-221	142	15	timely	timely	ADJ
chd-221	142	16	fashion	fashion	NOUN
chd-221	142	17	and	and	CCONJ
chd-221	142	18	banked	bank	VERB
chd-221	142	19	on	on	ADP
chd-221	142	20	site	site	NOUN
chd-221	142	21	using	use	VERB
chd-221	142	22	standard	standard	ADJ
chd-221	142	23	operating	operating	NOUN
chd-221	142	24	procedures	procedure	NOUN
chd-221	142	25	.	.	PUNCT
chd-221	143	1	although	although	SCONJ
chd-221	143	2	a	a	DET
chd-221	143	3	few	few	ADJ
chd-221	143	4	biobanks	biobank	NOUN
chd-221	143	5	in	in	ADP
chd-221	143	6	india	india	PROPN
chd-221	143	7	such	such	ADJ
chd-221	143	8	as	as	ADP
chd-221	143	9	sapinebio	sapinebio	NOUN
chd-221	143	10	have	have	VERB
chd-221	143	11	offshoot	offshoot	NOUN
chd-221	143	12	,	,	PUNCT
chd-221	143	13	there	there	PRON
chd-221	143	14	needs	need	VERB
chd-221	143	15	to	to	PART
chd-221	143	16	be	be	AUX
chd-221	143	17	strict	strict	ADJ
chd-221	143	18	informed	informed	ADJ
chd-221	143	19	consents	consent	NOUN
chd-221	143	20	and	and	CCONJ
chd-221	143	21	anonymised	anonymise	VERB
chd-221	143	22	patient	patient	ADJ
chd-221	143	23	specimens	specimen	NOUN
chd-221	143	24	with	with	ADP
chd-221	143	25	affiliated	affiliate	VERB
chd-221	143	26	clinical	clinical	ADJ
chd-221	143	27	data	datum	NOUN
chd-221	143	28	implemented	implement	VERB
chd-221	143	29	road	road	NOUN
chd-221	143	30	ahead	ahead	ADV
chd-221	143	31	the	the	DET
chd-221	143	32	capci	capci	NOUN
chd-221	143	33	is	be	AUX
chd-221	143	34	aimed	aim	VERB
chd-221	143	35	to	to	PART
chd-221	143	36	bridge	bridge	VERB
chd-221	143	37	the	the	DET
chd-221	143	38	gap	gap	NOUN
chd-221	143	39	between	between	ADP
chd-221	143	40	cancer	cancer	NOUN
chd-221	143	41	geneticists	geneticist	NOUN
chd-221	143	42	and	and	CCONJ
chd-221	143	43	clinicians	clinician	NOUN
chd-221	143	44	/	/	SYM
chd-221	143	45	urologists	urologist	NOUN
chd-221	143	46	associated	associate	VERB
chd-221	143	47	with	with	ADP
chd-221	143	48	pca	pca	NOUN
chd-221	143	49	diagnosis	diagnosis	NOUN
chd-221	143	50	.	.	PUNCT
chd-221	144	1	screening	screen	VERB
chd-221	144	2	genomic	genomic	ADJ
chd-221	144	3	parameters	parameter	NOUN
chd-221	144	4	for	for	ADP
chd-221	144	5	pca	pca	PROPN
chd-221	144	6	will	will	AUX
chd-221	144	7	discover	discover	VERB
chd-221	144	8	functional	functional	ADJ
chd-221	144	9	aspects	aspect	NOUN
chd-221	144	10	which	which	PRON
chd-221	144	11	in	in	ADP
chd-221	144	12	turn	turn	NOUN
chd-221	144	13	will	will	AUX
chd-221	144	14	help	help	VERB
chd-221	144	15	in	in	ADP
chd-221	144	16	understanding	understand	VERB
chd-221	144	17	pathogenesis	pathogenesis	NOUN
chd-221	144	18	and	and	CCONJ
chd-221	144	19	chemo	chemo	VERB
chd-221	144	20	preventive	preventive	ADJ
chd-221	144	21	therapeutic	therapeutic	ADJ
chd-221	144	22	measures	measure	NOUN
chd-221	144	23	.	.	PUNCT
chd-221	145	1	as	as	SCONJ
chd-221	145	2	we	we	PRON
chd-221	145	3	strive	strive	VERB
chd-221	145	4	for	for	ADP
chd-221	145	5	ample	ample	ADJ
chd-221	145	6	statistical	statistical	ADJ
chd-221	145	7	data	datum	NOUN
chd-221	145	8	that	that	PRON
chd-221	145	9	could	could	AUX
chd-221	145	10	be	be	AUX
chd-221	145	11	helpful	helpful	ADJ
chd-221	145	12	in	in	ADP
chd-221	145	13	explaining	explain	VERB
chd-221	145	14	genetic	genetic	ADJ
chd-221	145	15	-	-	PUNCT
chd-221	145	16	clinical	clinical	ADJ
chd-221	145	17	and	and	CCONJ
chd-221	145	18	genetic	genetic	ADJ
chd-221	145	19	-	-	PUNCT
chd-221	145	20	epidemiological	epidemiological	ADJ
chd-221	145	21	data	datum	NOUN
chd-221	145	22	,	,	PUNCT
chd-221	145	23	a	a	DET
chd-221	145	24	reliable	reliable	ADJ
chd-221	145	25	risk	risk	NOUN
chd-221	145	26	predicting	predict	VERB
chd-221	145	27	model	model	NOUN
chd-221	145	28	could	could	AUX
chd-221	145	29	ease	ease	VERB
chd-221	145	30	the	the	DET
chd-221	145	31	screening	screening	NOUN
chd-221	145	32	and	and	CCONJ
chd-221	145	33	treatment	treatment	NOUN
chd-221	145	34	regimen	regiman	NOUN
chd-221	145	35	(	(	PUNCT
chd-221	145	36	goh	goh	PROPN
chd-221	145	37	et	et	PROPN
chd-221	145	38	al	al	PROPN
chd-221	145	39	.	.	PROPN
chd-221	145	40	,	,	PUNCT
chd-221	145	41	2012	2012	NUM
chd-221	145	42	)	)	PUNCT
chd-221	145	43	.	.	PUNCT
chd-221	146	1	on	on	ADP
chd-221	146	2	the	the	DET
chd-221	146	3	other	other	ADJ
chd-221	146	4	hand	hand	NOUN
chd-221	146	5	,	,	PUNCT
chd-221	146	6	standard	standard	ADJ
chd-221	146	7	operating	operating	NOUN
chd-221	146	8	procedures	procedure	NOUN
chd-221	146	9	(	(	PUNCT
chd-221	146	10	sops	sop	NOUN
chd-221	146	11	)	)	PUNCT
chd-221	146	12	are	be	AUX
chd-221	146	13	not	not	PART
chd-221	146	14	properly	properly	ADV
chd-221	146	15	framed	frame	VERB
chd-221	146	16	and	and	CCONJ
chd-221	146	17	with	with	ADP
chd-221	146	18	very	very	ADV
chd-221	146	19	limited	limited	ADJ
chd-221	146	20	progress	progress	NOUN
chd-221	146	21	in	in	ADP
chd-221	146	22	this	this	DET
chd-221	146	23	field	field	NOUN
chd-221	146	24	in	in	ADP
chd-221	146	25	india	india	PROPN
chd-221	146	26	,	,	PUNCT
chd-221	146	27	efforts	effort	NOUN
chd-221	146	28	to	to	PART
chd-221	146	29	distinguish	distinguish	VERB
chd-221	146	30	between	between	ADP
chd-221	146	31	indolent	indolent	ADJ
chd-221	146	32	and	and	CCONJ
chd-221	146	33	aggressive	aggressive	ADJ
chd-221	146	34	tumors	tumor	NOUN
chd-221	146	35	could	could	AUX
chd-221	146	36	be	be	AUX
chd-221	146	37	on	on	ADP
chd-221	146	38	the	the	DET
chd-221	146	39	anvil	anvil	NOUN
chd-221	146	40	.	.	PUNCT
chd-221	147	1	this	this	PRON
chd-221	147	2	can	can	AUX
chd-221	147	3	be	be	AUX
chd-221	147	4	possible	possible	ADJ
chd-221	147	5	largely	largely	ADV
chd-221	147	6	due	due	ADJ
chd-221	147	7	to	to	ADP
chd-221	147	8	reproducibility	reproducibility	NOUN
chd-221	147	9	of	of	ADP
chd-221	147	10	data	datum	NOUN
chd-221	147	11	pertaining	pertain	VERB
chd-221	147	12	to	to	ADP
chd-221	147	13	tumor	tumor	NOUN
chd-221	147	14	heterogeneity	heterogeneity	NOUN
chd-221	147	15	observed	observe	VERB
chd-221	147	16	in	in	ADP
chd-221	147	17	the	the	DET
chd-221	147	18	same	same	ADJ
chd-221	147	19	patient	patient	NOUN
chd-221	147	20	between	between	ADP
chd-221	147	21	primary	primary	ADJ
chd-221	147	22	and	and	CCONJ
chd-221	147	23	metastatic	metastatic	ADJ
chd-221	147	24	lesions	lesion	NOUN
chd-221	147	25	.	.	PUNCT
chd-221	148	1	one	one	PRON
chd-221	148	2	can	can	AUX
chd-221	148	3	address	address	VERB
chd-221	148	4	the	the	DET
chd-221	148	5	heterogeneity	heterogeneity	NOUN
chd-221	148	6	problems	problem	NOUN
chd-221	148	7	through	through	ADP
chd-221	148	8	spatial	spatial	ADJ
chd-221	148	9	transcriptomics	transcriptomic	NOUN
chd-221	148	10	approach	approach	NOUN
chd-221	148	11	,	,	PUNCT
chd-221	148	12	especially	especially	ADV
chd-221	148	13	using	use	VERB
chd-221	148	14	tma	tma	PROPN
chd-221	148	15	/	/	SYM
chd-221	148	16	ffpe	ffpe	NOUN
chd-221	148	17	sections	section	NOUN
chd-221	148	18	(	(	PUNCT
chd-221	148	19	brady	brady	PROPN
chd-221	148	20	et	et	PROPN
chd-221	148	21	al	al	PROPN
chd-221	148	22	.	.	PROPN
chd-221	148	23	,	,	PUNCT
chd-221	148	24	nature	nature	NOUN
chd-221	148	25	communication	communication	NOUN
chd-221	148	26	,	,	PUNCT
chd-221	148	27	2021).the	2021).the	DET
chd-221	148	28	capci	capci	NOUN
chd-221	148	29	’s	’s	PART
chd-221	148	30	establishment	establishment	NOUN
chd-221	148	31	of	of	ADP
chd-221	148	32	sops	sop	NOUN
chd-221	148	33	would	would	AUX
chd-221	148	34	aid	aid	VERB
chd-221	148	35	in	in	ADP
chd-221	148	36	developing	develop	VERB
chd-221	148	37	a	a	DET
chd-221	148	38	better	well	ADJ
chd-221	148	39	method	method	NOUN
chd-221	148	40	of	of	ADP
chd-221	148	41	data	datum	NOUN
chd-221	148	42	evaluation	evaluation	NOUN
chd-221	148	43	obtained	obtain	VERB
chd-221	148	44	from	from	ADP
chd-221	148	45	different	different	ADJ
chd-221	148	46	centers	center	NOUN
chd-221	148	47	with	with	ADP
chd-221	148	48	focus	focus	NOUN
chd-221	148	49	on	on	ADP
chd-221	148	50	sample	sample	NOUN
chd-221	148	51	collection	collection	NOUN
chd-221	148	52	and	and	CCONJ
chd-221	148	53	storage	storage	NOUN
chd-221	148	54	along	along	ADP
chd-221	148	55	with	with	ADP
chd-221	148	56	improving	improve	VERB
chd-221	148	57	dna	dna	PROPN
chd-221	148	58	,	,	PUNCT
chd-221	148	59	rna	rna	NOUN
chd-221	148	60	and	and	CCONJ
chd-221	148	61	protein	protein	NOUN
chd-221	148	62	extraction	extraction	NOUN
chd-221	148	63	methodologies	methodology	NOUN
chd-221	148	64	.	.	PUNCT
chd-221	149	1	a	a	DET
chd-221	149	2	need	need	NOUN
chd-221	149	3	for	for	ADP
chd-221	149	4	establishment	establishment	NOUN
chd-221	149	5	of	of	ADP
chd-221	149	6	biobanks	biobank	NOUN
chd-221	149	7	to	to	PART
chd-221	149	8	achieve	achieve	VERB
chd-221	149	9	a	a	DET
chd-221	149	10	decent	decent	ADJ
chd-221	149	11	amount	amount	NOUN
chd-221	149	12	of	of	ADP
chd-221	149	13	source	source	NOUN
chd-221	149	14	material	material	NOUN
chd-221	149	15	for	for	ADP
chd-221	149	16	future	future	ADJ
chd-221	149	17	studies	study	NOUN
chd-221	149	18	would	would	AUX
chd-221	149	19	provide	provide	VERB
chd-221	149	20	an	an	DET
chd-221	149	21	impetus	impetus	NOUN
chd-221	149	22	and	and	CCONJ
chd-221	149	23	this	this	PRON
chd-221	149	24	is	be	AUX
chd-221	149	25	only	only	ADV
chd-221	149	26	possible	possible	ADJ
chd-221	149	27	by	by	ADP
chd-221	149	28	bringing	bring	VERB
chd-221	149	29	collaborative	collaborative	ADJ
chd-221	149	30	convergence	convergence	NOUN
chd-221	149	31	to	to	ADP
chd-221	149	32	the	the	DET
chd-221	149	33	fore	fore	NOUN
chd-221	149	34	,	,	PUNCT
chd-221	149	35	as	as	SCONJ
chd-221	149	36	we	we	PRON
chd-221	149	37	say	say	VERB
chd-221	149	38	“	"	PUNCT
chd-221	149	39	ome	ome	PROPN
chd-221	149	40	”	"	PUNCT
chd-221	149	41	(	(	PUNCT
chd-221	149	42	many	many	ADJ
chd-221	149	43	~	~	PUNCT
chd-221	149	44	together	together	ADV
chd-221	149	45	)	)	PUNCT
chd-221	149	46	.	.	PUNCT
chd-221	150	1	declarations	declaration	NOUN
chd-221	150	2	acknowledgments	acknowledgment	VERB
chd-221	150	3	the	the	DET
chd-221	150	4	authors	author	NOUN
chd-221	150	5	would	would	AUX
chd-221	150	6	like	like	VERB
chd-221	150	7	to	to	PART
chd-221	150	8	acknowledge	acknowledge	VERB
chd-221	150	9	all	all	DET
chd-221	150	10	the	the	DET
chd-221	150	11	patients	patient	NOUN
chd-221	150	12	and	and	CCONJ
chd-221	150	13	their	their	PRON
chd-221	150	14	family	family	NOUN
chd-221	150	15	,	,	PUNCT
chd-221	150	16	members	member	NOUN
chd-221	150	17	of	of	ADP
chd-221	150	18	support	support	NOUN
chd-221	150	19	staff	staff	NOUN
chd-221	150	20	of	of	ADP
chd-221	150	21	the	the	DET
chd-221	150	22	hospital	hospital	NOUN
chd-221	150	23	for	for	ADP
chd-221	150	24	possible	possible	ADJ
chd-221	150	25	assistance	assistance	NOUN
chd-221	150	26	in	in	ADP
chd-221	150	27	many	many	ADJ
chd-221	150	28	ways	way	NOUN
chd-221	150	29	.	.	PUNCT
chd-221	151	1	authors	author	NOUN
chd-221	151	2	’	’	PART
chd-221	151	3	contributions	contribution	NOUN
chd-221	151	4	ps	ps	PROPN
chd-221	151	5	ideated	ideate	VERB
chd-221	151	6	and	and	CCONJ
chd-221	151	7	conceptualized	conceptualize	VERB
chd-221	151	8	framework	framework	NOUN
chd-221	151	9	for	for	ADP
chd-221	151	10	capci	capci	NOUN
chd-221	151	11	.	.	PUNCT
chd-221	152	1	ss	ss	PROPN
chd-221	152	2	and	and	CCONJ
chd-221	152	3	bdk	bdk	PROPN
chd-221	152	4	wrote	write	VERB
chd-221	152	5	the	the	DET
chd-221	152	6	first	first	ADJ
chd-221	152	7	draft	draft	NOUN
chd-221	152	8	with	with	ADP
chd-221	152	9	ds	d	NOUN
chd-221	152	10	,	,	PUNCT
chd-221	152	11	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	VERB
chd-221	152	12	e11	e11	ADJ
chd-221	152	13	cancer	cancer	NOUN
chd-221	152	14	health	health	NOUN
chd-221	152	15	disparities	disparity	NOUN
chd-221	152	16	ns	ns	ADJ
chd-221	152	17	and	and	CCONJ
chd-221	152	18	ps	ps	PROPN
chd-221	152	19	.	.	PROPN
chd-221	152	20	other	other	ADJ
chd-221	152	21	authors	author	NOUN
chd-221	152	22	chipped	chip	VERB
chd-221	152	23	in	in	ADP
chd-221	152	24	with	with	ADP
chd-221	152	25	lateral	lateral	ADJ
chd-221	152	26	sections	section	NOUN
chd-221	152	27	.	.	PUNCT
chd-221	153	1	availability	availability	NOUN
chd-221	153	2	http://www.bioclues.org/capci	http://www.bioclues.org/capci	PROPN
chd-221	153	3	competing	compete	VERB
chd-221	153	4	interests	interest	NOUN
chd-221	153	5	the	the	DET
chd-221	153	6	industrial	industrial	ADJ
chd-221	153	7	partners	partner	NOUN
chd-221	153	8	as	as	ADP
chd-221	153	9	a	a	DET
chd-221	153	10	part	part	NOUN
chd-221	153	11	of	of	ADP
chd-221	153	12	this	this	DET
chd-221	153	13	consortium	consortium	NOUN
chd-221	153	14	including	include	VERB
chd-221	153	15	the	the	DET
chd-221	153	16	academic	academic	ADJ
chd-221	153	17	authors	author	NOUN
chd-221	153	18	do	do	AUX
chd-221	153	19	not	not	PART
chd-221	153	20	have	have	VERB
chd-221	153	21	any	any	DET
chd-221	153	22	conflicts	conflict	NOUN
chd-221	153	23	of	of	ADP
chd-221	153	24	interests	interest	NOUN
chd-221	153	25	.	.	PUNCT
chd-221	154	1	bioclues.org	bioclues.org	X
chd-221	154	2	is	be	AUX
chd-221	154	3	a	a	DET
chd-221	154	4	not	not	PART
chd-221	154	5	-	-	PUNCT
chd-221	154	6	for	for	ADP
chd-221	154	7	-	-	PUNCT
chd-221	154	8	profit	profit	NOUN
chd-221	154	9	organization	organization	NOUN
chd-221	154	10	which	which	PRON
chd-221	154	11	propounded	propound	VERB
chd-221	154	12	the	the	DET
chd-221	154	13	capci	capci	PROPN
chd-221	154	14	.	.	PUNCT
chd-221	155	1	ethics	ethic	NOUN
chd-221	155	2	approval	approval	NOUN
chd-221	155	3	not	not	PART
chd-221	155	4	applicable	applicable	ADJ
chd-221	155	5	funding	funding	NOUN
chd-221	155	6	none	none	NOUN
chd-221	155	7	references	reference	VERB
chd-221	155	8	1	1	NUM
chd-221	155	9	.	.	PUNCT
chd-221	156	1	bajaj	bajaj	PROPN
chd-221	156	2	,	,	PUNCT
chd-221	156	3	a.	a.	NOUN
chd-221	156	4	(	(	PUNCT
chd-221	156	5	2020	2020	NUM
chd-221	156	6	,	,	PUNCT
chd-221	156	7	september	september	PROPN
chd-221	156	8	25	25	NUM
chd-221	156	9	)	)	PUNCT
chd-221	156	10	.	.	PUNCT
chd-221	157	1	the	the	DET
chd-221	157	2	genome	genome	NOUN
chd-221	157	3	india	india	PROPN
chd-221	157	4	project	project	NOUN
chd-221	157	5	.	.	PUNCT
chd-221	158	1	retrieved	retrieve	VERB
chd-221	158	2	from	from	ADP
chd-221	158	3	https://www.investindia.gov.in/team-indiablogs/genome-india-project	https://www.investindia.gov.in/team-indiablogs/genome-india-project	ADJ
chd-221	158	4	2	2	NUM
chd-221	158	5	.	.	PUNCT
chd-221	159	1	brady	brady	PROPN
chd-221	159	2	,	,	PUNCT
chd-221	159	3	l.	l.	PROPN
chd-221	159	4	,	,	PUNCT
chd-221	159	5	kriner	kriner	PROPN
chd-221	159	6	,	,	PUNCT
chd-221	159	7	m.	m.	NOUN
chd-221	159	8	,	,	PUNCT
chd-221	159	9	coleman	coleman	PROPN
chd-221	159	10	,	,	PUNCT
chd-221	159	11	i.	i.	PROPN
chd-221	159	12	et	et	PROPN
chd-221	159	13	al	al	PROPN
chd-221	159	14	.	.	PROPN
chd-221	159	15	interand	interand	VERB
chd-221	159	16	intra	intra	ADJ
chd-221	159	17	-	-	ADJ
chd-221	159	18	tumor	tumor	ADJ
chd-221	159	19	heterogeneity	heterogeneity	NOUN
chd-221	159	20	of	of	ADP
chd-221	159	21	metastatic	metastatic	ADJ
chd-221	159	22	prostate	prostate	NOUN
chd-221	159	23	cancer	cancer	NOUN
chd-221	159	24	determined	determine	VERB
chd-221	159	25	by	by	ADP
chd-221	159	26	digital	digital	ADJ
chd-221	159	27	spatial	spatial	ADJ
chd-221	159	28	gene	gene	NOUN
chd-221	159	29	expression	expression	NOUN
chd-221	159	30	profiling	profiling	NOUN
chd-221	159	31	.	.	PUNCT
chd-221	160	1	nat	nat	PROPN
chd-221	160	2	commun	commun	PROPN
chd-221	160	3	12	12	NUM
chd-221	160	4	,	,	PUNCT
chd-221	160	5	1426	1426	NUM
chd-221	160	6	(	(	PUNCT
chd-221	160	7	2021	2021	NUM
chd-221	160	8	)	)	PUNCT
chd-221	160	9	.	.	PUNCT
chd-221	161	1	https://doi.org/10.1038/s41467-021-21615-4	https://doi.org/10.1038/s41467-021-21615-4	NUM
chd-221	161	2	3	3	NUM
chd-221	161	3	.	.	X
chd-221	161	4	camp	camp	NOUN
chd-221	161	5	,	,	PUNCT
chd-221	161	6	n.	n.	PROPN
chd-221	161	7	j.	j.	PROPN
chd-221	161	8	,	,	PUNCT
chd-221	161	9	cannon	cannon	NOUN
chd-221	161	10	-	-	PUNCT
chd-221	161	11	albright	albright	PROPN
chd-221	161	12	,	,	PUNCT
chd-221	161	13	l.	l.	PROPN
chd-221	161	14	a.	a.	PROPN
chd-221	161	15	,	,	PUNCT
chd-221	161	16	farnham	farnham	PROPN
chd-221	161	17	,	,	PUNCT
chd-221	161	18	j.	j.	PROPN
chd-221	161	19	m.	m.	PROPN
chd-221	161	20	,	,	PUNCT
chd-221	161	21	baffoe	baffoe	VERB
chd-221	161	22	-	-	PUNCT
chd-221	161	23	bonnie	bonnie	NOUN
chd-221	161	24	,	,	PUNCT
chd-221	161	25	a.	a.	PROPN
chd-221	161	26	b.	b.	PROPN
chd-221	161	27	,	,	PUNCT
chd-221	161	28	george	george	PROPN
chd-221	161	29	,	,	PUNCT
chd-221	161	30	a.	a.	PROPN
chd-221	161	31	,	,	PUNCT
chd-221	161	32	powell	powell	PROPN
chd-221	161	33	,	,	PUNCT
chd-221	161	34	i.	i.	PROPN
chd-221	161	35	,	,	PUNCT
chd-221	161	36	bailey	bailey	PROPN
chd-221	161	37	-	-	PUNCT
chd-221	161	38	wilson	wilson	PROPN
chd-221	161	39	,	,	PUNCT
chd-221	161	40	j.	j.	PROPN
chd-221	161	41	e.	e.	PROPN
chd-221	161	42	,	,	PUNCT
chd-221	161	43	carpten	carpten	VERB
chd-221	161	44	,	,	PUNCT
chd-221	161	45	j.	j.	PROPN
chd-221	161	46	d.	d.	PROPN
chd-221	161	47	,	,	PUNCT
chd-221	161	48	giles	giles	PROPN
chd-221	161	49	,	,	PUNCT
chd-221	161	50	g.	g.	PROPN
chd-221	161	51	g.	g.	PROPN
chd-221	161	52	,	,	PUNCT
chd-221	161	53	hopper	hopper	NOUN
chd-221	161	54	,	,	PUNCT
chd-221	161	55	j.	j.	PROPN
chd-221	161	56	l.	l.	PROPN
chd-221	161	57	,	,	PUNCT
chd-221	161	58	severi	severi	PROPN
chd-221	161	59	,	,	PUNCT
chd-221	161	60	g.	g.	PROPN
chd-221	161	61	,	,	PUNCT
chd-221	161	62	english	english	PROPN
chd-221	161	63	,	,	PUNCT
chd-221	161	64	d.	d.	PROPN
chd-221	161	65	r.	r.	PROPN
chd-221	161	66	,	,	PUNCT
chd-221	161	67	foulkes	foulkes	PROPN
chd-221	161	68	,	,	PUNCT
chd-221	161	69	w.	w.	PROPN
chd-221	161	70	d.	d.	PROPN
chd-221	161	71	,	,	PUNCT
chd-221	161	72	maehle	maehle	PROPN
chd-221	161	73	,	,	PUNCT
chd-221	161	74	l.	l.	PROPN
chd-221	161	75	,	,	PUNCT
chd-221	161	76	moller	moller	PROPN
chd-221	161	77	,	,	PUNCT
chd-221	161	78	p.	p.	PROPN
chd-221	161	79	,	,	PUNCT
chd-221	161	80	eeles	eele	NOUN
chd-221	161	81	,	,	PUNCT
chd-221	161	82	r.	r.	PROPN
chd-221	161	83	,	,	PUNCT
chd-221	161	84	easton	easton	PROPN
chd-221	161	85	,	,	PUNCT
chd-221	161	86	d.	d.	PROPN
chd-221	161	87	,	,	PUNCT
chd-221	161	88	badzioch	badzioch	NOUN
chd-221	161	89	,	,	PUNCT
chd-221	161	90	m.	m.	NOUN
chd-221	161	91	d.	d.	PROPN
chd-221	161	92	,	,	PUNCT
chd-221	161	93	whittemore	whittemore	PROPN
chd-221	161	94	,	,	PUNCT
chd-221	161	95	a.	a.	PROPN
chd-221	161	96	s.	s.	PROPN
chd-221	161	97	,	,	PUNCT
chd-221	161	98	…	…	PUNCT
chd-221	161	99	isaacs	isaacs	PROPN
chd-221	161	100	,	,	PUNCT
chd-221	161	101	w.	w.	PROPN
chd-221	161	102	b.	b.	PROPN
chd-221	161	103	(	(	PUNCT
chd-221	161	104	2007	2007	NUM
chd-221	161	105	)	)	PUNCT
chd-221	161	106	.	.	PUNCT
chd-221	162	1	compelling	compelling	ADJ
chd-221	162	2	evidence	evidence	NOUN
chd-221	162	3	for	for	ADP
chd-221	162	4	a	a	DET
chd-221	162	5	prostate	prostate	NOUN
chd-221	162	6	cancer	cancer	NOUN
chd-221	162	7	gene	gene	NOUN
chd-221	162	8	at	at	ADP
chd-221	162	9	22q12.3	22q12.3	NUM
chd-221	162	10	by	by	ADP
chd-221	162	11	the	the	DET
chd-221	162	12	international	international	ADJ
chd-221	162	13	consortium	consortium	NOUN
chd-221	162	14	for	for	ADP
chd-221	162	15	prostate	prostate	NOUN
chd-221	162	16	cancer	cancer	NOUN
chd-221	162	17	genetics	genetic	NOUN
chd-221	162	18	.	.	PUNCT
chd-221	163	1	human	human	ADJ
chd-221	163	2	molecular	molecular	ADJ
chd-221	163	3	genetics	genetic	NOUN
chd-221	163	4	.	.	PUNCT
chd-221	164	1	https://doi.org/10.1093/hmg/ddm075	https://doi.org/10.1093/hmg/ddm075	PROPN
chd-221	164	2	4	4	NUM
chd-221	164	3	.	.	PUNCT
chd-221	164	4	catalona	catalona	PROPN
chd-221	164	5	,	,	PUNCT
chd-221	164	6	w.	w.	PROPN
chd-221	164	7	j.	j.	PROPN
chd-221	164	8	,	,	PUNCT
chd-221	164	9	&	&	CCONJ
chd-221	164	10	loeb	loeb	PROPN
chd-221	164	11	,	,	PUNCT
chd-221	164	12	s.	s.	PROPN
chd-221	164	13	(	(	PUNCT
chd-221	164	14	2010	2010	NUM
chd-221	164	15	)	)	PUNCT
chd-221	164	16	.	.	PUNCT
chd-221	165	1	prostate	prostate	NOUN
chd-221	165	2	cancer	cancer	NOUN
chd-221	165	3	screening	screening	NOUN
chd-221	165	4	and	and	CCONJ
chd-221	165	5	determining	determine	VERB
chd-221	165	6	the	the	DET
chd-221	165	7	appropriate	appropriate	ADJ
chd-221	165	8	prostatespecific	prostatespecific	NOUN
chd-221	165	9	antigen	antigen	ADJ
chd-221	165	10	cutoff	cutoff	NOUN
chd-221	165	11	values	value	NOUN
chd-221	165	12	.	.	PUNCT
chd-221	166	1	journal	journal	NOUN
chd-221	166	2	of	of	ADP
chd-221	166	3	the	the	DET
chd-221	166	4	national	national	ADJ
chd-221	166	5	comprehensive	comprehensive	ADJ
chd-221	166	6	cancer	cancer	NOUN
chd-221	166	7	network	network	NOUN
chd-221	166	8	:	:	PUNCT
chd-221	166	9	jnccn	jnccn	PROPN
chd-221	166	10	,	,	PUNCT
chd-221	166	11	8(2	8(2	NUM
chd-221	166	12	)	)	PUNCT
chd-221	166	13	,	,	PUNCT
chd-221	166	14	265–270	265–270	NUM
chd-221	166	15	.	.	PUNCT
chd-221	167	1	https://doi.org/10.6004/jnccn.2010.0017	https://doi.org/10.6004/jnccn.2010.0017	PROPN
chd-221	167	2	5	5	NUM
chd-221	167	3	.	.	PUNCT
chd-221	168	1	chen	chen	PROPN
chd-221	168	2	,	,	PUNCT
chd-221	168	3	r.	r.	PROPN
chd-221	168	4	,	,	PUNCT
chd-221	168	5	ren	ren	PROPN
chd-221	168	6	,	,	PUNCT
chd-221	168	7	s.	s.	PROPN
chd-221	168	8	,	,	PUNCT
chd-221	168	9	yiu	yiu	PROPN
chd-221	168	10	,	,	PUNCT
chd-221	168	11	m.	m.	NOUN
chd-221	168	12	k.	k.	PROPN
chd-221	168	13	,	,	PUNCT
chd-221	168	14	fai	fai	PROPN
chd-221	168	15	,	,	PUNCT
chd-221	168	16	n.	n.	PROPN
chd-221	168	17	c.	c.	PROPN
chd-221	168	18	,	,	PUNCT
chd-221	168	19	cheng	cheng	PROPN
chd-221	168	20	,	,	PUNCT
chd-221	168	21	w.	w.	PROPN
chd-221	168	22	s.	s.	PROPN
chd-221	168	23	,	,	PUNCT
chd-221	168	24	ian	ian	PROPN
chd-221	168	25	,	,	PUNCT
chd-221	168	26	l.	l.	PROPN
chd-221	168	27	h.	h.	PROPN
chd-221	168	28	,	,	PUNCT
chd-221	168	29	naito	naito	PROPN
chd-221	168	30	,	,	PUNCT
chd-221	168	31	s.	s.	PROPN
chd-221	168	32	,	,	PUNCT
chd-221	168	33	matsuda	matsuda	PROPN
chd-221	168	34	,	,	PUNCT
chd-221	168	35	t.	t.	PROPN
chd-221	168	36	,	,	PUNCT
chd-221	168	37	kehinde	kehinde	PROPN
chd-221	168	38	,	,	PUNCT
chd-221	168	39	e.	e.	PROPN
chd-221	168	40	,	,	PUNCT
chd-221	168	41	kural	kural	PROPN
chd-221	168	42	,	,	PUNCT
chd-221	168	43	a.	a.	NOUN
chd-221	168	44	,	,	PUNCT
chd-221	168	45	chiu	chiu	PROPN
chd-221	168	46	,	,	PUNCT
chd-221	168	47	j.	j.	PROPN
chd-221	168	48	y.	y.	PROPN
chd-221	168	49	,	,	PUNCT
chd-221	168	50	umbas	umbas	PROPN
chd-221	168	51	,	,	PUNCT
chd-221	168	52	r.	r.	PROPN
chd-221	168	53	,	,	PUNCT
chd-221	168	54	wei	wei	PROPN
chd-221	168	55	,	,	PUNCT
chd-221	168	56	q.	q.	PROPN
chd-221	168	57	,	,	PUNCT
chd-221	168	58	shi	shi	PROPN
chd-221	168	59	,	,	PUNCT
chd-221	168	60	x.	x.	PROPN
chd-221	168	61	,	,	PUNCT
chd-221	168	62	zhou	zhou	PROPN
chd-221	168	63	,	,	PUNCT
chd-221	168	64	l.	l.	PROPN
chd-221	168	65	,	,	PUNCT
chd-221	168	66	huang	huang	PROPN
chd-221	168	67	,	,	PUNCT
chd-221	168	68	j.	j.	PROPN
chd-221	168	69	,	,	PUNCT
chd-221	168	70	huang	huang	PROPN
chd-221	168	71	,	,	PUNCT
chd-221	168	72	y.	y.	PROPN
chd-221	168	73	,	,	PUNCT
chd-221	168	74	xie	xie	PROPN
chd-221	168	75	,	,	PUNCT
chd-221	168	76	l.	l.	PROPN
chd-221	168	77	,	,	PUNCT
chd-221	168	78	ma	ma	PROPN
chd-221	168	79	,	,	PUNCT
chd-221	168	80	l.	l.	PROPN
chd-221	168	81	,	,	PUNCT
chd-221	168	82	…	…	PUNCT
chd-221	168	83	sun	sun	NOUN
chd-221	168	84	,	,	PUNCT
chd-221	168	85	y.	y.	PROPN
chd-221	168	86	(	(	PUNCT
chd-221	168	87	2014	2014	NUM
chd-221	168	88	)	)	PUNCT
chd-221	168	89	.	.	PUNCT
chd-221	169	1	prostate	prostate	NOUN
chd-221	169	2	cancer	cancer	NOUN
chd-221	169	3	in	in	ADP
chd-221	169	4	asia	asia	PROPN
chd-221	169	5	:	:	PUNCT
chd-221	169	6	a	a	DET
chd-221	169	7	collaborative	collaborative	ADJ
chd-221	169	8	report	report	NOUN
chd-221	169	9	.	.	PUNCT
chd-221	170	1	asian	asian	ADJ
chd-221	170	2	journal	journal	PROPN
chd-221	170	3	of	of	ADP
chd-221	170	4	urology	urology	NOUN
chd-221	170	5	.	.	PUNCT
chd-221	171	1	https://doi.org/10.1016/j.ajur.2014.08.007	https://doi.org/10.1016/j.ajur.2014.08.007	PROPN
chd-221	171	2	6	6	NUM
chd-221	171	3	.	.	PUNCT
chd-221	172	1	dbgap	dbgap	PROPN
chd-221	172	2	.	.	PUNCT
chd-221	172	3	ellipse	ellipse	NOUN
chd-221	172	4	prostate	prostate	NOUN
chd-221	172	5	cancer	cancer	NOUN
chd-221	172	6	meta	meta	ADJ
chd-221	172	7	-	-	PUNCT
chd-221	172	8	analysis	analysis	NOUN
chd-221	172	9	and	and	CCONJ
chd-221	172	10	genotyping	genotyping	NOUN
chd-221	172	11	.	.	PUNCT
chd-221	173	1	dbgap	dbgap	PROPN
chd-221	173	2	study	study	NOUN
chd-221	173	3	accession	accession	NOUN
chd-221	173	4	:	:	PUNCT
chd-221	173	5	phs001120.v1.p1	phs001120.v1.p1	AUX
chd-221	173	6	retrieved	retrieve	VERB
chd-221	173	7	from	from	ADP
chd-221	173	8	https://www.ncbi.nlm.nih.gov/projects/	https://www.ncbi.nlm.nih.gov/projects/	NOUN
chd-221	173	9	gap	gap	NOUN
chd-221	173	10	/	/	SYM
chd-221	173	11	cgi	cgi	PROPN
chd-221	173	12	-	-	PUNCT
chd-221	173	13	bin	bin	NOUN
chd-221	173	14	/	/	SYM
chd-221	173	15	study.cgi?study_id	study.cgi?study_id	PROPN
chd-221	173	16	=	=	SYM
chd-221	173	17	phs001120.v1.p1	phs001120.v1.p1	NOUN
chd-221	173	18	#	#	NOUN
chd-221	173	19	restricted	restrict	VERB
chd-221	173	20	-	-	PUNCT
chd-221	173	21	access	access	NOUN
chd-221	173	22	-	-	PUNCT
chd-221	173	23	section	section	NOUN
chd-221	173	24	last	last	ADJ
chd-221	173	25	accessed	access	VERB
chd-221	173	26	:	:	PUNCT
chd-221	173	27	july	july	PROPN
chd-221	173	28	18	18	NUM
chd-221	173	29	,	,	PUNCT
chd-221	173	30	2021	2021	NUM
chd-221	173	31	.	.	PUNCT
chd-221	174	1	7	7	X
chd-221	174	2	.	.	X
chd-221	174	3	emmert	emmert	NOUN
chd-221	174	4	-	-	PUNCT
chd-221	174	5	streib	streib	PROPN
chd-221	174	6	,	,	PUNCT
chd-221	174	7	f.	f.	PROPN
chd-221	174	8	,	,	PUNCT
chd-221	174	9	dehmer	dehmer	NOUN
chd-221	174	10	,	,	PUNCT
chd-221	174	11	m.	m.	NOUN
chd-221	174	12	,	,	PUNCT
chd-221	174	13	&	&	CCONJ
chd-221	174	14	yli	yli	NOUN
chd-221	174	15	-	-	NOUN
chd-221	174	16	harja	harja	NOUN
chd-221	174	17	,	,	PUNCT
chd-221	174	18	o.	o.	NOUN
chd-221	174	19	(	(	PUNCT
chd-221	174	20	2017	2017	NUM
chd-221	174	21	)	)	PUNCT
chd-221	174	22	.	.	PUNCT
chd-221	175	1	lessons	lesson	NOUN
chd-221	175	2	from	from	ADP
chd-221	175	3	the	the	DET
chd-221	175	4	human	human	ADJ
chd-221	175	5	genome	genome	NOUN
chd-221	175	6	project	project	NOUN
chd-221	175	7	:	:	PUNCT
chd-221	175	8	modesty	modesty	NOUN
chd-221	175	9	,	,	PUNCT
chd-221	175	10	honesty	honesty	NOUN
chd-221	175	11	,	,	PUNCT
chd-221	175	12	and	and	CCONJ
chd-221	175	13	realism	realism	NOUN
chd-221	175	14	.	.	PUNCT
chd-221	176	1	in	in	ADP
chd-221	176	2	frontiers	frontier	NOUN
chd-221	176	3	in	in	ADP
chd-221	176	4	genetics	genetic	NOUN
chd-221	176	5	.	.	PUNCT
chd-221	177	1	https://doi.org/10.3389/fgene.2017.00184	https://doi.org/10.3389/fgene.2017.00184	PROPN
chd-221	177	2	8	8	NUM
chd-221	177	3	.	.	PUNCT
chd-221	177	4	fizazi	fizazi	PROPN
chd-221	177	5	k	k	PROPN
chd-221	177	6	,	,	PUNCT
chd-221	177	7	abrahamsson	abrahamsson	PROPN
chd-221	177	8	pa	pa	PROPN
chd-221	177	9	,	,	PUNCT
chd-221	177	10	ahlgren	ahlgren	NOUN
chd-221	177	11	g	g	PROPN
chd-221	177	12	,	,	PUNCT
chd-221	177	13	bellmunt	bellmunt	NOUN
chd-221	177	14	j	j	PROPN
chd-221	177	15	,	,	PUNCT
chd-221	177	16	castellano	castellano	PROPN
chd-221	177	17	d	d	PROPN
chd-221	177	18	,	,	PUNCT
chd-221	177	19	culine	culine	ADJ
chd-221	177	20	s	s	NOUN
chd-221	177	21	,	,	PUNCT
chd-221	177	22	de	de	X
chd-221	177	23	wit	wit	ADJ
chd-221	177	24	r	r	NOUN
chd-221	177	25	,	,	PUNCT
chd-221	177	26	gillessen	gillessen	NOUN
chd-221	177	27	s	s	PROPN
chd-221	177	28	,	,	PUNCT
chd-221	177	29	gschwend	gschwend	PROPN
chd-221	177	30	je	je	PROPN
chd-221	177	31	,	,	PUNCT
chd-221	177	32	hamdy	hamdy	PROPN
chd-221	177	33	f	f	PROPN
chd-221	177	34	,	,	PUNCT
chd-221	177	35	james	james	PROPN
chd-221	177	36	n	n	PRON
chd-221	177	37	,	,	PUNCT
chd-221	177	38	mcdermott	mcdermott	PROPN
chd-221	177	39	r	r	PROPN
chd-221	177	40	,	,	PUNCT
chd-221	177	41	miller	miller	PROPN
chd-221	177	42	k	k	PROPN
chd-221	177	43	,	,	PUNCT
chd-221	177	44	wiegel	wiegel	PROPN
chd-221	177	45	t	t	PROPN
chd-221	177	46	,	,	PUNCT
chd-221	177	47	wirth	wirth	PROPN
chd-221	177	48	m	m	PROPN
chd-221	177	49	,	,	PUNCT
chd-221	177	50	tombal	tombal	PROPN
chd-221	177	51	b.	b.	PROPN
chd-221	177	52	achievements	achievement	NOUN
chd-221	177	53	and	and	CCONJ
chd-221	177	54	perspectives	perspective	NOUN
chd-221	177	55	in	in	ADP
chd-221	177	56	prostate	prostate	NOUN
chd-221	177	57	cancer	cancer	NOUN
chd-221	177	58	phase	phase	NOUN
chd-221	177	59	3	3	NUM
chd-221	177	60	trials	trial	NOUN
chd-221	177	61	from	from	ADP
chd-221	177	62	genitourinary	genitourinary	ADJ
chd-221	177	63	research	research	NOUN
chd-221	177	64	groups	group	NOUN
chd-221	177	65	in	in	ADP
chd-221	177	66	europe	europe	PROPN
chd-221	177	67	:	:	PUNCT
chd-221	177	68	introducing	introduce	VERB
chd-221	177	69	the	the	DET
chd-221	177	70	prostate	prostate	NOUN
chd-221	177	71	cancer	cancer	NOUN
chd-221	177	72	consortium	consortium	NOUN
chd-221	177	73	in	in	ADP
chd-221	177	74	europe	europe	PROPN
chd-221	177	75	.	.	PUNCT
chd-221	178	1	eur	eur	PROPN
chd-221	178	2	urol	urol	PROPN
chd-221	178	3	.	.	PUNCT
chd-221	179	1	2015	2015	NUM
chd-221	179	2	may;67(5):904	may;67(5):904	NOUN
chd-221	179	3	-	-	SYM
chd-221	179	4	12	12	NUM
chd-221	179	5	.	.	PUNCT
chd-221	180	1	doi	doi	NOUN
chd-221	180	2	:	:	PUNCT
chd-221	181	1	10.1016	10.1016	NUM
chd-221	181	2	/	/	SYM
chd-221	181	3	j.eururo.2014.08.076	j.eururo.2014.08.076	PROPN
chd-221	181	4	.	.	PROPN
chd-221	181	5	epub	epub	PROPN
chd-221	181	6	2014	2014	NUM
chd-221	181	7	sep	sep	PROPN
chd-221	181	8	11	11	NUM
chd-221	181	9	.	.	PUNCT
chd-221	182	1	pmid	pmid	NOUN
chd-221	182	2	:	:	PUNCT
chd-221	182	3	2521858	2521858	NUM
chd-221	182	4	9	9	NUM
chd-221	182	5	.	.	PUNCT
chd-221	182	6	gaffney	gaffney	PROPN
chd-221	182	7	ef	ef	PROPN
chd-221	182	8	,	,	PUNCT
chd-221	182	9	riegman	riegman	NOUN
chd-221	182	10	ph	ph	PROPN
chd-221	182	11	,	,	PUNCT
chd-221	182	12	grizzle	grizzle	NOUN
chd-221	182	13	we	we	PRON
chd-221	182	14	,	,	PUNCT
chd-221	182	15	watson	watson	PROPN
chd-221	182	16	ph	ph	PROPN
chd-221	182	17	.	.	PROPN
chd-221	182	18	factors	factor	NOUN
chd-221	182	19	that	that	PRON
chd-221	182	20	drive	drive	VERB
chd-221	182	21	the	the	DET
chd-221	182	22	increasing	increase	VERB
chd-221	182	23	use	use	NOUN
chd-221	182	24	of	of	ADP
chd-221	182	25	ffpe	ffpe	ADJ
chd-221	182	26	tissue	tissue	NOUN
chd-221	182	27	in	in	ADP
chd-221	182	28	basic	basic	ADJ
chd-221	182	29	and	and	CCONJ
chd-221	182	30	translational	translational	ADJ
chd-221	182	31	cancer	cancer	NOUN
chd-221	182	32	research	research	NOUN
chd-221	182	33	.	.	PUNCT
chd-221	183	1	biotech	biotech	ADJ
chd-221	183	2	histochem	histochem	NOUN
chd-221	183	3	.	.	PUNCT
chd-221	184	1	2018;93(5):373	2018;93(5):373	NUM
chd-221	184	2	-	-	SYM
chd-221	184	3	386	386	NUM
chd-221	184	4	.	.	PUNCT
chd-221	184	5	doi	doi	NOUN
chd-221	184	6	:	:	PUNCT
chd-221	184	7	10.1080/10520295.2018.1446101	10.1080/10520295.2018.1446101	NUM
chd-221	184	8	.	.	PUNCT
chd-221	185	1	epub	epub	PROPN
chd-221	185	2	2018	2018	NUM
chd-221	185	3	aug	aug	PROPN
chd-221	185	4	16	16	NUM
chd-221	185	5	.	.	PUNCT
chd-221	186	1	pmid	pmid	NOUN
chd-221	186	2	:	:	PUNCT
chd-221	186	3	30113239	30113239	NUM
chd-221	186	4	.	.	PUNCT
chd-221	187	1	10	10	NUM
chd-221	187	2	.	.	PUNCT
chd-221	188	1	gibbs	gibbs	PROPN
chd-221	188	2	,	,	PUNCT
chd-221	188	3	r.	r.	PROPN
chd-221	188	4	a.	a.	PROPN
chd-221	188	5	(	(	PUNCT
chd-221	188	6	2020	2020	NUM
chd-221	188	7	)	)	PUNCT
chd-221	188	8	.	.	PUNCT
chd-221	189	1	the	the	DET
chd-221	189	2	human	human	ADJ
chd-221	189	3	genome	genome	NOUN
chd-221	189	4	project	project	NOUN
chd-221	189	5	changed	change	VERB
chd-221	189	6	everything	everything	PRON
chd-221	189	7	.	.	PUNCT
chd-221	190	1	in	in	ADP
chd-221	190	2	nature	nature	NOUN
chd-221	190	3	reviews	review	VERB
chd-221	190	4	genetics	genetic	NOUN
chd-221	190	5	.	.	PUNCT
chd-221	191	1	https://doi.org/10.1038/s41576-020-0275-3	https://doi.org/10.1038/s41576-020-0275-3	PROPN
chd-221	191	2	11	11	NUM
chd-221	191	3	.	.	PUNCT
chd-221	192	1	goh	goh	PROPN
chd-221	192	2	,	,	PUNCT
chd-221	192	3	c.	c.	PROPN
chd-221	192	4	l.	l.	PROPN
chd-221	192	5	,	,	PUNCT
chd-221	192	6	schumacher	schumacher	PROPN
chd-221	192	7	,	,	PUNCT
chd-221	192	8	f.	f.	PROPN
chd-221	192	9	r.	r.	PROPN
chd-221	192	10	,	,	PUNCT
chd-221	192	11	easton	easton	PROPN
chd-221	192	12	,	,	PUNCT
chd-221	192	13	d.	d.	PROPN
chd-221	192	14	,	,	PUNCT
chd-221	192	15	muir	muir	PROPN
chd-221	192	16	,	,	PUNCT
chd-221	192	17	k.	k.	PROPN
chd-221	192	18	,	,	PUNCT
chd-221	192	19	henderson	henderson	PROPN
chd-221	192	20	,	,	PUNCT
chd-221	192	21	b.	b.	PROPN
chd-221	192	22	,	,	PUNCT
chd-221	192	23	kote	kote	VERB
chd-221	192	24	-	-	PUNCT
chd-221	192	25	jarai	jarai	PROPN
chd-221	192	26	,	,	PUNCT
chd-221	192	27	z.	z.	PROPN
chd-221	192	28	,	,	PUNCT
chd-221	192	29	&	&	CCONJ
chd-221	192	30	eeles	eeles	PROPN
chd-221	192	31	,	,	PUNCT
chd-221	192	32	r.	r.	PROPN
chd-221	192	33	a.	a.	PROPN
chd-221	192	34	(	(	PUNCT
chd-221	192	35	2012	2012	NUM
chd-221	192	36	)	)	PUNCT
chd-221	192	37	.	.	PUNCT
chd-221	193	1	genetic	genetic	ADJ
chd-221	193	2	variants	variant	NOUN
chd-221	193	3	associated	associate	VERB
chd-221	193	4	with	with	ADP
chd-221	193	5	predisposition	predisposition	NOUN
chd-221	193	6	to	to	ADP
chd-221	193	7	prostate	prostate	NOUN
chd-221	193	8	cancer	cancer	NOUN
chd-221	193	9	and	and	CCONJ
chd-221	193	10	potential	potential	ADJ
chd-221	193	11	clinical	clinical	ADJ
chd-221	193	12	implications	implication	NOUN
chd-221	193	13	.	.	PUNCT
chd-221	194	1	in	in	ADP
chd-221	194	2	journal	journal	NOUN
chd-221	194	3	of	of	ADP
chd-221	194	4	internal	internal	ADJ
chd-221	194	5	medicine	medicine	NOUN
chd-221	194	6	.	.	PUNCT
chd-221	195	1	https://doi.org/10.1111/j.1365-2796.2012.02511.x	https://doi.org/10.1111/j.1365-2796.2012.02511.x	NOUN
chd-221	195	2	12	12	NUM
chd-221	195	3	.	.	PUNCT
chd-221	196	1	gupta	gupta	PROPN
chd-221	196	2	,	,	PUNCT
chd-221	196	3	a.	a.	NOUN
chd-221	196	4	,	,	PUNCT
chd-221	196	5	shukla	shukla	NOUN
chd-221	196	6	,	,	PUNCT
chd-221	196	7	n.	n.	NOUN
chd-221	196	8	,	,	PUNCT
chd-221	196	9	nehra	nehra	NOUN
chd-221	196	10	,	,	PUNCT
chd-221	196	11	m.	m.	NOUN
chd-221	196	12	,	,	PUNCT
chd-221	196	13	gupta	gupta	PROPN
chd-221	196	14	,	,	PUNCT
chd-221	196	15	s.	s.	PROPN
chd-221	196	16	,	,	PUNCT
chd-221	196	17	malik	malik	PROPN
chd-221	196	18	,	,	PUNCT
chd-221	196	19	b.	b.	PROPN
chd-221	196	20	,	,	PUNCT
chd-221	196	21	mishra	mishra	PROPN
chd-221	196	22	,	,	PUNCT
chd-221	196	23	a.	a.	PROPN
chd-221	196	24	k.	k.	PROPN
chd-221	196	25	,	,	PUNCT
chd-221	196	26	vijay	vijay	NOUN
chd-221	196	27	,	,	PUNCT
chd-221	196	28	m.	m.	NOUN
chd-221	196	29	,	,	PUNCT
chd-221	196	30	batra	batra	PROPN
chd-221	196	31	,	,	PUNCT
chd-221	196	32	j.	j.	PROPN
chd-221	196	33	,	,	PUNCT
chd-221	196	34	lohiya	lohiya	PROPN
chd-221	196	35	,	,	PUNCT
chd-221	196	36	n.	n.	PROPN
chd-221	196	37	k.	k.	PROPN
chd-221	196	38	,	,	PUNCT
chd-221	196	39	sharma	sharma	PROPN
chd-221	196	40	,	,	PUNCT
chd-221	196	41	d.	d.	PROPN
chd-221	196	42	,	,	PUNCT
chd-221	196	43	&	&	CCONJ
chd-221	196	44	suravajhala	suravajhala	PROPN
chd-221	196	45	,	,	PUNCT
chd-221	196	46	p.	p.	NOUN
chd-221	196	47	(	(	PUNCT
chd-221	196	48	2020	2020	NUM
chd-221	196	49	)	)	PUNCT
chd-221	196	50	.	.	PUNCT
chd-221	197	1	a	a	DET
chd-221	197	2	pilot	pilot	NOUN
chd-221	197	3	study	study	NOUN
chd-221	197	4	on	on	ADP
chd-221	197	5	the	the	DET
chd-221	197	6	whole	whole	ADJ
chd-221	197	7	exome	exome	NOUN
chd-221	197	8	sequencing	sequencing	NOUN
chd-221	197	9	of	of	ADP
chd-221	197	10	prostate	prostate	NOUN
chd-221	197	11	cancer	cancer	NOUN
chd-221	197	12	in	in	ADP
chd-221	197	13	the	the	DET
chd-221	197	14	indian	indian	ADJ
chd-221	197	15	phenotype	phenotype	NOUN
chd-221	197	16	reveals	reveal	VERB
chd-221	197	17	distinct	distinct	ADJ
chd-221	197	18	polymorphisms	polymorphism	NOUN
chd-221	197	19	.	.	PUNCT
chd-221	198	1	frontiers	frontier	NOUN
chd-221	198	2	in	in	ADP
chd-221	198	3	genetics	genetic	NOUN
chd-221	198	4	.	.	PUNCT
chd-221	199	1	https://doi.org/10.3389/fgene.2020.00874https://doi.org/1	https://doi.org/10.3389/fgene.2020.00874https://doi.org/1	PROPN
chd-221	199	2	0.1016	0.1016	NUM
chd-221	199	3	/	/	SYM
chd-221	199	4	j.eururo.2014.08.076	j.eururo.2014.08.076	PROPN
chd-221	199	5	13	13	NUM
chd-221	199	6	.	.	PUNCT
chd-221	199	7	international	international	ADJ
chd-221	199	8	agency	agency	NOUN
chd-221	199	9	for	for	ADP
chd-221	199	10	research	research	NOUN
chd-221	199	11	in	in	ADP
chd-221	199	12	cancer	cancer	NOUN
chd-221	199	13	(	(	PUNCT
chd-221	199	14	who	who	PRON
chd-221	199	15	)	)	PUNCT
chd-221	199	16	.	.	PUNCT
chd-221	200	1	(	(	PUNCT
chd-221	200	2	n.d	n.d	PROPN
chd-221	200	3	.	.	PROPN
chd-221	200	4	)	)	PUNCT
chd-221	200	5	.	.	PUNCT
chd-221	201	1	global	global	ADJ
chd-221	201	2	cancer	cancer	NOUN
chd-221	201	3	observatory	observatory	NOUN
chd-221	201	4	.	.	PUNCT
chd-221	202	1	retrieved	retrieve	VERB
chd-221	202	2	from	from	ADP
chd-221	202	3	https://gco.iarc.fr/	https://gco.iarc.fr/	PRON
chd-221	202	4	last	last	ADV
chd-221	202	5	accessed	access	VERB
chd-221	202	6	:	:	PUNCT
chd-221	202	7	july	july	PROPN
chd-221	202	8	18	18	NUM
chd-221	202	9	,	,	PUNCT
chd-221	202	10	2021	2021	NUM
chd-221	202	11	.	.	PUNCT
chd-221	203	1	14	14	NUM
chd-221	203	2	.	.	X
chd-221	203	3	ittmann	ittmann	PROPN
chd-221	203	4	,	,	PUNCT
chd-221	203	5	m.	m.	NOUN
chd-221	203	6	,	,	PUNCT
chd-221	203	7	huang	huang	PROPN
chd-221	203	8	,	,	PUNCT
chd-221	203	9	j.	j.	PROPN
chd-221	203	10	,	,	PUNCT
chd-221	203	11	radaelli	radaelli	PROPN
chd-221	203	12	,	,	PUNCT
chd-221	203	13	e.	e.	PROPN
chd-221	203	14	,	,	PUNCT
chd-221	203	15	martin	martin	PROPN
chd-221	203	16	,	,	PUNCT
chd-221	203	17	p.	p.	PROPN
chd-221	203	18	,	,	PUNCT
chd-221	203	19	signoretti	signoretti	PROPN
chd-221	203	20	,	,	PUNCT
chd-221	203	21	s.	s.	PROPN
chd-221	203	22	,	,	PUNCT
chd-221	203	23	sullivan	sullivan	PROPN
chd-221	203	24	,	,	PUNCT
chd-221	203	25	r.	r.	PROPN
chd-221	203	26	,	,	PUNCT
chd-221	203	27	simons	simons	PROPN
chd-221	203	28	,	,	PUNCT
chd-221	203	29	b.	b.	PROPN
chd-221	203	30	w.	w.	PROPN
chd-221	203	31	,	,	PUNCT
chd-221	203	32	ward	ward	PROPN
chd-221	203	33	,	,	PUNCT
chd-221	203	34	j.	j.	PROPN
chd-221	203	35	m.	m.	PROPN
chd-221	203	36	,	,	PUNCT
chd-221	203	37	robinson	robinson	PROPN
chd-221	203	38	,	,	PUNCT
chd-221	203	39	b.	b.	PROPN
chd-221	203	40	d.	d.	PROPN
chd-221	203	41	,	,	PUNCT
chd-221	203	42	chu	chu	PROPN
chd-221	203	43	,	,	PUNCT
chd-221	203	44	g.	g.	PROPN
chd-221	203	45	c.	c.	PROPN
chd-221	203	46	,	,	PUNCT
chd-221	203	47	loda	loda	PROPN
chd-221	203	48	,	,	PUNCT
chd-221	203	49	m.	m.	NOUN
chd-221	203	50	,	,	PUNCT
chd-221	203	51	thomas	thomas	PROPN
chd-221	203	52	,	,	PUNCT
chd-221	203	53	g.	g.	PROPN
chd-221	203	54	,	,	PUNCT
chd-221	203	55	borowsky	borowsky	PROPN
chd-221	203	56	,	,	PUNCT
chd-221	203	57	a.	a.	NOUN
chd-221	203	58	,	,	PUNCT
chd-221	203	59	&	&	CCONJ
chd-221	203	60	cardiff	cardiff	PROPN
chd-221	203	61	,	,	PUNCT
chd-221	203	62	r.	r.	PROPN
chd-221	203	63	d.	d.	PROPN
chd-221	203	64	(	(	PUNCT
chd-221	203	65	2013	2013	NUM
chd-221	203	66	)	)	PUNCT
chd-221	203	67	.	.	PUNCT
chd-221	204	1	animal	animal	NOUN
chd-221	204	2	models	model	NOUN
chd-221	204	3	of	of	ADP
chd-221	204	4	human	human	ADJ
chd-221	204	5	prostate	prostate	NOUN
chd-221	204	6	cancer	cancer	NOUN
chd-221	204	7	:	:	PUNCT
chd-221	204	8	the	the	DET
chd-221	204	9	https://www.investindia.gov.in/team-india-blogs/genome-india-project	https://www.investindia.gov.in/team-india-blogs/genome-india-project	INTJ
chd-221	204	10	https://www.investindia.gov.in/team-india-blogs/genome-india-project	https://www.investindia.gov.in/team-india-blogs/genome-india-project	PROPN
chd-221	205	1	https://doi.org/10.6004/jnccn.2010.0017	https://doi.org/10.6004/jnccn.2010.0017	PROPN
chd-221	205	2	https://doi.org/10.1016/j.ajur.2014.08.007	https://doi.org/10.1016/j.ajur.2014.08.007	PROPN
chd-221	205	3	https://doi.org/10.3389/fgene.2017.00184	https://doi.org/10.3389/fgene.2017.00184	PROPN
chd-221	205	4	https://doi.org/10.1038/s41576-020-0275-3	https://doi.org/10.1038/s41576-020-0275-3	PUNCT
chd-221	205	5	https://doi.org/10.1111/j.1365-2796.2012.02511.x	https://doi.org/10.1111/j.1365-2796.2012.02511.x	NOUN
chd-221	205	6	https://doi.org/10.1016/j.eururo.2014.08.076	https://doi.org/10.1016/j.eururo.2014.08.076	NUM
chd-221	205	7	https://doi.org/10.1016/j.eururo.2014.08.076	https://doi.org/10.1016/j.eururo.2014.08.076	PROPN
chd-221	205	8	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PART
chd-221	205	9	e12	e12	NOUN
chd-221	205	10	cancer	cancer	NOUN
chd-221	205	11	health	health	NOUN
chd-221	205	12	disparities	disparity	NOUN
chd-221	205	13	consensus	consensus	NOUN
chd-221	205	14	report	report	NOUN
chd-221	205	15	of	of	ADP
chd-221	205	16	the	the	DET
chd-221	205	17	new	new	PROPN
chd-221	205	18	york	york	PROPN
chd-221	205	19	meeting	meeting	NOUN
chd-221	205	20	of	of	ADP
chd-221	205	21	the	the	DET
chd-221	205	22	mouse	mouse	NOUN
chd-221	205	23	models	model	NOUN
chd-221	205	24	of	of	ADP
chd-221	205	25	human	human	ADJ
chd-221	205	26	cancers	cancer	NOUN
chd-221	205	27	consortium	consortium	NOUN
chd-221	205	28	prostate	prostate	NOUN
chd-221	205	29	pathologycommittee	pathologycommittee	NOUN
chd-221	205	30	in	in	ADP
chd-221	205	31	cancer	cancer	NOUN
chd-221	205	32	research	research	NOUN
chd-221	205	33	.	.	PUNCT
chd-221	206	1	https://doi.org/10.1158/0008-5472.can-12-4213	https://doi.org/10.1158/0008-5472.can-12-4213	PRON
chd-221	207	1	15	15	NUM
chd-221	207	2	.	.	PUNCT
chd-221	207	3	jackson	jackson	PROPN
chd-221	207	4	ja	ja	PROPN
chd-221	207	5	,	,	PUNCT
chd-221	207	6	laikre	laikre	PROPN
chd-221	207	7	l	l	PROPN
chd-221	207	8	,	,	PUNCT
chd-221	207	9	baker	baker	PROPN
chd-221	207	10	cs	cs	PROPN
chd-221	207	11	,	,	PUNCT
chd-221	207	12	kendall	kendall	PROPN
chd-221	207	13	kc	kc	PROPN
chd-221	207	14	(	(	PUNCT
chd-221	207	15	2012	2012	NUM
chd-221	207	16	)	)	PUNCT
chd-221	207	17	guidelines	guideline	NOUN
chd-221	207	18	for	for	ADP
chd-221	207	19	collecting	collect	VERB
chd-221	207	20	and	and	CCONJ
chd-221	207	21	maintaining	maintain	VERB
chd-221	207	22	archives	archive	NOUN
chd-221	207	23	for	for	ADP
chd-221	207	24	genetic	genetic	ADJ
chd-221	207	25	monitoring	monitoring	NOUN
chd-221	207	26	.	.	PUNCT
chd-221	208	1	conserv	conserv	NOUN
chd-221	208	2	.	.	PUNCT
chd-221	209	1	genet	genet	NOUN
chd-221	209	2	.	.	PUNCT
chd-221	210	1	resour	resour	NOUN
chd-221	210	2	.	.	PUNCT
chd-221	211	1	16	16	NUM
chd-221	211	2	.	.	PUNCT
chd-221	212	1	jain	jain	PROPN
chd-221	212	2	,	,	PUNCT
chd-221	212	3	a.	a.	PROPN
chd-221	212	4	,	,	PUNCT
chd-221	212	5	bhoyar	bhoyar	PROPN
chd-221	212	6	,	,	PUNCT
chd-221	212	7	r.	r.	PROPN
chd-221	212	8	c.	c.	PROPN
chd-221	212	9	,	,	PUNCT
chd-221	212	10	pandhare	pandhare	NOUN
chd-221	212	11	,	,	PUNCT
chd-221	212	12	k.	k.	PROPN
chd-221	212	13	,	,	PUNCT
chd-221	212	14	mishra	mishra	PROPN
chd-221	212	15	,	,	PUNCT
chd-221	212	16	a.	a.	PROPN
chd-221	212	17	,	,	PUNCT
chd-221	212	18	sharma	sharma	PROPN
chd-221	212	19	,	,	PUNCT
chd-221	212	20	d.	d.	PROPN
chd-221	212	21	,	,	PUNCT
chd-221	212	22	imran	imran	PROPN
chd-221	212	23	,	,	PUNCT
chd-221	212	24	m.	m.	NOUN
chd-221	212	25	,	,	PUNCT
chd-221	212	26	senthivel	senthivel	VERB
chd-221	212	27	,	,	PUNCT
chd-221	212	28	v.	v.	ADV
chd-221	212	29	,	,	PUNCT
chd-221	212	30	divakar	divakar	PROPN
chd-221	212	31	,	,	PUNCT
chd-221	212	32	m.	m.	NOUN
chd-221	212	33	k.	k.	PROPN
chd-221	212	34	,	,	PUNCT
chd-221	212	35	rophina	rophina	PROPN
chd-221	212	36	,	,	PUNCT
chd-221	212	37	m.	m.	NOUN
chd-221	212	38	,	,	PUNCT
chd-221	212	39	jolly	jolly	PROPN
chd-221	212	40	,	,	PUNCT
chd-221	212	41	b.	b.	PROPN
chd-221	212	42	,	,	PUNCT
chd-221	212	43	batra	batra	PROPN
chd-221	212	44	,	,	PUNCT
chd-221	212	45	a.	a.	PROPN
chd-221	212	46	,	,	PUNCT
chd-221	212	47	sharma	sharma	PROPN
chd-221	212	48	,	,	PUNCT
chd-221	212	49	s.	s.	PROPN
chd-221	212	50	,	,	PUNCT
chd-221	212	51	siwach	siwach	PROPN
chd-221	212	52	,	,	PUNCT
chd-221	212	53	s.	s.	PROPN
chd-221	212	54	,	,	PUNCT
chd-221	212	55	jadhao	jadhao	PROPN
chd-221	212	56	,	,	PUNCT
chd-221	212	57	a.	a.	NOUN
chd-221	212	58	g.	g.	PROPN
chd-221	212	59	,	,	PUNCT
chd-221	212	60	palande	palande	NOUN
chd-221	212	61	,	,	PUNCT
chd-221	212	62	n.	n.	PROPN
chd-221	212	63	v.	v.	PROPN
chd-221	212	64	,	,	PUNCT
chd-221	212	65	jha	jha	PROPN
chd-221	212	66	,	,	PUNCT
chd-221	212	67	g.	g.	PROPN
chd-221	212	68	n.	n.	PROPN
chd-221	212	69	,	,	PUNCT
chd-221	212	70	ashrafi	ashrafi	PROPN
chd-221	212	71	,	,	PUNCT
chd-221	212	72	n.	n.	PROPN
chd-221	212	73	,	,	PUNCT
chd-221	212	74	mishra	mishra	PROPN
chd-221	212	75	,	,	PUNCT
chd-221	212	76	p.	p.	PROPN
chd-221	212	77	k.	k.	PROPN
chd-221	212	78	,	,	PUNCT
chd-221	212	79	vidhya	vidhya	PROPN
chd-221	212	80	,	,	PUNCT
chd-221	212	81	a.	a.	PROPN
chd-221	212	82	k.	k.	PROPN
chd-221	212	83	,	,	PUNCT
chd-221	212	84	…	…	PUNCT
chd-221	212	85	sivasubbu	sivasubbu	PROPN
chd-221	212	86	,	,	PUNCT
chd-221	212	87	s.	s.	PROPN
chd-221	212	88	(	(	PUNCT
chd-221	212	89	2021	2021	NUM
chd-221	212	90	)	)	PUNCT
chd-221	212	91	.	.	PUNCT
chd-221	213	1	indigenomes	indigenome	NOUN
chd-221	213	2	:	:	PUNCT
chd-221	213	3	a	a	DET
chd-221	213	4	comprehensive	comprehensive	ADJ
chd-221	213	5	resource	resource	NOUN
chd-221	213	6	of	of	ADP
chd-221	213	7	genetic	genetic	ADJ
chd-221	213	8	variants	variant	NOUN
chd-221	213	9	from	from	ADP
chd-221	213	10	over	over	ADP
chd-221	213	11	1000	1000	NUM
chd-221	213	12	indian	indian	ADJ
chd-221	213	13	genomes	genome	NOUN
chd-221	213	14	.	.	PUNCT
chd-221	214	1	nucleic	nucleic	ADJ
chd-221	214	2	acids	acid	NOUN
chd-221	214	3	research	research	NOUN
chd-221	214	4	,	,	PUNCT
chd-221	214	5	49(d1	49(d1	NUM
chd-221	214	6	)	)	PUNCT
chd-221	214	7	.	.	PUNCT
chd-221	215	1	https://doi.org/10.1093/nar/gkaa923	https://doi.org/10.1093/nar/gkaa923	PROPN
chd-221	215	2	17	17	NUM
chd-221	215	3	.	.	PUNCT
chd-221	216	1	kershaw	kershaw	PROPN
chd-221	216	2	,	,	PUNCT
chd-221	216	3	t.	t.	PROPN
chd-221	216	4	s.	s.	PROPN
chd-221	216	5	,	,	PUNCT
chd-221	216	6	mood	mood	NOUN
chd-221	216	7	,	,	PUNCT
chd-221	216	8	d.	d.	PROPN
chd-221	216	9	w.	w.	PROPN
chd-221	216	10	,	,	PUNCT
chd-221	216	11	newth	newth	PROPN
chd-221	216	12	,	,	PUNCT
chd-221	216	13	g.	g.	PROPN
chd-221	216	14	,	,	PUNCT
chd-221	216	15	ronis	ronis	PROPN
chd-221	216	16	,	,	PUNCT
chd-221	216	17	d.	d.	PROPN
chd-221	216	18	l.	l.	PROPN
chd-221	216	19	,	,	PUNCT
chd-221	216	20	sanda	sanda	PROPN
chd-221	216	21	,	,	PUNCT
chd-221	216	22	m.	m.	NOUN
chd-221	216	23	g.	g.	PROPN
chd-221	216	24	,	,	PUNCT
chd-221	216	25	vaishampayan	vaishampayan	PROPN
chd-221	216	26	,	,	PUNCT
chd-221	216	27	u.	u.	PROPN
chd-221	216	28	,	,	PUNCT
chd-221	216	29	&	&	CCONJ
chd-221	216	30	northouse	northouse	PROPN
chd-221	216	31	,	,	PUNCT
chd-221	216	32	l.	l.	PROPN
chd-221	216	33	l.	l.	PROPN
chd-221	216	34	(	(	PUNCT
chd-221	216	35	2008	2008	NUM
chd-221	216	36	)	)	PUNCT
chd-221	216	37	.	.	PUNCT
chd-221	217	1	longitudinal	longitudinal	ADJ
chd-221	217	2	analysis	analysis	NOUN
chd-221	217	3	of	of	ADP
chd-221	217	4	a	a	DET
chd-221	217	5	model	model	NOUN
chd-221	217	6	to	to	PART
chd-221	217	7	predict	predict	VERB
chd-221	217	8	quality	quality	NOUN
chd-221	217	9	of	of	ADP
chd-221	217	10	life	life	NOUN
chd-221	217	11	in	in	ADP
chd-221	217	12	prostate	prostate	NOUN
chd-221	217	13	cancer	cancer	NOUN
chd-221	217	14	patients	patient	NOUN
chd-221	217	15	and	and	CCONJ
chd-221	217	16	their	their	PRON
chd-221	217	17	spouses	spouse	NOUN
chd-221	217	18	.	.	PUNCT
chd-221	218	1	annals	annal	NOUN
chd-221	218	2	of	of	ADP
chd-221	218	3	behavioral	behavioral	ADJ
chd-221	218	4	medicine	medicine	NOUN
chd-221	218	5	.	.	PUNCT
chd-221	219	1	https://doi.org/10.1007/s12160-0089058-3	https://doi.org/10.1007/s12160-0089058-3	PROPN
chd-221	219	2	18	18	NUM
chd-221	219	3	.	.	PUNCT
chd-221	219	4	kote	kote	VERB
chd-221	219	5	-	-	PUNCT
chd-221	219	6	jarai	jarai	PROPN
chd-221	219	7	,	,	PUNCT
chd-221	219	8	z.	z.	PROPN
chd-221	219	9	,	,	PUNCT
chd-221	219	10	easton	easton	PROPN
chd-221	219	11	,	,	PUNCT
chd-221	219	12	d.	d.	PROPN
chd-221	219	13	f.	f.	PROPN
chd-221	219	14	,	,	PUNCT
chd-221	219	15	stanford	stanford	PROPN
chd-221	219	16	,	,	PUNCT
chd-221	219	17	j.	j.	PROPN
chd-221	219	18	l.	l.	PROPN
chd-221	219	19	,	,	PUNCT
chd-221	219	20	ostrander	ostrander	PROPN
chd-221	219	21	,	,	PUNCT
chd-221	219	22	e.	e.	PROPN
chd-221	219	23	a.	a.	PROPN
chd-221	219	24	,	,	PUNCT
chd-221	219	25	schleutker	schleutker	NOUN
chd-221	219	26	,	,	PUNCT
chd-221	219	27	j.	j.	PROPN
chd-221	219	28	,	,	PUNCT
chd-221	219	29	ingles	ingles	PROPN
chd-221	219	30	,	,	PUNCT
chd-221	219	31	s.	s.	PROPN
chd-221	219	32	a.	a.	PROPN
chd-221	219	33	,	,	PUNCT
chd-221	219	34	schaid	schaid	PROPN
chd-221	219	35	,	,	PUNCT
chd-221	219	36	d.	d.	PROPN
chd-221	219	37	,	,	PUNCT
chd-221	219	38	thibodeau	thibodeau	PROPN
chd-221	219	39	,	,	PUNCT
chd-221	219	40	s.	s.	PROPN
chd-221	219	41	,	,	PUNCT
chd-221	219	42	dörk	dörk	PROPN
chd-221	219	43	,	,	PUNCT
chd-221	219	44	t.	t.	PROPN
chd-221	219	45	,	,	PUNCT
chd-221	219	46	neal	neal	PROPN
chd-221	219	47	,	,	PUNCT
chd-221	219	48	d.	d.	PROPN
chd-221	219	49	,	,	PUNCT
chd-221	219	50	cox	cox	PROPN
chd-221	219	51	,	,	PUNCT
chd-221	219	52	a.	a.	PROPN
chd-221	219	53	,	,	PUNCT
chd-221	219	54	maier	maier	PROPN
chd-221	219	55	,	,	PUNCT
chd-221	219	56	c.	c.	PROPN
chd-221	219	57	,	,	PUNCT
chd-221	219	58	vogel	vogel	PROPN
chd-221	219	59	,	,	PUNCT
chd-221	219	60	w.	w.	PROPN
chd-221	219	61	,	,	PUNCT
chd-221	219	62	guy	guy	NOUN
chd-221	219	63	,	,	PUNCT
chd-221	219	64	m.	m.	NOUN
chd-221	219	65	,	,	PUNCT
chd-221	219	66	muir	muir	PROPN
chd-221	219	67	,	,	PUNCT
chd-221	219	68	k.	k.	PROPN
chd-221	219	69	,	,	PUNCT
chd-221	219	70	lophatananon	lophatananon	PROPN
chd-221	219	71	,	,	PUNCT
chd-221	219	72	a.	a.	NOUN
chd-221	219	73	,	,	PUNCT
chd-221	219	74	kedda	kedda	NOUN
chd-221	219	75	,	,	PUNCT
chd-221	219	76	m.	m.	NOUN
chd-221	219	77	a.	a.	PROPN
chd-221	219	78	,	,	PUNCT
chd-221	219	79	spurdle	spurdle	PROPN
chd-221	219	80	,	,	PUNCT
chd-221	219	81	a.	a.	NOUN
chd-221	219	82	,	,	PUNCT
chd-221	219	83	steginga	steginga	NOUN
chd-221	219	84	,	,	PUNCT
chd-221	219	85	s.	s.	PROPN
chd-221	219	86	,	,	PUNCT
chd-221	219	87	…	…	PUNCT
chd-221	219	88	eeles	eele	NOUN
chd-221	219	89	,	,	PUNCT
chd-221	219	90	r.	r.	PROPN
chd-221	219	91	a.	a.	PROPN
chd-221	219	92	(	(	PUNCT
chd-221	219	93	2008	2008	NUM
chd-221	219	94	)	)	PUNCT
chd-221	219	95	.	.	PUNCT
chd-221	220	1	multiple	multiple	ADJ
chd-221	220	2	novel	novel	ADJ
chd-221	220	3	prostate	prostate	NOUN
chd-221	220	4	cancer	cancer	NOUN
chd-221	220	5	predisposition	predisposition	NOUN
chd-221	220	6	loci	locus	NOUN
chd-221	220	7	confirmed	confirm	VERB
chd-221	220	8	by	by	ADP
chd-221	220	9	an	an	DET
chd-221	220	10	international	international	ADJ
chd-221	220	11	study	study	NOUN
chd-221	220	12	:	:	PUNCT
chd-221	220	13	the	the	DET
chd-221	220	14	practical	practical	ADJ
chd-221	220	15	consortium	consortium	NOUN
chd-221	220	16	.	.	PUNCT
chd-221	221	1	cancer	cancer	NOUN
chd-221	221	2	epidemiology	epidemiology	NOUN
chd-221	221	3	biomarkers	biomarker	NOUN
chd-221	221	4	and	and	CCONJ
chd-221	221	5	prevention	prevention	NOUN
chd-221	221	6	.	.	PUNCT
chd-221	222	1	https://doi.org/10.1158/10559965.epi-08-0317	https://doi.org/10.1158/10559965.epi-08-0317	ADJ
chd-221	222	2	19	19	NUM
chd-221	222	3	.	.	PUNCT
chd-221	222	4	lele	lele	PROPN
chd-221	222	5	,	,	PUNCT
chd-221	222	6	r.	r.	PROPN
chd-221	222	7	d.	d.	PROPN
chd-221	222	8	(	(	PUNCT
chd-221	222	9	2003	2003	NUM
chd-221	222	10	)	)	PUNCT
chd-221	222	11	.	.	PUNCT
chd-221	223	1	the	the	DET
chd-221	223	2	human	human	ADJ
chd-221	223	3	genome	genome	NOUN
chd-221	223	4	project	project	NOUN
chd-221	223	5	:	:	PUNCT
chd-221	223	6	its	its	PRON
chd-221	223	7	implications	implication	NOUN
chd-221	223	8	in	in	ADP
chd-221	223	9	clinical	clinical	ADJ
chd-221	223	10	medicine	medicine	NOUN
chd-221	223	11	.	.	PUNCT
chd-221	224	1	in	in	ADP
chd-221	224	2	journal	journal	PROPN
chd-221	224	3	of	of	ADP
chd-221	224	4	association	association	NOUN
chd-221	224	5	of	of	ADP
chd-221	224	6	physicians	physician	NOUN
chd-221	224	7	of	of	ADP
chd-221	224	8	india	india	PROPN
chd-221	224	9	20	20	NUM
chd-221	224	10	.	.	PUNCT
chd-221	225	1	li	li	PROPN
chd-221	225	2	,	,	PUNCT
chd-221	225	3	k.	k.	PROPN
chd-221	225	4	,	,	PUNCT
chd-221	225	5	luo	luo	PROPN
chd-221	225	6	,	,	PUNCT
chd-221	225	7	h.	h.	PROPN
chd-221	225	8	,	,	PUNCT
chd-221	225	9	huang	huang	PROPN
chd-221	225	10	,	,	PUNCT
chd-221	225	11	l.	l.	PROPN
chd-221	225	12	,	,	PUNCT
chd-221	225	13	luo	luo	PROPN
chd-221	225	14	,	,	PUNCT
chd-221	225	15	h.	h.	PROPN
chd-221	225	16	,	,	PUNCT
chd-221	225	17	&	&	CCONJ
chd-221	225	18	zhu	zhu	PROPN
chd-221	225	19	,	,	PUNCT
chd-221	225	20	x.	x.	NOUN
chd-221	225	21	(	(	PUNCT
chd-221	225	22	2020	2020	NUM
chd-221	225	23	)	)	PUNCT
chd-221	225	24	.	.	PUNCT
chd-221	226	1	microsatellite	microsatellite	ADJ
chd-221	226	2	instability	instability	NOUN
chd-221	226	3	:	:	PUNCT
chd-221	226	4	a	a	DET
chd-221	226	5	review	review	NOUN
chd-221	226	6	of	of	ADP
chd-221	226	7	what	what	PRON
chd-221	226	8	the	the	DET
chd-221	226	9	oncologist	oncologist	NOUN
chd-221	226	10	should	should	AUX
chd-221	226	11	know	know	VERB
chd-221	226	12	.	.	PUNCT
chd-221	227	1	cancer	cancer	NOUN
chd-221	227	2	cell	cell	PROPN
chd-221	227	3	international	international	PROPN
chd-221	227	4	.	.	PUNCT
chd-221	228	1	20(1	20(1	NUM
chd-221	228	2	)	)	PUNCT
chd-221	228	3	,	,	PUNCT
chd-221	228	4	16	16	NUM
chd-221	228	5	.	.	PUNCT
chd-221	228	6	https://doi.org/10.1186/s12935-019-1091-8	https://doi.org/10.1186/s12935-019-1091-8	NOUN
chd-221	228	7	21	21	NUM
chd-221	228	8	.	.	PUNCT
chd-221	229	1	loeb	loeb	PROPN
chd-221	229	2	s	s	PROPN
chd-221	229	3	,	,	PUNCT
chd-221	229	4	catalona	catalona	PROPN
chd-221	229	5	wj	wj	PROPN
chd-221	229	6	.	.	PUNCT
chd-221	230	1	prostate	prostate	NOUN
chd-221	230	2	-	-	PUNCT
chd-221	230	3	specific	specific	ADJ
chd-221	230	4	antigen	antigen	NOUN
chd-221	230	5	in	in	ADP
chd-221	230	6	clinical	clinical	ADJ
chd-221	230	7	practice	practice	NOUN
chd-221	230	8	.	.	PUNCT
chd-221	231	1	cancer	cancer	NOUN
chd-221	231	2	lett	lett	PROPN
chd-221	231	3	.	.	PUNCT
chd-221	232	1	2007	2007	NUM
chd-221	232	2	apr	apr	NOUN
chd-221	232	3	28;249(1):30	28;249(1):30	NUM
chd-221	232	4	-	-	SYM
chd-221	232	5	9	9	NUM
chd-221	232	6	.	.	PUNCT
chd-221	232	7	doi	doi	NOUN
chd-221	232	8	:	:	PUNCT
chd-221	232	9	10.1016	10.1016	NUM
chd-221	232	10	/	/	SYM
chd-221	232	11	j.canlet.2006.12.022	j.canlet.2006.12.022	PROPN
chd-221	232	12	.	.	PUNCT
chd-221	233	1	epub	epub	PROPN
chd-221	233	2	2007	2007	NUM
chd-221	233	3	jan	jan	PROPN
chd-221	233	4	26	26	NUM
chd-221	233	5	.	.	PUNCT
chd-221	234	1	pmid	pmid	NOUN
chd-221	234	2	:	:	PUNCT
chd-221	234	3	17258389	17258389	NUM
chd-221	234	4	.	.	PUNCT
chd-221	235	1	22	22	NUM
chd-221	235	2	.	.	PUNCT
chd-221	235	3	martens	martens	PROPN
chd-221	235	4	,	,	PUNCT
chd-221	235	5	f.	f.	PROPN
chd-221	235	6	k.	k.	PROPN
chd-221	235	7	,	,	PUNCT
chd-221	235	8	kers	kers	PROPN
chd-221	235	9	,	,	PUNCT
chd-221	235	10	j.	j.	PROPN
chd-221	235	11	g.	g.	PROPN
chd-221	235	12	,	,	PUNCT
chd-221	235	13	&	&	CCONJ
chd-221	235	14	janssens	janssens	PROPN
chd-221	235	15	,	,	PUNCT
chd-221	235	16	a.	a.	PROPN
chd-221	235	17	c.	c.	PROPN
chd-221	235	18	j.	j.	PROPN
chd-221	235	19	w.	w.	PROPN
chd-221	235	20	(	(	PUNCT
chd-221	235	21	2016	2016	NUM
chd-221	235	22	)	)	PUNCT
chd-221	235	23	.	.	PUNCT
chd-221	236	1	risk	risk	NOUN
chd-221	236	2	analysis	analysis	NOUN
chd-221	236	3	of	of	ADP
chd-221	236	4	prostate	prostate	NOUN
chd-221	236	5	cancer	cancer	NOUN
chd-221	236	6	in	in	ADP
chd-221	236	7	practical	practical	ADJ
chd-221	236	8	consortium	consortium	NOUN
chd-221	236	9	letter	letter	NOUN
chd-221	236	10	.	.	PUNCT
chd-221	237	1	in	in	ADP
chd-221	237	2	cancer	cancer	NOUN
chd-221	237	3	epidemiology	epidemiology	NOUN
chd-221	237	4	biomarkers	biomarker	NOUN
chd-221	237	5	and	and	CCONJ
chd-221	237	6	prevention	prevention	NOUN
chd-221	237	7	.	.	PUNCT
chd-221	238	1	https://doi.org/10.1158/1055-9965.epi-15-0904	https://doi.org/10.1158/1055-9965.epi-15-0904	NUM
chd-221	238	2	23	23	NUM
chd-221	238	3	.	.	PUNCT
chd-221	239	1	murofushi	murofushi	PROPN
chd-221	239	2	,	,	PUNCT
chd-221	239	3	y.	y.	PROPN
chd-221	239	4	,	,	PUNCT
chd-221	239	5	nagano	nagano	PROPN
chd-221	239	6	,	,	PUNCT
chd-221	239	7	s.	s.	PROPN
chd-221	239	8	,	,	PUNCT
chd-221	239	9	kamizono	kamizono	PROPN
chd-221	239	10	,	,	PUNCT
chd-221	239	11	j.	j.	PROPN
chd-221	239	12	,	,	PUNCT
chd-221	239	13	takahashi	takahashi	PROPN
chd-221	239	14	,	,	PUNCT
chd-221	239	15	t.	t.	PROPN
chd-221	239	16	,	,	PUNCT
chd-221	239	17	fujiwara	fujiwara	PROPN
chd-221	239	18	,	,	PUNCT
chd-221	239	19	h.	h.	PROPN
chd-221	239	20	,	,	PUNCT
chd-221	239	21	komiya	komiya	PROPN
chd-221	239	22	,	,	PUNCT
chd-221	239	23	s.	s.	PROPN
chd-221	239	24	,	,	PUNCT
chd-221	239	25	...	...	PUNCT
chd-221	239	26	&	&	CCONJ
chd-221	239	27	kosai	kosai	PROPN
chd-221	239	28	,	,	PUNCT
chd-221	239	29	k.	k.	PROPN
chd-221	239	30	i.	i.	PROPN
chd-221	239	31	(	(	PUNCT
chd-221	239	32	2006	2006	NUM
chd-221	239	33	)	)	PUNCT
chd-221	239	34	.	.	PUNCT
chd-221	240	1	cell	cell	NOUN
chd-221	240	2	cyclespecific	cyclespecific	NOUN
chd-221	240	3	changes	change	NOUN
chd-221	240	4	in	in	ADP
chd-221	240	5	htert	htert	NOUN
chd-221	240	6	promoter	promoter	NOUN
chd-221	240	7	activity	activity	NOUN
chd-221	240	8	in	in	ADP
chd-221	240	9	normal	normal	ADJ
chd-221	240	10	and	and	CCONJ
chd-221	240	11	cancerous	cancerous	ADJ
chd-221	240	12	cells	cell	NOUN
chd-221	240	13	in	in	ADP
chd-221	240	14	adenoviral	adenoviral	ADJ
chd-221	240	15	gene	gene	NOUN
chd-221	240	16	therapy	therapy	NOUN
chd-221	240	17	:	:	PUNCT
chd-221	240	18	a	a	DET
chd-221	240	19	promising	promising	ADJ
chd-221	240	20	implication	implication	NOUN
chd-221	240	21	of	of	ADP
chd-221	240	22	telomerase	telomerase	NOUN
chd-221	240	23	-	-	PUNCT
chd-221	240	24	dependent	dependent	ADJ
chd-221	240	25	targeted	target	VERB
chd-221	240	26	cancer	cancer	NOUN
chd-221	240	27	gene	gene	NOUN
chd-221	240	28	therapy	therapy	NOUN
chd-221	240	29	.	.	PUNCT
chd-221	241	1	international	international	ADJ
chd-221	241	2	journal	journal	PROPN
chd-221	241	3	of	of	ADP
chd-221	241	4	oncology	oncology	NOUN
chd-221	241	5	.	.	PUNCT
chd-221	242	1	29(3	29(3	NUM
chd-221	242	2	)	)	PUNCT
chd-221	242	3	,	,	PUNCT
chd-221	242	4	681	681	NUM
chd-221	242	5	-	-	SYM
chd-221	242	6	688	688	NUM
chd-221	242	7	.	.	NUM
chd-221	243	1	24	24	NUM
chd-221	243	2	.	.	PUNCT
chd-221	244	1	namekawa	namekawa	PROPN
chd-221	244	2	,	,	PUNCT
chd-221	244	3	t.	t.	PROPN
chd-221	244	4	,	,	PUNCT
chd-221	244	5	ikeda	ikeda	PROPN
chd-221	244	6	,	,	PUNCT
chd-221	244	7	k.	k.	PROPN
chd-221	244	8	,	,	PUNCT
chd-221	244	9	horie	horie	PROPN
chd-221	244	10	-	-	PUNCT
chd-221	244	11	inoue	inoue	NOUN
chd-221	244	12	,	,	PUNCT
chd-221	244	13	k.	k.	PROPN
chd-221	244	14	,	,	PUNCT
chd-221	244	15	&	&	CCONJ
chd-221	244	16	inoue	inoue	PROPN
chd-221	244	17	,	,	PUNCT
chd-221	244	18	s.	s.	PROPN
chd-221	244	19	(	(	PUNCT
chd-221	244	20	2019	2019	NUM
chd-221	244	21	)	)	PUNCT
chd-221	244	22	.	.	PUNCT
chd-221	245	1	application	application	NOUN
chd-221	245	2	of	of	ADP
chd-221	245	3	prostate	prostate	NOUN
chd-221	245	4	cancer	cancer	NOUN
chd-221	245	5	models	model	NOUN
chd-221	245	6	for	for	ADP
chd-221	245	7	preclinical	preclinical	ADJ
chd-221	245	8	study	study	NOUN
chd-221	245	9	:	:	PUNCT
chd-221	245	10	advantages	advantage	NOUN
chd-221	245	11	and	and	CCONJ
chd-221	245	12	limitations	limitation	NOUN
chd-221	245	13	of	of	ADP
chd-221	245	14	cell	cell	NOUN
chd-221	245	15	lines	line	NOUN
chd-221	245	16	,	,	PUNCT
chd-221	245	17	patient	patient	NOUN
chd-221	245	18	-	-	PUNCT
chd-221	245	19	derived	derive	VERB
chd-221	245	20	xenografts	xenograft	NOUN
chd-221	245	21	,	,	PUNCT
chd-221	245	22	and	and	CCONJ
chd-221	245	23	three	three	NUM
chd-221	245	24	-	-	PUNCT
chd-221	245	25	dimensional	dimensional	ADJ
chd-221	245	26	culture	culture	NOUN
chd-221	245	27	of	of	ADP
chd-221	245	28	patient	patient	NOUN
chd-221	245	29	-	-	PUNCT
chd-221	245	30	derived	derive	VERB
chd-221	245	31	cells	cell	NOUN
chd-221	245	32	.	.	PUNCT
chd-221	246	1	cells	cell	NOUN
chd-221	246	2	.	.	PUNCT
chd-221	247	1	8(1	8(1	NOUN
chd-221	247	2	)	)	PUNCT
chd-221	247	3	,	,	PUNCT
chd-221	247	4	74	74	NUM
chd-221	247	5	.	.	X
chd-221	247	6	25	25	NUM
chd-221	247	7	.	.	PUNCT
chd-221	248	1	national	national	PROPN
chd-221	248	2	cancer	cancer	PROPN
chd-221	248	3	institute	institute	PROPN
chd-221	248	4	.	.	PUNCT
chd-221	249	1	(	(	PUNCT
chd-221	249	2	n.d	n.d	PROPN
chd-221	249	3	.	.	PROPN
chd-221	249	4	)	)	PUNCT
chd-221	249	5	.	.	PUNCT
chd-221	250	1	prostate	prostate	NOUN
chd-221	250	2	cancer	cancer	NOUN
chd-221	250	3	transatlantic	transatlantic	ADJ
chd-221	250	4	consortium	consortium	NOUN
chd-221	250	5	(	(	PUNCT
chd-221	250	6	captc	captc	NOUN
chd-221	250	7	)	)	PUNCT
chd-221	250	8	.	.	PUNCT
chd-221	251	1	26	26	NUM
chd-221	251	2	.	.	PUNCT
chd-221	251	3	national	national	ADJ
chd-221	251	4	centre	centre	NOUN
chd-221	251	5	for	for	ADP
chd-221	251	6	cell	cell	NOUN
chd-221	251	7	sciences	science	NOUN
chd-221	251	8	,	,	PUNCT
chd-221	251	9	pune	pune	NOUN
chd-221	251	10	:	:	PUNCT
chd-221	251	11	https://www.nccs.res.in/	https://www.nccs.res.in/	NOUN
chd-221	251	12	last	last	ADJ
chd-221	251	13	accessed	access	VERB
chd-221	251	14	:	:	PUNCT
chd-221	251	15	september	september	PROPN
chd-221	251	16	1	1	NUM
chd-221	251	17	,	,	PUNCT
chd-221	251	18	2021	2021	NUM
chd-221	251	19	.	.	PUNCT
chd-221	252	1	27	27	NUM
chd-221	252	2	.	.	PUNCT
chd-221	252	3	national	national	PROPN
chd-221	252	4	institute	institute	PROPN
chd-221	252	5	of	of	ADP
chd-221	252	6	health	health	PROPN
chd-221	252	7	(	(	PUNCT
chd-221	252	8	n.d	n.d	PROPN
chd-221	252	9	.	.	PROPN
chd-221	252	10	)	)	PUNCT
chd-221	252	11	.	.	PUNCT
chd-221	253	1	retrieved	retrieve	VERB
chd-221	253	2	from	from	ADP
chd-221	253	3	https://www.nih.gov/	https://www.nih.gov/	PROPN
chd-221	253	4	last	last	ADJ
chd-221	253	5	accessed	access	VERB
chd-221	253	6	:	:	PUNCT
chd-221	253	7	july	july	PROPN
chd-221	253	8	18	18	NUM
chd-221	253	9	,	,	PUNCT
chd-221	253	10	2021	2021	NUM
chd-221	253	11	.	.	PUNCT
chd-221	254	1	28	28	NUM
chd-221	254	2	.	.	X
chd-221	255	1	nieboer	nieboer	NOUN
chd-221	255	2	,	,	PUNCT
chd-221	255	3	d.	d.	PROPN
chd-221	255	4	,	,	PUNCT
chd-221	255	5	tomer	tomer	PROPN
chd-221	255	6	,	,	PUNCT
chd-221	255	7	a.	a.	NOUN
chd-221	255	8	,	,	PUNCT
chd-221	255	9	rizopoulos	rizopoulos	PROPN
chd-221	255	10	,	,	PUNCT
chd-221	255	11	d.	d.	PROPN
chd-221	255	12	,	,	PUNCT
chd-221	255	13	roobol	roobol	PROPN
chd-221	255	14	,	,	PUNCT
chd-221	255	15	m.	m.	NOUN
chd-221	255	16	j.	j.	PROPN
chd-221	255	17	,	,	PUNCT
chd-221	255	18	&	&	CCONJ
chd-221	255	19	steyerberg	steyerberg	PROPN
chd-221	255	20	,	,	PUNCT
chd-221	255	21	e.	e.	PROPN
chd-221	255	22	w.	w.	PROPN
chd-221	255	23	(	(	PUNCT
chd-221	255	24	2018	2018	NUM
chd-221	255	25	)	)	PUNCT
chd-221	255	26	.	.	PUNCT
chd-221	256	1	active	active	ADJ
chd-221	256	2	surveillance	surveillance	NOUN
chd-221	256	3	:	:	PUNCT
chd-221	256	4	a	a	DET
chd-221	256	5	review	review	NOUN
chd-221	256	6	of	of	ADP
chd-221	256	7	risk	risk	NOUN
chd-221	256	8	-	-	PUNCT
chd-221	256	9	based	base	VERB
chd-221	256	10	,	,	PUNCT
chd-221	256	11	dynamic	dynamic	ADJ
chd-221	256	12	monitoring	monitoring	NOUN
chd-221	256	13	.	.	PUNCT
chd-221	257	1	translational	translational	ADJ
chd-221	257	2	andrology	andrology	NOUN
chd-221	257	3	and	and	CCONJ
chd-221	257	4	urology	urology	NOUN
chd-221	257	5	.	.	PUNCT
chd-221	258	1	7(1	7(1	NUM
chd-221	258	2	)	)	PUNCT
chd-221	258	3	,	,	PUNCT
chd-221	258	4	106–115	106–115	NUM
chd-221	258	5	.	.	PUNCT
chd-221	258	6	https://doi.org/10.21037/tau.2017.12.27	https://doi.org/10.21037/tau.2017.12.27	PROPN
chd-221	258	7	29	29	NUM
chd-221	258	8	.	.	PUNCT
chd-221	259	1	nogrady	nogrady	PROPN
chd-221	259	2	,	,	PUNCT
chd-221	259	3	b.	b.	PROPN
chd-221	259	4	(	(	PUNCT
chd-221	259	5	2018	2018	NUM
chd-221	259	6	)	)	PUNCT
chd-221	259	7	.	.	PUNCT
chd-221	260	1	how	how	SCONJ
chd-221	260	2	indian	indian	ADJ
chd-221	260	3	biotech	biotech	NOUN
chd-221	260	4	is	be	AUX
chd-221	260	5	driving	drive	VERB
chd-221	260	6	innovation	innovation	NOUN
chd-221	260	7	.	.	PUNCT
chd-221	261	1	in	in	ADP
chd-221	261	2	nature	nature	NOUN
chd-221	261	3	.	.	PUNCT
chd-221	262	1	https://doi.org/10.1038/d41586-01807671-9	https://doi.org/10.1038/d41586-01807671-9	PROPN
chd-221	262	2	30	30	NUM
chd-221	262	3	.	.	PUNCT
chd-221	263	1	oladoyinbo	oladoyinbo	PROPN
chd-221	263	2	,	,	PUNCT
chd-221	263	3	c.	c.	PROPN
chd-221	263	4	a.	a.	PROPN
chd-221	263	5	,	,	PUNCT
chd-221	263	6	akinbule	akinbule	NOUN
chd-221	263	7	,	,	PUNCT
chd-221	263	8	o.	o.	PROPN
chd-221	263	9	o.	o.	PROPN
chd-221	263	10	,	,	PUNCT
chd-221	263	11	bolajoko	bolajoko	NOUN
chd-221	263	12	,	,	PUNCT
chd-221	263	13	o.	o.	PROPN
chd-221	263	14	o.	o.	PROPN
chd-221	263	15	,	,	PUNCT
chd-221	263	16	aheto	aheto	PROPN
chd-221	263	17	,	,	PUNCT
chd-221	263	18	j.	j.	PROPN
chd-221	263	19	m.	m.	PROPN
chd-221	263	20	,	,	PUNCT
chd-221	263	21	faruk	faruk	PROPN
chd-221	263	22	,	,	PUNCT
chd-221	263	23	m.	m.	NOUN
chd-221	263	24	,	,	PUNCT
chd-221	263	25	bassey	bassey	NOUN
chd-221	263	26	,	,	PUNCT
chd-221	263	27	i.	i.	PROPN
chd-221	263	28	e.	e.	PROPN
chd-221	263	29	,	,	PUNCT
chd-221	263	30	...	...	PUNCT
chd-221	263	31	&	&	CCONJ
chd-221	263	32	gali	gali	PROPN
chd-221	263	33	,	,	PUNCT
chd-221	263	34	r.	r.	PROPN
chd-221	263	35	(	(	PUNCT
chd-221	263	36	2020	2020	NUM
chd-221	263	37	)	)	PUNCT
chd-221	263	38	.	.	PUNCT
chd-221	264	1	risk	risk	NOUN
chd-221	264	2	factors	factor	NOUN
chd-221	264	3	for	for	ADP
chd-221	264	4	prostate	prostate	NOUN
chd-221	264	5	cancer	cancer	NOUN
chd-221	264	6	in	in	ADP
chd-221	264	7	west	west	ADJ
chd-221	264	8	african	african	ADJ
chd-221	264	9	men	man	NOUN
chd-221	264	10	:	:	PUNCT
chd-221	264	11	the	the	DET
chd-221	264	12	prostate	prostate	NOUN
chd-221	264	13	cancer	cancer	NOUN
chd-221	264	14	transatlantic	transatlantic	ADJ
chd-221	264	15	consortium	consortium	NOUN
chd-221	264	16	(	(	PUNCT
chd-221	264	17	captc	captc	NOUN
chd-221	264	18	)	)	PUNCT
chd-221	264	19	cohort	cohort	NOUN
chd-221	264	20	study	study	NOUN
chd-221	264	21	.	.	PUNCT
chd-221	265	1	cancer	cancer	NOUN
chd-221	265	2	health	health	NOUN
chd-221	265	3	disparities	disparity	NOUN
chd-221	265	4	.	.	PUNCT
chd-221	266	1	4	4	X
chd-221	266	2	.	.	X
chd-221	266	3	31	31	NUM
chd-221	266	4	.	.	PUNCT
chd-221	267	1	oladoyinbo	oladoyinbo	PROPN
chd-221	267	2	,	,	PUNCT
chd-221	267	3	c.	c.	PROPN
chd-221	267	4	a.	a.	PROPN
chd-221	267	5	,	,	PUNCT
chd-221	267	6	akinbule	akinbule	NOUN
chd-221	267	7	,	,	PUNCT
chd-221	267	8	o.	o.	PROPN
chd-221	267	9	o.	o.	PROPN
chd-221	267	10	,	,	PUNCT
chd-221	267	11	sobo	sobo	PROPN
chd-221	267	12	,	,	PUNCT
chd-221	267	13	a.	a.	NOUN
chd-221	267	14	a.	a.	PROPN
chd-221	267	15	,	,	PUNCT
chd-221	267	16	bolajoko	bolajoko	NOUN
chd-221	267	17	,	,	PUNCT
chd-221	267	18	o.	o.	PROPN
chd-221	267	19	o.	o.	PROPN
chd-221	267	20	,	,	PUNCT
chd-221	267	21	&	&	CCONJ
chd-221	267	22	bassey	bassey	PROPN
chd-221	267	23	,	,	PUNCT
chd-221	267	24	i.	i.	PROPN
chd-221	267	25	e.	e.	PROPN
chd-221	267	26	(	(	PUNCT
chd-221	267	27	2018	2018	NUM
chd-221	267	28	)	)	PUNCT
chd-221	267	29	.	.	PUNCT
chd-221	268	1	behavioural	behavioural	ADJ
chd-221	268	2	risk	risk	NOUN
chd-221	268	3	factors	factor	NOUN
chd-221	268	4	associated	associate	VERB
chd-221	268	5	with	with	ADP
chd-221	268	6	prostate	prostate	NOUN
chd-221	268	7	cancer	cancer	NOUN
chd-221	268	8	:	:	PUNCT
chd-221	268	9	the	the	DET
chd-221	268	10	prostate	prostate	NOUN
chd-221	268	11	cancer	cancer	NOUN
chd-221	268	12	transatlantic	transatlantic	ADJ
chd-221	268	13	consortium	consortium	NOUN
chd-221	268	14	(	(	PUNCT
chd-221	268	15	captc	captc	NOUN
chd-221	268	16	)	)	PUNCT
chd-221	268	17	cohort	cohort	NOUN
chd-221	268	18	study	study	NOUN
chd-221	268	19	.	.	PUNCT
chd-221	269	1	journal	journal	PROPN
chd-221	269	2	of	of	ADP
chd-221	269	3	global	global	ADJ
chd-221	269	4	oncology	oncology	NOUN
chd-221	269	5	.	.	PUNCT
chd-221	270	1	https://doi.org/10.1200/jgo.18.93000	https://doi.org/10.1200/jgo.18.93000	PROPN
chd-221	270	2	32	32	NUM
chd-221	270	3	.	.	PUNCT
chd-221	271	1	patel	patel	PROPN
chd-221	271	2	,	,	PUNCT
chd-221	271	3	a.	a.	PROPN
chd-221	271	4	r.	r.	PROPN
chd-221	271	5	,	,	PUNCT
chd-221	271	6	&	&	CCONJ
chd-221	271	7	klein	klein	PROPN
chd-221	271	8	,	,	PUNCT
chd-221	271	9	e.	e.	PROPN
chd-221	271	10	a.	a.	PROPN
chd-221	271	11	(	(	PUNCT
chd-221	271	12	2009	2009	NUM
chd-221	271	13	)	)	PUNCT
chd-221	271	14	.	.	PUNCT
chd-221	272	1	risk	risk	NOUN
chd-221	272	2	factors	factor	NOUN
chd-221	272	3	for	for	ADP
chd-221	272	4	prostate	prostate	NOUN
chd-221	272	5	cancer	cancer	NOUN
chd-221	272	6	.	.	PUNCT
chd-221	273	1	nature	nature	NOUN
chd-221	273	2	clinical	clinical	ADJ
chd-221	273	3	practice	practice	NOUN
chd-221	273	4	urology	urology	NOUN
chd-221	273	5	,	,	PUNCT
chd-221	273	6	6(2	6(2	NUM
chd-221	273	7	)	)	PUNCT
chd-221	273	8	,	,	PUNCT
chd-221	273	9	87–95	87–95	NUM
chd-221	273	10	.	.	PUNCT
chd-221	274	1	https://doi.org/10.1038/ncpuro1290	https://doi.org/10.1038/ncpuro1290	PROPN
chd-221	274	2	33	33	NUM
chd-221	274	3	.	.	PUNCT
chd-221	275	1	punnen	punnen	PROPN
chd-221	275	2	,	,	PUNCT
chd-221	275	3	s.	s.	PROPN
chd-221	275	4	,	,	PUNCT
chd-221	275	5	cowan	cowan	PROPN
chd-221	275	6	,	,	PUNCT
chd-221	275	7	j.	j.	PROPN
chd-221	275	8	e.	e.	PROPN
chd-221	275	9	,	,	PUNCT
chd-221	275	10	dunn	dunn	PROPN
chd-221	275	11	,	,	PUNCT
chd-221	275	12	l.	l.	PROPN
chd-221	275	13	b.	b.	PROPN
chd-221	275	14	,	,	PUNCT
chd-221	275	15	shumay	shumay	PROPN
chd-221	275	16	,	,	PUNCT
chd-221	275	17	d.	d.	PROPN
chd-221	275	18	m.	m.	PROPN
chd-221	275	19	,	,	PUNCT
chd-221	275	20	carroll	carroll	PROPN
chd-221	275	21	,	,	PUNCT
chd-221	275	22	p.	p.	PROPN
chd-221	275	23	r.	r.	PROPN
chd-221	275	24	,	,	PUNCT
chd-221	275	25	&	&	CCONJ
chd-221	275	26	cooperberg	cooperberg	PROPN
chd-221	275	27	,	,	PUNCT
chd-221	275	28	m.r	m.r	PROPN
chd-221	275	29	.	.	PROPN
chd-221	275	30	(	(	PUNCT
chd-221	275	31	2013	2013	NUM
chd-221	275	32	)	)	PUNCT
chd-221	275	33	.	.	PUNCT
chd-221	276	1	a	a	DET
chd-221	276	2	longitudinal	longitudinal	ADJ
chd-221	276	3	study	study	NOUN
chd-221	276	4	of	of	ADP
chd-221	276	5	anxiety	anxiety	NOUN
chd-221	276	6	,	,	PUNCT
chd-221	276	7	depression	depression	NOUN
chd-221	276	8	and	and	CCONJ
chd-221	276	9	distress	distress	NOUN
chd-221	276	10	as	as	ADP
chd-221	276	11	predictors	predictor	NOUN
chd-221	276	12	of	of	ADP
chd-221	276	13	sexual	sexual	ADJ
chd-221	276	14	and	and	CCONJ
chd-221	276	15	urinary	urinary	ADJ
chd-221	276	16	quality	quality	NOUN
chd-221	276	17	of	of	ADP
chd-221	276	18	life	life	NOUN
chd-221	276	19	in	in	ADP
chd-221	276	20	men	man	NOUN
chd-221	276	21	with	with	ADP
chd-221	276	22	prostate	prostate	NOUN
chd-221	276	23	cancer	cancer	NOUN
chd-221	276	24	.	.	PUNCT
chd-221	277	1	bju	bju	PROPN
chd-221	277	2	international	international	PROPN
chd-221	277	3	.	.	PUNCT
chd-221	278	1	https://doi.org/10.1111/bju.12209	https://doi.org/10.1111/bju.12209	PROPN
chd-221	278	2	34	34	NUM
chd-221	278	3	.	.	PUNCT
chd-221	279	1	retrieved	retrieve	VERB
chd-221	279	2	from	from	ADP
chd-221	279	3	https://epi.grants.cancer.gov/captc/	https://epi.grants.cancer.gov/captc/	NOUN
chd-221	279	4	last	last	ADV
chd-221	279	5	accessed	access	VERB
chd-221	279	6	:	:	PUNCT
chd-221	279	7	july	july	PROPN
chd-221	279	8	18	18	NUM
chd-221	279	9	,	,	PUNCT
chd-221	279	10	2021	2021	NUM
chd-221	279	11	.	.	PUNCT
chd-221	280	1	35	35	NUM
chd-221	280	2	.	.	PUNCT
chd-221	281	1	russell	russell	PROPN
chd-221	281	2	,	,	PUNCT
chd-221	281	3	p.	p.	PROPN
chd-221	281	4	j.	j.	PROPN
chd-221	281	5	,	,	PUNCT
chd-221	281	6	&	&	CCONJ
chd-221	281	7	kingsley	kingsley	PROPN
chd-221	281	8	,	,	PUNCT
chd-221	281	9	e.	e.	PROPN
chd-221	281	10	a.	a.	PROPN
chd-221	281	11	(	(	PUNCT
chd-221	281	12	2003	2003	NUM
chd-221	281	13	)	)	PUNCT
chd-221	281	14	.	.	PUNCT
chd-221	282	1	human	human	ADJ
chd-221	282	2	prostate	prostate	NOUN
chd-221	282	3	cancer	cancer	NOUN
chd-221	282	4	cell	cell	NOUN
chd-221	282	5	lines	line	NOUN
chd-221	282	6	.	.	PUNCT
chd-221	283	1	in	in	ADP
chd-221	283	2	methods	method	NOUN
chd-221	283	3	in	in	ADP
chd-221	283	4	molecular	molecular	ADJ
chd-221	283	5	medicine	medicine	NOUN
chd-221	283	6	.	.	PUNCT
chd-221	284	1	https://doi.org/10.1385/1-59259-372-0:21	https://doi.org/10.1385/1-59259-372-0:21	PROPN
chd-221	284	2	https://doi.org/10.1158/0008-5472.can-12-4213	https://doi.org/10.1158/0008-5472.can-12-4213	DET
chd-221	284	3	https://doi.org/10.1093/nar/gkaa923	https://doi.org/10.1093/nar/gkaa923	PROPN
chd-221	284	4	https://doi.org/10.1007/s12160-008-9058-3	https://doi.org/10.1007/s12160-008-9058-3	NUM
chd-221	284	5	https://doi.org/10.1007/s12160-008-9058-3	https://doi.org/10.1007/s12160-008-9058-3	NUM
chd-221	284	6	https://doi.org/10.1158/1055-9965.epi-08-0317	https://doi.org/10.1158/1055-9965.epi-08-0317	NUM
chd-221	284	7	https://doi.org/10.1158/1055-9965.epi-08-0317	https://doi.org/10.1158/1055-9965.epi-08-0317	NUM
chd-221	284	8	https://doi.org/10.1186/s12935-019-1091-8	https://doi.org/10.1186/s12935-019-1091-8	NUM
chd-221	284	9	https://doi.org/10.1158/1055-9965.epi-15-0904	https://doi.org/10.1158/1055-9965.epi-15-0904	PROPN
chd-221	284	10	https://doi.org/10.21037/tau.2017.12.27	https://doi.org/10.21037/tau.2017.12.27	PROPN
chd-221	284	11	https://doi.org/10.1038/d41586-018-07671-9	https://doi.org/10.1038/d41586-018-07671-9	NOUN
chd-221	284	12	https://doi.org/10.1038/d41586-018-07671-9	https://doi.org/10.1038/d41586-018-07671-9	NOUN
chd-221	284	13	https://doi.org/10.1200/jgo.18.93000	https://doi.org/10.1200/jgo.18.93000	PROPN
chd-221	284	14	https://doi.org/10.1038/ncpuro1290	https://doi.org/10.1038/ncpuro1290	PROPN
chd-221	284	15	https://doi.org/10.1111/bju.12209	https://doi.org/10.1111/bju.12209	PROPN
chd-221	284	16	https://doi.org/10.1385/1-59259-372-0:21	https://doi.org/10.1385/1-59259-372-0:21	NOUN
chd-221	284	17	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	VERB
chd-221	284	18	e13	e13	NOUN
chd-221	284	19	cancer	cancer	NOUN
chd-221	284	20	health	health	NOUN
chd-221	284	21	disparities	disparity	NOUN
chd-221	284	22	36	36	NUM
chd-221	284	23	.	.	PUNCT
chd-221	285	1	sapien	sapien	PROPN
chd-221	285	2	bio	bio	PROPN
chd-221	285	3	:	:	PUNCT
chd-221	285	4	https://sapienbio.co.in/	https://sapienbio.co.in/	PROPN
chd-221	285	5	last	last	ADV
chd-221	285	6	accessed	access	VERB
chd-221	285	7	:	:	PUNCT
chd-221	285	8	september	september	PROPN
chd-221	285	9	1	1	NUM
chd-221	285	10	,	,	PUNCT
chd-221	285	11	2021	2021	NUM
chd-221	285	12	.	.	PUNCT
chd-221	286	1	37	37	NUM
chd-221	286	2	.	.	X
chd-221	286	3	saranyutanon	saranyutanon	PROPN
chd-221	286	4	,	,	PUNCT
chd-221	286	5	s.	s.	PROPN
chd-221	286	6	,	,	PUNCT
chd-221	286	7	deshmukh	deshmukh	PROPN
chd-221	286	8	,	,	PUNCT
chd-221	286	9	s.	s.	PROPN
chd-221	286	10	k.	k.	PROPN
chd-221	286	11	,	,	PUNCT
chd-221	286	12	dasgupta	dasgupta	PROPN
chd-221	286	13	,	,	PUNCT
chd-221	286	14	s.	s.	PROPN
chd-221	286	15	,	,	PUNCT
chd-221	286	16	pai	pai	PROPN
chd-221	286	17	,	,	PUNCT
chd-221	286	18	s.	s.	PROPN
chd-221	286	19	,	,	PUNCT
chd-221	286	20	singh	singh	PROPN
chd-221	286	21	,	,	PUNCT
chd-221	286	22	s.	s.	PROPN
chd-221	286	23	,	,	PUNCT
chd-221	286	24	&	&	CCONJ
chd-221	286	25	singh	singh	PROPN
chd-221	286	26	,	,	PUNCT
chd-221	286	27	a.	a.	NOUN
chd-221	286	28	p.	p.	NOUN
chd-221	286	29	(	(	PUNCT
chd-221	286	30	2020	2020	NUM
chd-221	286	31	)	)	PUNCT
chd-221	286	32	.	.	PUNCT
chd-221	287	1	cellular	cellular	ADJ
chd-221	287	2	and	and	CCONJ
chd-221	287	3	molecular	molecular	ADJ
chd-221	287	4	progression	progression	NOUN
chd-221	287	5	of	of	ADP
chd-221	287	6	prostate	prostate	NOUN
chd-221	287	7	cancer	cancer	NOUN
chd-221	287	8	:	:	PUNCT
chd-221	287	9	models	model	NOUN
chd-221	287	10	for	for	ADP
chd-221	287	11	basic	basic	ADJ
chd-221	287	12	and	and	CCONJ
chd-221	287	13	preclinical	preclinical	ADJ
chd-221	287	14	research	research	NOUN
chd-221	287	15	.	.	PUNCT
chd-221	288	1	cancers	cancer	NOUN
chd-221	288	2	,	,	PUNCT
chd-221	288	3	12(9	12(9	NUM
chd-221	288	4	)	)	PUNCT
chd-221	288	5	,	,	PUNCT
chd-221	288	6	2651	2651	NUM
chd-221	288	7	.	.	PUNCT
chd-221	289	1	38	38	NUM
chd-221	289	2	.	.	PUNCT
chd-221	290	1	schaid	schaid	PROPN
chd-221	290	2	,	,	PUNCT
chd-221	290	3	d.	d.	PROPN
chd-221	290	4	j.	j.	PROPN
chd-221	290	5	,	,	PUNCT
chd-221	290	6	&	&	CCONJ
chd-221	290	7	chang	chang	PROPN
chd-221	290	8	,	,	PUNCT
chd-221	290	9	b.	b.	PROPN
chd-221	290	10	l.	l.	PROPN
chd-221	290	11	(	(	PUNCT
chd-221	290	12	2005	2005	NUM
chd-221	290	13	)	)	PUNCT
chd-221	290	14	.	.	PUNCT
chd-221	291	1	description	description	NOUN
chd-221	291	2	of	of	ADP
chd-221	291	3	the	the	DET
chd-221	291	4	international	international	ADJ
chd-221	291	5	consortium	consortium	NOUN
chd-221	291	6	for	for	ADP
chd-221	291	7	prostate	prostate	NOUN
chd-221	291	8	cancer	cancer	NOUN
chd-221	291	9	genetics	genetic	NOUN
chd-221	291	10	,	,	PUNCT
chd-221	291	11	and	and	CCONJ
chd-221	291	12	failure	failure	NOUN
chd-221	291	13	to	to	PART
chd-221	291	14	replicate	replicate	VERB
chd-221	291	15	linkage	linkage	NOUN
chd-221	291	16	of	of	ADP
chd-221	291	17	hereditary	hereditary	ADJ
chd-221	291	18	prostate	prostate	NOUN
chd-221	291	19	cancer	cancer	NOUN
chd-221	291	20	to	to	ADP
chd-221	291	21	20q13	20q13	NUM
chd-221	291	22	.	.	PUNCT
chd-221	291	23	prostate	prostate	NOUN
chd-221	291	24	.	.	PUNCT
chd-221	292	1	https://doi.org/10.1002/	https://doi.org/10.1002/	PROPN
chd-221	292	2	pros.20198	pros.20198	PROPN
chd-221	292	3	39	39	NUM
chd-221	292	4	.	.	PUNCT
chd-221	292	5	schröder	schröder	PROPN
chd-221	292	6	fh	fh	PROPN
chd-221	292	7	,	,	PUNCT
chd-221	292	8	roobol	roobol	NOUN
chd-221	292	9	-	-	PUNCT
chd-221	292	10	bouts	bout	NOUN
chd-221	292	11	m	m	NOUN
chd-221	292	12	,	,	PUNCT
chd-221	292	13	vis	vis	X
chd-221	292	14	an	an	X
chd-221	292	15	,	,	PUNCT
chd-221	292	16	van	van	PROPN
chd-221	292	17	der	der	PROPN
chd-221	292	18	kwast	kwast	PROPN
chd-221	292	19	t	t	PROPN
chd-221	292	20	,	,	PUNCT
chd-221	292	21	kranse	kranse	PROPN
chd-221	292	22	r.	r.	PROPN
chd-221	292	23	prostate	prostate	NOUN
chd-221	292	24	-	-	PUNCT
chd-221	292	25	specific	specific	ADJ
chd-221	292	26	antigen	antigen	NOUN
chd-221	292	27	-	-	PUNCT
chd-221	292	28	based	base	VERB
chd-221	292	29	early	early	ADJ
chd-221	292	30	detection	detection	NOUN
chd-221	292	31	of	of	ADP
chd-221	292	32	prostate	prostate	NOUN
chd-221	292	33	cancer	cancer	NOUN
chd-221	292	34	--	--	PUNCT
chd-221	292	35	validation	validation	NOUN
chd-221	292	36	of	of	ADP
chd-221	292	37	screening	screen	VERB
chd-221	292	38	without	without	ADP
chd-221	292	39	rectal	rectal	ADJ
chd-221	292	40	examination	examination	NOUN
chd-221	292	41	.	.	PUNCT
chd-221	293	1	urology	urology	NOUN
chd-221	293	2	.	.	PUNCT
chd-221	294	1	2001	2001	NUM
chd-221	294	2	jan;57(1):83	jan;57(1):83	PROPN
chd-221	294	3	-	-	PROPN
chd-221	294	4	90	90	NUM
chd-221	294	5	.	.	PUNCT
chd-221	295	1	doi	doi	NOUN
chd-221	295	2	:	:	PUNCT
chd-221	295	3	10.1016	10.1016	NUM
chd-221	295	4	/	/	SYM
chd-221	295	5	s0090	s0090	PROPN
chd-221	295	6	-	-	PUNCT
chd-221	295	7	4295(00)00863	4295(00)00863	NUM
chd-221	295	8	-	-	PUNCT
chd-221	295	9	3	3	NUM
chd-221	295	10	.	.	PUNCT
chd-221	296	1	pmid	pmid	NOUN
chd-221	296	2	:	:	PUNCT
chd-221	296	3	11164149	11164149	NUM
chd-221	296	4	.	.	PUNCT
chd-221	297	1	40	40	NUM
chd-221	297	2	.	.	PUNCT
chd-221	297	3	shukla	shukla	NOUN
chd-221	297	4	,	,	PUNCT
chd-221	297	5	n.	n.	NOUN
chd-221	297	6	,	,	PUNCT
chd-221	297	7	siva	siva	PROPN
chd-221	297	8	n	n	PROPN
chd-221	297	9	,	,	PUNCT
chd-221	297	10	sivakumar	sivakumar	PROPN
chd-221	297	11	mb	mb	PROPN
chd-221	297	12	,	,	PUNCT
chd-221	297	13	parveen	parveen	PROPN
chd-221	297	14	r	r	PROPN
chd-221	297	15	,	,	PUNCT
chd-221	297	16	mishra	mishra	PROPN
chd-221	297	17	ak	ak	PROPN
chd-221	297	18	,	,	PUNCT
chd-221	297	19	shah	shah	PROPN
chd-221	297	20	a	a	X
chd-221	297	21	,	,	PUNCT
chd-221	297	22	medicherla	medicherla	PROPN
chd-221	297	23	km	km	PROPN
chd-221	297	24	,	,	PUNCT
chd-221	297	25	&	&	CCONJ
chd-221	297	26	suravajhala	suravajhala	PROPN
chd-221	297	27	p.	p.	PROPN
chd-221	297	28	(	(	PUNCT
chd-221	297	29	2021	2021	NUM
chd-221	297	30	)	)	PUNCT
chd-221	297	31	.	.	PUNCT
chd-221	298	1	extraction	extraction	NOUN
chd-221	298	2	of	of	ADP
chd-221	298	3	dna	dna	PROPN
chd-221	298	4	and	and	CCONJ
chd-221	298	5	rna	rna	NOUN
chd-221	298	6	from	from	ADP
chd-221	298	7	formalin	formalin	NOUN
chd-221	298	8	-	-	PUNCT
chd-221	298	9	fixed	fix	VERB
chd-221	298	10	paraffin	paraffin	NOUN
chd-221	298	11	-	-	PUNCT
chd-221	298	12	embedded	embed	VERB
chd-221	298	13	tissue	tissue	NOUN
chd-221	298	14	specimens	specimen	NOUN
chd-221	298	15	.	.	PUNCT
chd-221	299	1	bio-101	bio-101	NOUN
chd-221	299	2	:	:	PUNCT
chd-221	299	3	e4095	e4095	VERB
chd-221	299	4	.	.	PUNCT
chd-221	300	1	doi	doi	NOUN
chd-221	300	2	:	:	PUNCT
chd-221	300	3	10.21769	10.21769	NUM
chd-221	300	4	/	/	SYM
chd-221	300	5	bioprotoc	bioprotoc	PROPN
chd-221	300	6	.4095	.4095	PROPN
chd-221	300	7	.	.	PUNCT
chd-221	301	1	41	41	NUM
chd-221	301	2	.	.	PUNCT
chd-221	301	3	sivasubbu	sivasubbu	PROPN
chd-221	301	4	,	,	PUNCT
chd-221	301	5	s.	s.	PROPN
chd-221	301	6	,	,	PUNCT
chd-221	301	7	&	&	CCONJ
chd-221	301	8	scaria	scaria	PROPN
chd-221	301	9	,	,	PUNCT
chd-221	301	10	v.	v.	PROPN
chd-221	301	11	(	(	PUNCT
chd-221	301	12	2019	2019	NUM
chd-221	301	13	)	)	PUNCT
chd-221	301	14	.	.	PUNCT
chd-221	302	1	genomics	genomic	NOUN
chd-221	302	2	of	of	ADP
chd-221	302	3	rare	rare	ADJ
chd-221	302	4	genetic	genetic	ADJ
chd-221	302	5	diseases	disease	NOUN
chd-221	302	6	-	-	PUNCT
chd-221	302	7	experiences	experience	NOUN
chd-221	302	8	from	from	ADP
chd-221	302	9	india	india	PROPN
chd-221	302	10	.	.	PUNCT
chd-221	303	1	human	human	ADJ
chd-221	303	2	genomics	genomics	PROPN
chd-221	303	3	.	.	PUNCT
chd-221	304	1	https://doi.org/10.1186/s40246-019-0215-5	https://doi.org/10.1186/s40246-019-0215-5	NUM
chd-221	304	2	42	42	NUM
chd-221	304	3	.	.	PUNCT
chd-221	305	1	szulkin	szulkin	PROPN
chd-221	305	2	,	,	PUNCT
chd-221	305	3	r.	r.	PROPN
chd-221	305	4	,	,	PUNCT
chd-221	305	5	whitington	whitington	NOUN
chd-221	305	6	,	,	PUNCT
chd-221	305	7	t.	t.	PROPN
chd-221	305	8	,	,	PUNCT
chd-221	305	9	eklund	eklund	PROPN
chd-221	305	10	,	,	PUNCT
chd-221	305	11	m.	m.	NOUN
chd-221	305	12	,	,	PUNCT
chd-221	305	13	aly	aly	PROPN
chd-221	305	14	,	,	PUNCT
chd-221	305	15	m.	m.	NOUN
chd-221	305	16	,	,	PUNCT
chd-221	305	17	eeles	eele	NOUN
chd-221	305	18	,	,	PUNCT
chd-221	305	19	r.	r.	PROPN
chd-221	305	20	a.	a.	PROPN
chd-221	305	21	,	,	PUNCT
chd-221	305	22	easton	easton	PROPN
chd-221	305	23	,	,	PUNCT
chd-221	305	24	d.	d.	PROPN
chd-221	305	25	,	,	PUNCT
chd-221	305	26	kote	kote	VERB
chd-221	305	27	-	-	PUNCT
chd-221	305	28	jarai	jarai	PROPN
chd-221	305	29	,	,	PUNCT
chd-221	305	30	z.	z.	PROPN
chd-221	305	31	,	,	PUNCT
chd-221	305	32	amin	amin	PROPN
chd-221	305	33	al	al	PROPN
chd-221	305	34	olama	olama	PROPN
chd-221	305	35	,	,	PUNCT
chd-221	305	36	a.	a.	NOUN
chd-221	305	37	,	,	PUNCT
chd-221	305	38	benlloch	benlloch	ADV
chd-221	305	39	,	,	PUNCT
chd-221	305	40	s.	s.	PROPN
chd-221	305	41	,	,	PUNCT
chd-221	305	42	muir	muir	PROPN
chd-221	305	43	,	,	PUNCT
chd-221	305	44	k.	k.	PROPN
chd-221	305	45	,	,	PUNCT
chd-221	305	46	giles	giles	PROPN
chd-221	305	47	,	,	PUNCT
chd-221	305	48	g.	g.	PROPN
chd-221	305	49	g.	g.	PROPN
chd-221	305	50	,	,	PUNCT
chd-221	305	51	southey	southey	PROPN
chd-221	305	52	,	,	PUNCT
chd-221	305	53	m.	m.	PROPN
chd-221	305	54	c.	c.	PROPN
chd-221	305	55	,	,	PUNCT
chd-221	305	56	fitzgerald	fitzgerald	PROPN
chd-221	305	57	,	,	PUNCT
chd-221	305	58	l.	l.	PROPN
chd-221	305	59	m.	m.	PROPN
chd-221	305	60	,	,	PUNCT
chd-221	305	61	henderson	henderson	PROPN
chd-221	305	62	,	,	PUNCT
chd-221	305	63	b.	b.	PROPN
chd-221	305	64	e.	e.	PROPN
chd-221	305	65	,	,	PUNCT
chd-221	305	66	schumacher	schumacher	PROPN
chd-221	305	67	,	,	PUNCT
chd-221	305	68	f.	f.	PROPN
chd-221	305	69	,	,	PUNCT
chd-221	305	70	haiman	haiman	PROPN
chd-221	305	71	,	,	PUNCT
chd-221	305	72	c.	c.	PROPN
chd-221	305	73	a.	a.	PROPN
chd-221	305	74	,	,	PUNCT
chd-221	305	75	schleutker	schleutker	NOUN
chd-221	305	76	,	,	PUNCT
chd-221	305	77	j.	j.	PROPN
chd-221	305	78	,	,	PUNCT
chd-221	305	79	wahlfors	wahlfor	NOUN
chd-221	305	80	,	,	PUNCT
chd-221	305	81	t.	t.	PROPN
chd-221	305	82	,	,	PUNCT
chd-221	305	83	tammela	tammela	PROPN
chd-221	305	84	,	,	PUNCT
chd-221	305	85	t.l	t.l	PROPN
chd-221	305	86	.	.	PUNCT
chd-221	305	87	j.	j.	PROPN
chd-221	305	88	,	,	PUNCT
chd-221	305	89	…	…	PUNCT
chd-221	305	90	wiklund	wiklund	NOUN
chd-221	305	91	,	,	PUNCT
chd-221	305	92	f.	f.	PROPN
chd-221	305	93	(	(	PUNCT
chd-221	305	94	2015	2015	NUM
chd-221	305	95	)	)	PUNCT
chd-221	305	96	.	.	PUNCT
chd-221	306	1	prediction	prediction	NOUN
chd-221	306	2	of	of	ADP
chd-221	306	3	individual	individual	ADJ
chd-221	306	4	genetic	genetic	ADJ
chd-221	306	5	risk	risk	NOUN
chd-221	306	6	to	to	ADP
chd-221	306	7	prostate	prostate	NOUN
chd-221	306	8	cancer	cancer	NOUN
chd-221	306	9	using	use	VERB
chd-221	306	10	a	a	DET
chd-221	306	11	polygenic	polygenic	ADJ
chd-221	306	12	score	score	NOUN
chd-221	306	13	.	.	PUNCT
chd-221	307	1	prostate	prostate	NOUN
chd-221	307	2	.	.	PUNCT
chd-221	308	1	https://doi.org/	https://doi.org/	PROPN
chd-221	308	2	10.1002	10.1002	NUM
chd-221	308	3	/	/	SYM
chd-221	308	4	pros.23037	pros.23037	PROPN
chd-221	308	5	43	43	NUM
chd-221	308	6	.	.	PUNCT
chd-221	309	1	vlachostergios	vlachostergio	NOUN
chd-221	309	2	,	,	PUNCT
chd-221	309	3	p.	p.	PROPN
chd-221	309	4	j.	j.	PROPN
chd-221	309	5	,	,	PUNCT
chd-221	309	6	puca	puca	PROPN
chd-221	309	7	,	,	PUNCT
chd-221	309	8	l.	l.	PROPN
chd-221	309	9	,	,	PUNCT
chd-221	309	10	&	&	CCONJ
chd-221	309	11	beltran	beltran	PROPN
chd-221	309	12	,	,	PUNCT
chd-221	309	13	h.	h.	PROPN
chd-221	309	14	(	(	PUNCT
chd-221	309	15	2017	2017	NUM
chd-221	309	16	)	)	PUNCT
chd-221	309	17	.	.	PUNCT
chd-221	310	1	emerging	emerge	VERB
chd-221	310	2	variants	variant	NOUN
chd-221	310	3	of	of	ADP
chd-221	310	4	castration	castration	NOUN
chd-221	310	5	-	-	PUNCT
chd-221	310	6	resistant	resistant	ADJ
chd-221	310	7	prostate	prostate	NOUN
chd-221	310	8	cancer	cancer	NOUN
chd-221	310	9	.	.	PUNCT
chd-221	311	1	current	current	ADJ
chd-221	311	2	oncology	oncology	NOUN
chd-221	311	3	reports	report	NOUN
chd-221	311	4	.	.	PUNCT
chd-221	312	1	https://doi.org/10.1007/s11912017-0593-6	https://doi.org/10.1007/s11912017-0593-6	PROPN
chd-221	312	2	https://doi.org/10.1002/pros.20198	https://doi.org/10.1002/pros.20198	ADJ
chd-221	312	3	https://doi.org/10.1002/pros.20198	https://doi.org/10.1002/pros.20198	ADJ
chd-221	312	4	https://doi.org/10.1186/s40246-019-0215-5	https://doi.org/10.1186/s40246-019-0215-5	NUM
chd-221	312	5	https://doi.org/10.1002/pros.23037	https://doi.org/10.1002/pros.23037	NOUN
chd-221	312	6	https://doi.org/10.1002/pros.23037	https://doi.org/10.1002/pros.23037	NOUN
chd-221	312	7	introduction	introduction	NOUN
chd-221	312	8	organization	organization	NOUN
chd-221	312	9	current	current	ADJ
chd-221	312	10	progress	progress	NOUN
chd-221	312	11	and	and	CCONJ
chd-221	312	12	future	future	ADJ
chd-221	312	13	activities	activity	NOUN
chd-221	312	14	indian	indian	ADJ
chd-221	312	15	context	context	NOUN
chd-221	312	16	of	of	ADP
chd-221	312	17	human	human	ADJ
chd-221	312	18	genome	genome	NOUN
chd-221	312	19	project	project	NOUN
chd-221	312	20	international	international	ADJ
chd-221	312	21	consortia	consortium	NOUN
chd-221	312	22	on	on	ADP
chd-221	312	23	pca	pca	PROPN
chd-221	312	24	capci	capci	PROPN
chd-221	312	25	organization	organization	PROPN
chd-221	312	26	,	,	PUNCT
chd-221	312	27	goals	goal	NOUN
chd-221	312	28	and	and	CCONJ
chd-221	312	29	objectives	objective	VERB
chd-221	312	30	patient	patient	ADJ
chd-221	312	31	longitudinal	longitudinal	ADJ
chd-221	312	32	follow	follow	NOUN
chd-221	312	33	-	-	PUNCT
chd-221	312	34	ups	up	NOUN
chd-221	312	35	figure	figure	NOUN
chd-221	312	36	1	1	NUM
chd-221	312	37	:	:	PUNCT
chd-221	312	38	a	a	DET
chd-221	312	39	pictorial	pictorial	ADJ
chd-221	312	40	representation	representation	NOUN
chd-221	312	41	of	of	ADP
chd-221	312	42	capci	capci	PROPN
chd-221	312	43	inception	inception	NOUN
chd-221	312	44	,	,	PUNCT
chd-221	312	45	current	current	ADJ
chd-221	312	46	developments	development	NOUN
chd-221	312	47	and	and	CCONJ
chd-221	312	48	future	future	ADJ
chd-221	312	49	goals	goal	NOUN
chd-221	312	50	overcoming	overcome	VERB
chd-221	312	51	sample	sample	NOUN
chd-221	312	52	conundrum	conundrum	NOUN
chd-221	312	53	for	for	ADP
chd-221	312	54	isolation	isolation	NOUN
chd-221	312	55	of	of	ADP
chd-221	312	56	biomolecules	biomolecule	NOUN
chd-221	312	57	for	for	ADP
chd-221	312	58	next	next	ADJ
chd-221	312	59	generation	generation	NOUN
chd-221	312	60	sequencing	sequence	VERB
chd-221	312	61	cell	cell	NOUN
chd-221	312	62	lines	line	NOUN
chd-221	312	63	in	in	ADP
chd-221	312	64	pca	pca	PROPN
chd-221	312	65	research	research	NOUN
chd-221	312	66	need	need	NOUN
chd-221	312	67	for	for	ADP
chd-221	312	68	pca	pca	PROPN
chd-221	312	69	biobank	biobank	PROPN
chd-221	312	70	road	road	NOUN
chd-221	312	71	ahead	ahead	ADV
chd-221	312	72	declarations	declaration	NOUN
chd-221	312	73	acknowledgments	acknowledgment	NOUN
chd-221	312	74	authors	author	NOUN
chd-221	312	75	’	’	PART
chd-221	312	76	contributions	contribution	NOUN
chd-221	312	77	availability	availability	NOUN
chd-221	312	78	competing	compete	VERB
chd-221	312	79	interests	interest	NOUN
chd-221	312	80	ethics	ethic	NOUN
chd-221	312	81	approval	approval	NOUN
chd-221	312	82	funding	funding	NOUN